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Abstract: 
Delirium is a syndrome which is characterised by a change in cognition, attentional 
difficulties and alterations to the sleep-wake cycle. In most cases it is caused by the 
onset of a physical illness. Delirium is more commonly found in older people aged 65 
years or older, with prevalence in hospital being as high as 42%. Delirium is associated 
with negative outcomes such as increased length of hospital admissions, 
institutionalisation and mortality. 
There are tools which can identify and measure delirium and its associated symptoms. 
The Delirium Rating Scale-Revised-98 is claimed to be a valid tool, but its use in older 
patients in general hospital has not been fully investigated and there is limited research 
to support its validity in such a population.  
A cohort study of older people with mental health problems admitted to general hospital 
was used to establish whether the DRS±R±98 was able to distinguish delirium from 
other mental health problems, to examine the association between DRS-R-98 scores, 
demographic variables and health problems and to study outcomes associated with 
delirium. 250 patients over 70 years admitted to hospital as an emergency and likely to 
have a mental health problem on the basis of screening were recruited and 249 
completed a battery of questionnaires including the DRS-R-98 at baseline. 180 days 
later 121 participants completed a follow-up questionnaire. 128 participants were lost to 
follow-up due to refusal of the outcomes questionnaire, ill-health, withdrawal, mortality 
or being un-contactable after the baseline questionnaire.  
Delirium was common in the study population (43%).The odds of having delirium 
increased with the presence of dementia (odds ratio=6.7) and functional disability 
(odds ratio=4.5). It was not significantly associated with mortality or length of stay in 
hospital. It was associated with recoverable cognitive impairment.   
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The DRS-R-98 has reasonable content, concurrent and predictive validity but compared 
with clinician diagnosis the sensitivity and specificity of the DRS-R-98 were modest 
(about 0.75). The validity of the DRS-R-98 was not as strongly supported as in other 
research, which reported sensitivity and specificity as high as 0.98 and 0.77 
respectively. This could be due to the differences in participant populations, as the 
participants of this study were all older patients with mental health problems on general 
hospital wards.  
In view of its ability to discriminate groups the DRS-R-98 is sufficiently valid for use in 
epidemiological research, but its moderate sensitivity and specificity make it unsuitable 
for use alone in clinical practice on individual patients, especially in populations where 
co-morbid dementia is prevalent.  
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1 WHAT IS DELIRIUM? 
There are different definitions of delirium and those which attempt to provide a 
consensus definition of the psychiatric diagnosis are complex.  This chapter explains 
what delirium is, its associated symptoms as well as the risk factors and precipitants. 
1.1 DEFINITION OF DELIRIUM: 
Delirium is a syndrome characterised by a sudden onset of fluctuating, generalised 
disturbance of cognitive function and consciousness. It is a neuropsychiatric response to 
physical illness or toxicity within the body (National Institute for health and Clinical 
Excellence ± NICE 2010).  
1.1.2 Definition of cognition: Cognition is the process by which knowledge is gained 
and used. It includes the ability to use language, to reason and think as well as the 
process of memory (Banyard and Grayson 2000). 
1.2 ONSET AND COURSE OF DELIRIUM: According to the DSM IV-TR (American 
Psychiatric Association - APA 2000), the features of the onset and course of delirium 
are: 
 -An onset over a short period of time (from hours to several days). 
-Fluctuation of symptom severity (over minutes to hours). 
1.2.1 Core features: According to the DSM IV-TR (APA 2000) the core features of 
delirium are: 
 -Impairment of attention and difficulty in actively processing information. 
-A change in cognition, including memory impairment, tangential thought processes and 
disorientation of time and place. 
-Disturbances to the sleep/wake cycle, including day-time drowsiness and night-time 
wakefulness. 
1.2.2 Associated features: Associated features include: 
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 -Disturbances to speech and language, including aphasia (difficulty in 
communicating verbally) and dysnomia (difficulty in retrieving words or names from 
memory) (World Health Organisation ± WHO 1992). 
 -Perceptual disturbances, including hallucination or illusions (APA 2000). 
 -Disturbances to psychomotor function, including hyperactivity, hypoactivity or a 
mixture of the two (WHO 1992). 
 -Delusions (WHO 1992). 
 -Emotional changes (NICE 2010) including emotional lability, apathy, depression 
and anxiety (Gelder et al. 2009). 
1.2.3 Subtypes: Two possible subtypes of delirium may be present during the 
syndrome, and manifest themselves in different ways, hypoactive delirium and 
hyperactive delirium (Meagher et al. 2008). Hypoactive delirium presents itself in the 
sufferer becoming apathetic, withdrawn or quiet and a decrease of voluntary 
movement. The sufferer may also become lethargic, drowsy or comatose. (Schofield 
2008).  
Hyperactive delirium presents itself in the sufferer becoming hyper-vigilant, agitated, 
restlessness and in extreme cases physically combative (Sagawa et al. 2009). 
The subtypes may indicate differing aetiology of the syndrome with different causes of 
the delirium producing different presentations (Meagher et al. 1998).  
Multiple factors may cause an episode of delirium and these should be monitored 
throughout the duration of the syndrome (Gelder et al. 2009). 
1.3. AETIOLOGY: Delirium has many causes and the syndrome has been associated 
with infections, intoxication and medications, but can also be linked to virtually any 
medical condition (Fong et al. 2009).  
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1.3.1 Precipitants and causes:  
There are several risk factors which may predispose people to delirium and precipitants 
which may cause the onset. The more risk factors, the less precipitant is needed and 
vice versa. 
Delirium is associated with infection and can be a marker for its severity (George et al 
1997). Renal and electrolyte disturbances may affect homeostasis and in due course 
have a potentially toxic effect on the brain (Korevaar et al. 2005) 
There is also an association between delirium and brain injury. Delirium may occur as a 
result of the brain injury itself or the associated medical problems (Kennedy et al. 
2003). Injury caused by stroke, bleed or infarct is a risk factor for delirium which has 
been found to develop at, or shortly after, the onset and could be a result of the 
disruption to neurotransmitter systems. (McManus et al 2009). 
Oxygen deprivation, particularly post-operative hypoxia, has been associated with 
delirium (Kazmierski et al. 2000). This is due to a decrease in oxidative metabolism and 
a decline in neurotransmitters within the brain (such as acetylcholine) thus causing 
cognitive dysfunction (Parikh and Chung 1995). 
Sufferers of advanced cancer have also been noted to be susceptible to delirium, 
particularly in those suffering from lung cancer (Lawler et al. 2000). This can be due to 
hypoxia or liver and renal failure, but has been most strongly associated with the use of 
opioid pain management (Sagawa 2009)  
Anticholinergic medications may cause side effects including cognitive dysfunction, 
which could lead to the development of delirium (Tune 2001). The development of 
delirium has also been linked to drugs such as benzodiazepines and opiates 
(Alagiakrishnan and Wiens 2004).Where multiple risk factors are present one dose of a 
hypnotic may be enough to contribute to an onset of delirium thus acting as a 
precipitant (Inouye 2006). In addition, the low level anticholinergic effects of many 
drugs are cumulative and polypharmacy is implicated. 
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The withdrawal from long-WHUPDOFRKRODQGRSLDWHXVHPD\FDXVHµDOFRKROLQGXFHG
SV\FKRVLV¶RUdelirium tremens (DT) (Eyer et al. 2001). The symptoms of delirium 
tremens, such as hallucinations and memory impairments, manifest themselves in a 
similar way to delirium and a marked tremor can occur (Gelder et al. 2009).  
Sleep deprivation has been associated with changes in mental status (Weinhouse et al. 
2009) and may cause delirium. During sleep the brain repairs defective processes and 
allows the brain to return to a state where it can process new knowledge. Therefore if 
sleep deprivation occurs it may become a risk factor for developing delirium (Sanders 
and Maze 2010). 
1.3.2. Predisposition and risk factors:  
1.3.2.1 Age: Delirium is more commonly found in older people during an acute illness 
(Korevaar 2005), with the prevalence in hospitalised older people ranging from between 
14% and 24% on admission units (Inouye 1998), from 15% to 53% after an operation 
(Agostini and Inouye 2003) and 70% to 87% in intensive care (Pisani et al. 2003). 
Incidence of a new delirium during hospital admission ranges from 3% to 29% (Siddiqi 
et al. 2006). There are a number of theories as to why this group appears to be more 
vulnerable to the syndrome. 
Older people are more likely to suffer from a greater number of physical illnesses which 
may be risk factors and increase the likelihood of developing delirium (Lindesay 2009). 
As delirium is a syndrome with more than one cause, an older person already suffering 
from a number of illnesses could have a greater number of precipitants than a younger 
person (Young and Inouye 2007). Older people may be more likely to suffer from 
cardiac or respiratory illnesses which, may lead to an onset due to a reduction of 
oxygen in the brain (Gelder 2009).  
Within this age group there is a rise in the prevalence of a pre-existing cognitive 
impairment, the presence of which increases the likelihood of developing delirium if the 
sufferer becomes physically unwell (Iseli et al. 2007). 
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1.3.2.2 Dementia: Dementia is a chronic global cognitive impairment with an insidious 
onset (The Royal College of Psychiatrists, 2005) which can be seen as a key risk factor 
for developing delirium (DSM-IV-TR). As both delirium and dementia cause cognitive 
problems, delirium may be mistaken for dementia (Trzepacz et al. 1998). The 
fundamental differentiating factors are that, unlike dementia, delirium has a sudden 
onset and symptoms fluctuate in their severity (APA 2000). Delirium may be 
superimposed on dementia, causing a worsening in cognitive function from the pre-
existing level (Fick et al. 2007). Delirium can be more difficult to identify in people 
suffering from end-stage dementia and Lewy Body dementia, both of which can result in 
a chronic delirium-like state (Trzepacz et al. 1998).  
1.4 NEGATIVE OUTCOMES: Delirium is associated with a number of potential negative 
outcomes. 
Delirium is associated with an increase in the death rate in sufferers, both during and 
shortly after discharge from hospital, with an increase of 25% to 33% within six months 
(Inouye 2000).   
Delirium may worsen dementia: The syndrome itself may be a predictor of future 
episodes of delirium and it may also be a significant marker of further cognitive and 
functional decline (Adamis et al. 2006). Delirium may be a marker of subsequent 
dementia in older people, with incidence of dementia rising from 5.6% to 18.1% in the 
three year period after the initial onset of delirium (Rockwood et al. 1999). Although the 
symptoms of delirium may be reversible, cognitive recovery may not be assured and 
the delirium may persist. It has also been reported that 6 months after the onset is 
detected, persistent delirium is still prevalent in 21% of cases,  (Cole et al. 2009) and 
twelve months after the onset, both functional and cognitive ability may be worsened 
(Young and Inouye 2007).  
There has also been shown to be an increase in institutionalisation for sufferers of 
delirium after discharge from hospital, the arrangements for which may also increase 
the length of stay in hospital (George et al. 1997). 
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However the degree to which delirium or the conditions with which it is associated are 
causally associated with negative outcomes is unclear.  
1.5 RESOURCE USE: Delirium has been associated with an increased length of stay in 
hospital and a greater need for medical services (Saravay 2004). This could be due to 
the length of time needed to treat both the physical illness and the delirium, or because 
of the behavioural problems associated with delirium, such as non-compliance with 
treatment (Milisen et al. 2004). 
 
1.6 AWARENESS: Although commonly present in hospitals, delirium is often not 
detected by healthcare professionals (Anderson 2005).  Identifying the syndrome is not 
always straightforward due to the fluctuation and heterogeneity of the symptoms 
(Siddiqi 2006).  
In order to screen for possible delirium during hospital admission, risk factors (as 
mentioned) should be taken into account, changes to behaviour and cognitive ability 
recorded and possible symptoms of delirium noted (NICE 2010). Quantitative delirium 
screening and rating tools have been designed for and implemented in diagnosis. These 
PD\EHXVHGGXULQJDSDWLHQW¶VDGPLVVLRQWRLGHQWLI\DQRQVHWRIGHOLULXPDQGFDQEH
used to monitor the effectiveness of medication during treatment (Trzepacz et al. 
2001). 
However, even in high-risk wards such as orthopaedics (on which the likelihood of 
delirium is increased) screening is rarely carried out (Holmes and House 2000). 
A history should be taken from any reliable informant (such as a relative or carer) in a 
cognitively impaired patient (Bruera et al. 2009). The lack of cognitive history may 
H[SODLQZK\GHPHQWLDDQGGHOLULXPDUHXQGHUGLDJQRVHGDV³FRQIXVHG´SDWLHQWVPD\
simply be left without a diagnosis. If available, it can allow a clinician to ascertain a 
baseline of cognitive function prior to the onset of the delirium, to identify the effect the 
delirium has had. In cases where a person with delirium has a pre-existing dementia, 
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an informant can identify the suddenness of any onset of increased cognitive 
impairment (APA 2000). 
1.7 REDUCE IMPACT: Delirium can be treated and may resolve within days or weeks 
(Cole 2009). Healthcare systems and the management of patients may increase the 
likelihood of developing delirium (Young and Inouye 2007). The management of those 
at risk of developing delirium and treatment if the syndrome occurs may reduce 
negative outcomes associated with delirium.  
The use of many drugs, especially those which may cause sedation or anticholinergic 
effects have been associated with delirium (Attard 2008). On admission a review of 
current medications and a reduction in unnecessary drugs may be advised (NICE 2010).  
While not a causal factor, environmental strategies (such as clear signposting around 
the ward and the use of clocks) and the provision of orientation aids may be used to 
reduce the manifestations of the illness, such as agitation (Burns et al. 2004).As sleep 
deprivation has also been linked to the development of delirium noise reduction and 
ensuring a dark environment at night time may also help to prevent onset (Weinhouse 
2009). 
Patients with delirium may become more agitated in hospital if they suffer from sensory 
impairments such as visual or hearing difficulties (Anderson 2005). These may 
exacerbate the confusion they experience and increase the likelihood of developing 
delirium. Despite the lack of thorough research, it appears that simple interventions 
such as the provision of a patient¶s hearing aid and glasses may reduce the severity and 
duration of the episode of delirium (Mahony et al. 2011). 
The presence of family and friends may help to re-orientate those suffering from 
delirium (Meagher et al. 1996). They may be able to provide the sufferer with 
reassurance (Anderson 2004) as well identify any change in WKHVXIIHUHU¶VFRJQLWLYH
status (Bruera et al. 2009). 
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Addressing constipation and dehydration may help to reduce the impact of delirium 
(Mahony et al. 2011). The avoidance of falls, pressure sores and over-sedation in the 
sufferer may also reduce the impact and aid the resolution of the symptoms (Ross and 
Alexander 2001).  
1.8 TREATMENT: Prompt treatment of the underlying illness or infection is critical in 
managing delirium (APA 2000). Symptoms of delirium may also be treated using 
antipsychotics such as haloperidol (Attard et al. 2008). Improvement in cognitive ability 
may occur within 24 hours after a low dose (Ross and Alexander 2001). However, such 
treatment has been associated with over-sedation and side effects such as hypotension 
and premature death in those suffering from dementia (Seitz et al. 2007). 
It must be noted that, in order to treat delirium it must first be identified. Diagnostic 
criteria and screening tools are available to aid in this task and allow accurate diagnoses 
to be carried out.  
From this overview it can be seen what delirium is, its associated symptoms, the risk 
factors and precipitants which may lead to an onset and the impact it can have on 
sufferers and resources. An aim of this thesis was to identify a valid tool to diagnose 
delirium and distinguishing it from other mental health problems. The first stage was to 
look at different tools available and how they identify delirium. From this the validity of 
the most appropriate tool could be analysed and by using it to detect delirium in a 
cohort of older people with mental health problems identify the factors and outcomes 
associated with having delirium. 
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2 DIAGNOSING AND RATING DELIRIUM: 
 
2.1 INTRODUCTION: Delirium is associated with negative outcome and the 
phenomena may be distressing to family and other carers, meaning that the syndrome 
requires explanation and treatment. One of the key issues surrounding this issue 
appears to be early recognition of the syndrome (NICE 2010). Delirium is common in 
older patients on general hospital wards, but it is not always detected by healthcare 
professionals meaning that the prevalence may be under-estimated and in some cases 
treatment may not be given. Alternatively symptoms may be misinterpreted as a 
permanent cognitive impairment (Schofield 2008) leading to inappropriate decision 
making in terms of treatment. The use of delirium diagnostic tools on general hospital 
wards could increase identification of the syndrome which could potentially lead to 
treatment and a decrease in the associated negative outcomes (Lindesay 2009).  
Whilst there are a great many tools available, only those which may be used specifically 
in the diagnosis and rating of delirium and for which there is an established evidence 
base have been examined.  
2.2 DIAGNOSTIC CRITERIA: 
Both the ICD-10 and DSM-IV-TR provide diagnostic criteria from which delirium can be 
identified. However, while the ICD-10 provides a coding system for all diseases the 
DSM-IV-TR was designed to be used by psychiatrists and is specific to the diagnosis of 
mental disorders (Andrews et al. 1999). Both definitions are given in this chapter as 
both may be used by health care professionals.  
2.2.1 International Classification of Disease (ICD-10): Designed to be used by 
medical doctors and psychiatrists, the ICD-10 provides diagnostic criteria for clinical and 
research use (WHO 1992).  
The ICD-10 states that for a diagnosis of delirium to be made there should be 
symptoms presenting of each of six core areas: clouding of consciousness; change in 
cognitive abilities (including memory problems and disorientation); psycho-motor 
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problems; disturbance to sleep/wake cycle; underlying physical illness and acute onset 
with fluctuations in symptom severity  (see figure 1). The ICD-10 also highlights the 
QHHGWRJDLQDKLVWRU\RIWKHSDWLHQW¶VSUH-syndrome cognitive ability before a formal 
diagnosis and provides criteria for not only delirium but also delirium complicating 
dementia (WHO 1992). 
It has been argued that the criteria are restrictive DQGWKHWRRO¶VVHQVLWLYLW\SRRU 
(Lindesay 2009). This could lead to fewer diagnoses of delirium being made due to the 
incorrect identification of sufferers of delirium as not having the syndrome. 
2.2.2 Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR): The 
most recent revision of this diagnostic manual lists inclusion/exclusion criteria for 
delirium based on clinical findings associated with the syndrome (APA 2000) (see figure 
1). The DSM-IV-TR also emphasises the importance of gaining an accurate history of 
WKHSDWLHQW¶VSULRUFRJQLWLYHDELOLW\VRWKDWDPLVGLDJQRVLVRIGHmentia may not be 
made. In addition the guidelines stress language difficulties (such as aphasia) that a 
sufferer of delirium may experience, which may present when the DSM-IV-TR user 
interviews the patient (APA 2000).  It is often considered to be the gold-standard when 
identifying delirium (Radtke 2008).  
The DSM-IV-TR provides guidelines to diagnosing delirium but is written by and for 
qualified doctors who have received training in the diagnosis of a number of cognitive 
impairments and mental health problems (DeJonge et al. 2005).  
2.3 MEASURING COGNITIVE CHANGES AND IMPAIRMENT: Mini Mental State 
Examination: (Folstein et al. 1975): This tool was primarily designed to be a screening 
tool for cognitive impairment but can be used to indicate a change in cognitive function, 
and identify the onset of an impairment associated with delirium. Whilst not diagnostic 
in its own right, it can be used to alert clinicians to the presence of cognitive 
dysfunction (Lindesay 2009) by drawing attention to symptoms associated with delirium 
such as disorientation, attentional disturbances, language difficulties and memory 
SUREOHPV,WDOORZVDµVQDSVKRW¶RIWKHSDWLHQW¶VFRJQLWLYe function and can identify 
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changes during an episode of delirium (Breibart et al. 1997). Its questions, either in its 
entirety, or the few directly related to orientation, attention and memory have been 
taken and used to form conclusions about deficits to these abilities in other tools. 
2.4 SCALES:  The criteria reported in the ICD-10 and DSM-IV-TR provide a diagnostic 
framework for healthcare professionals and the basic structure of other, more easy to 
use screening and rating tools.  
2.5 SCREENING SCALES: Tools which are designed to identify persons who do have 
an illness or syndrome from those who do not (Wilson and Jungner 1968).  
2.5.1 Confusion Assessment Method (CAM): This tool was created to aid the 
diagnosis of delirium. It involves the measurement of the fluctuation and severity of 9 
features of delirium: acute onset; inattention; disorganised thinking; altered level of 
consciousness; disorientation (to time, place and person); memory impairment; 
perceptual disturbances; psychomotor agitation or retardation; and altered sleep-wake 
cycle (Inouye et al. 2003). An algorithm based on the core features of delirium as 
reported by the DSM-III is then used, and, if potential sufferers are found to have an 
acute onset with a fluctuating course, inattention and either altered level of 
consciousness or disorganised thinking then a diagnosis of delirium is suggested 
(Inouye et al. 2000). 
CAM has good sensitivity (values between 77% and 100%) (Hestermann et al. 2009) 
(Vreeswijk et al. 2009) and specificity (between 84% and 99%) (Laurila et al. 2002) 
(Gonzalez et al. 2004). It also has high positive predictive values (between 94% and 
100%) and negative predictive values (of between 97% and 100%) when used in an 
emergency department setting (Monette et al. 2001).This indicates that CAM is a valid 
tool which can be used to detect the presence or absence of delirium. CAM has also 
been shown to be an accurate tool when used in intensive care units (Meagher 2001). 
However, when nurses use CAM the levels of sensitivity and specificity are affected, and 
decrease to 67% and 91% respectively (Lemiengre 2006).  This suggests that prior 
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training and the ability to identify the underlying features of delirium are needed in 
order to use this tool to identify the presence of the syndrome (Reade et al. 2011).  
2.5.2 CAM-ICU: This tool differs from CAM in that it measure symptoms of delirium in 
severely unwell patients using the following two steps: the first being to rate the level 
of consciousness from a score of +4, representing severe motor agitation to the extent 
where the patient becomes combative, to -5 where the patient is unrousable (Ely et al.  
2001a). Step two involves noting the presence of 4 delirium features: presence of an 
acute change or fluctuation of symptoms; presence of attentional difficulties; a change 
in the level of the pDWLHQW¶VFRQVFLRXVQHVV; and the patient demonstrating disorganised 
thinking. CAM has been found to have a sensitivity of 95 -100% and specificity of 89 ± 
93% (Ely et al. 2001b).  
It is also important to note diurnal variations, differences in sleep-wake cycles and 
emotional disturbance are not measured by CAM-ICU and that factors such as sedation 
and intubation (which are common on an ICU) may complicate the diagnosis when 
using this tool (Hewson-Conroy et al. 2011). 
2.5.3 NEECHAM Confusion Scale: The NEECHAM Confusion Scale (NEECHAM) is a 
nursing screening tool which was designed to detect delirium quickly in acutely unwell 
hospital patients, but has also been used in intensive care units (Vreeswijk et al. 2009). 
It measures and rates the symptoms and physical indicators for delirium. It measures 
symptoms at three levels: level 1 measures information processing (attention, following 
commandVDQGRULHQWDWLRQ/HYHOPHDVXUHVEHKDYLRXUDOV\PSWRPVWKHSHUVRQ¶V
appearance, motor function and language difficulties). Level 3 consists of physiological 
measures (abnormal temperature, systolic blood pressure, diastolic blood pressure, 
heart rate, respiration rate and oxygen saturation) (Neelon et al. 1996). 
The NEECHAM scale has a sensitivity of between 86 and 95% and specificity of 78 -87% 
in patients on both medical and surgical wards (Neelon et al. 1996) (Van Gemert and 
Schuurmans 2007).  
23 
 
2.5.4 Delirium Observation Screening scale (DOS): The DOS is a 25 item scale 
designed to aid nursing staff in the recognition of delirium whilst delivering care 
(Schuurmans et al. 2001). After clinical studies the 25 items were reduced to 13: 
orientation (to time and place); consciousness; ability to maintain attention (both in 
actions, speech and distractibility); language; memory; motor behaviour (hyper and 
hypo activity); hallucinations; emotional lability (Scheffer et al. 2011). When used by 
nursing staff the DOS has been found to have a sensitivity of 89% and 94% and 
specificity of 76% and 88% (Van Gemert and Schuurmans 2007)(Schuurmans et al. 
2003).  
2.5.5 Cognitive Test for Delirium (CTD): The CTD is a screening tool designed to 
identify delirium in an intensive care settings in patients who cannot speak (Trzepacz et 
al. 2001). Non-verbal methods of communication are used to test for the items of: 
concentration; consciousness; memory; orientation; understanding and reasoning. 
(Hart et al. 1996).The CTD has been found to have sensitivity of 72% and 100% and 
specificity of 71% and 99% (Hart et al. 1996) (Kennedy et al. 2003). 
2.5.6 Nursing Delirium Screening Scale (NuDESC): The NuDESC is a 5 item 
screening scale designed to be used by nursing staff throughout a working shift and 
rates the presence of ten symptoms: hallucinations (both auditory and visual); 
language difficulties; behavioural problems; motor retardation; and disorientation 
(Gaudreau 2005). It has been reported as having a sensitivity of 85% - 95% and 
specificity of 86% -87% (Gaudreau 2005) (Radtke 2008). 
 
2.6 SEVERITY SCALES: These are tools which have two uses. With a cut-off point they 
distinguish the presence or absence of an illness while at the same time quantitatively 
measuring the severity of the symptoms present.  
 
 2.6.1 Delirium Index (DI): The DI was designed to rate the presence and the 
severity of delirium symptoms in elderly patients, and scores are based solely on the 
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UHVHDUFKHU¶VRUFOLQLFLDQ¶VREVHUYDWLRQRIWKHSDWLHQW(Schuurmans et al. 2003). The 
index is designed to be used alongside the MMSE, using at least the first five questions 
as the basis of observed symptoms. It also measures seven of the ten symptoms 
assessed by CAM: disorganised thinking; inattention; altered state of consciousness; 
memory impairment; disorientation; perceptual disturbances; psychomotor agitation 
and psychomotor retardation (McCusker et al. 2004). Unlike the CAM, the DI allocates 
scores from 0 (meaning the symptom is not present) to 3 (meaning the symptom is 
present and at its severest) and provides DQRYHUDOOVFRUHWRµUDWH¶WKHGHOLULXP 
When used alongside the Informant Questionnaire of Cognitive Decline in the Elderly 
(IQCODE) it distinguishes between symptoms caused by delirium and those caused by 
dementia. This may increase the specificity of the tool and also allows the identification 
of delirium superimposed on dementia, as levels of pre-existing cognitive impairment 
will be known and a sudden onset of worsening dysfunction can be identified (Jorm 
2004).  
However, due to the differences in scoring between CAM and the CAM questions posed 
by the DI (in that a rating system is in place), the resulting conclusions made by the DI 
may exaggerate the number of symptoms and lower the specificity of the scale (Cole et 
al. 2002).   
 
2.6.2 Memorial Delirium Assessment Scale (MDAS): The MDAS was designed to 
provide clinicians with an aid to diagnose and rate the symptoms of delirium and to 
measure the changes in those presented during medical intervention (Lawlor et al. 
2000)7KH0'$6LVEDVHGRQWKH'60,9¶VFULWHULDIRUGHOLULXPDVZHOODVV\PSWRPV
noted previously in the DSM IIIR. The MDAS is a ten item scale measuring: reduced 
consciousness; disorientation; short-term memory impairment; ability to repeat digits; 
disorganized thinking; reduced ability to maintain and shift attention; hallucinations or 
illusions (information also provided by informants); delusions; abnormal motor 
behaviours and altered sleep-wake cycle.  
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Analysis of this tool has revealed that it has high levels of specificity (between 75 and 
100% though only modest levels of sensitivity (between 65 and 96%) (Breitbart et al. 
1997) (Lawlor et al. 2000). 
 
2.6.3 Delirium-O-Meter (DOM): The DOM is a 12 item tool designed for nursing staff 
to quickly rate behaviours associated with delirium (Vreeswijk et al. 2009). Based on 
the DSM-IV, the content of the scale is similar to the DOS, NEECHAM, DRS and CAM 
and rates the symptoms of delusion, hallucinations, difficulty sustaining or shifting 
attention, hypoactivity, hyperactivity, fluctuation of functional ability, consciousness, 
language difficulties, disorientation as well as anxiety and apathy levels  (de Jonghe et 
al. 2005). Although little evidence is available, DOM has a reported specificity of 
between 66.7% and 83% and is sensitive to change (de Jonge et al. 2005).  
 
2.6.4 Delirium Rating Scale (DRS): Based on the DSM III, the DRS is a 10 item 
scale designed for clinicians to detect and rate symptoms of severity after patient 
interview (Trzepacz et al. 1988). These items are: hallucinations; delusions; cognitive 
status; psychomotor behaviours; lability of mood; fluctuation of symptom severity; 
disturbance to the sleep/wake cycle and presence of an underlying physical disorder 
(Trzepacz et al. 1988). The reported sensitivity of the scale is between 94% and 98% 
and specificity between 62% and 94% (Trzepacz 1999) (Rosen et al. 1994) (Grassi et 
al. 2001). It is designed to evaluate the prevalence and severity of delirious symptoms 
E\PHDVXULQJFULWHULDIRUWHPSRUDORQVHWDQGYDULDELOLW\FRPSDUHGWRWKHSDWLHQWV¶XVXDO
presentation. It does this by investigating not only the presentation available to the 
clinician or researcher at the time of the interview but also by ascertaining data from 
the patient¶s history (Bosisio et al. 2006). The DRS is able to distinguish between 
delirium and other disorders by asking questions specific to the syndrome, such as 
those around physical illness (Trzepacz 2001); however, it has been shown to have 
limited validity in differentiating between delirium and other organic mental illnesses 
(Trzepacz 1999). Despite this, the sensitivity of the DRs-R-98 allows clinicians to 
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measure the effectiveness of treatments based on changes in symptom severity 
(Meagher et al. 2008). 
 
2.6.5 Delirium Rating Scale ± Revised ± 98: In 1998 a revised version of the DRS 
was produced by the original author. As well as the items included in the DRS, the DRS-
R-98 also includes items which allow the scale to be repeated throughout the SDWLHQW¶V
hospital admission so it can be used to detect the onset of delirium and measure its 
progression throughout treatment (Trzepacz et al. 2000). As in the original version, it 
measures the onset and fluctuation of symptoms and uses information from interviews 
with both the patient and an informant. The revised version is a 16 item scale split into 
two sections; 3 diagnostic  items to be recorded on initial rating and 13 items which 
may be repeated to measure effectiveness of treatment (Wong et al. 2010). In the 
revised version of the DRS the item measuring cognitive difficulties is split into five 
separate factors of; orientation, language, visuospatial ability and short and long term 
memory problems (see appendix 1). The original DRS item measuring psychomotor 
behaviour is split into two thus measuring and distinguishing between motor retardation 
and motor agitation (Trzepacz et al. 2001).  
2.7 REVIEW: Using the diagnostic features identified in the two diagnostic manuals, 
the ICD-10 and DSM-IV-TR, Figure 1 details the comparison of the items measured in 
each tool. 
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                               Figure 1: Items measured by screening and rating scales of delirium 
Symptoms ICD - 10 DSM-IV-TR CAM CAM -ICU NEECHAM DOS CTD NuDESC DI MDAS Delirium-O-Meter DRS DRS-R-98 
Change in cognition X X
1 
X X
2 
 X X
5 
 X X  X X 
Symptom fluctuation X X X X    
6 
  X X X 
Sudden onset X X X X        X X 
Physical illness X X   X       X X 
Impairment of attention X X X X X X   X X X  X 
Consciousness X X X X  X X  X X X  X 
Disorientation X X X
 
 X X X X
 
X X X  X 
Memory impairment X X X   X X  X X
7 
  X 
Disturbance to sleep/wake cycle X X X X     X X  X X 
Disturbance to psychomotor function X X X X X X  X X X X X X 
Distinguishes hypo from hyperactivity X  X X  X  X X  X  X 
Language disturbances  X   X X  X   X  X 
Mood/Emotions X X    X     X X X 
Delusions  X        X X X X 
Hallucinations X X X   X  X X X X X X 
Other     X
3,4 
        
1 
includes changes to visuo-spatial ability.  
2 ĚĞƐĐƌŝďĞĚĂƐ ‘ĚŝƐŽƌŐĂŶŝƐĞĚƚŚŝŶŬŝŶŐ 
3ƉĞƌƐŽŶ ?ƐĂƉƉĞĂƌĂŶĐĞ 
4 
physiological measures of temperature, blood pressure, heart rate, respiration rate and oxygen saturation 
5 
includes understanding and reasoning 
6 
whilst there is no specific item to measure the fluctuation of symptom severity, measures are taken over three 12- hour periods which may highlight this 
7
pecifies short-term memory impairment and ability to repeat digits 
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The DRS-R-98 was chosen as the measure of delirium in this research. The reasons for 
this choice were: Evidence indicates that it is compatible with other scales and easy to 
use (Adamis et al. 2010). While there is research supporting the validity of the CAM in 
diagnosing delirium (Ely et al. 2001a) it requires that the user must have specialist 
training and be able to identify the underlying features of delirium before adequate 
levels of sensitivity and specificity of diagnosis are achieved (Lemiengre 2006). DRS-R-
98 does not appear to loose sensitivity when used by someone other than a 
psychiatrist, meaning that it could be utilised by a more multi-disciplinary staff 
(Trezpacz 1999). 
As the DRS-R-98 was to be used in general hospital wards the use of the CAM-ICU or 
CTD, both of which were designed to be used in ICU settings, was not considered. The 
NEECHAM, NuDESC, DOM DOS and DI reported modest levels of specificity, meaning 
that there is a possibility that the prevalence of delirium may be exaggerated.  
The DRS-R-98 also appears to have an acceptable scope of symptom coverage, being 
composed of items which include all the symptoms noted by both the DSM-IV-TR and 
ICD-10 (Trzepacz et al. 2001) and has a degree of flexibility with ratings being based 
on examination, patient interview, SDWLHQW¶VKLVWRU\DQGUHSRUWVIURPnursing staff and 
family (Fonseca et al. 2005). 
 However, there may be problems with the ability of the DRS-R-98 to distinguish 
delirium from other mental health problems, most notably dementia. Though the 
scale¶s author reports that the DRS-R-98 is able to distinguish delirium from dementia, 
schizophrenia and depression (Trzepacz et al. 2001), there is evidence that the 
sensitivity and specificity are compromised when used to identify the presence of 
delirium in participants suffering from dementia (Andrew et al. 2009).  
Therefore, before analysing the results and associations of DRS-R-98 scores within the 
cohort study, the validity of the tool was first examined. In order to do this the 
different aspects of validity were first defined.  
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3 VALIDITY AND HOW IT IS MEASURED 
 
3.1 DEFINITION: Validity refers to the extent to which a test or measure actually 
measures what it is intend to (Banyard and Grayson 2000). It is only when a test is 
seen to be valid that inferences can be made about the data it is designed to collect, 
for example the characteristics of a person or group that the test was designed to 
measure (Bowling 2009). 
There are different aspects of validity which may be examined, however the three key 
types are content validity, criterion validity and construct validity.  
3.2 CONTENT VALIDITY:  The content validity of a test refers to the extent to which 
its content is representative of the desired concept and the particular body of 
knowledge from which the test derives. This means that even if broader questions 
regarding the same topic were added to the scale, the new scale and the original scale 
should still allow the user to come to the same conclusions (Walsh and Betz 2000). 
Therefore if a scale has good content validity accurate inferences can be made, as it 
reflects the all aspects of the overall topic. It describes whether any important items 
are missing.  
&RQWHQWYDOLGLW\LVQRWWHVWHGWKURXJKWKHDQDO\VLVRIWKHWHVW¶VVFRUHVEXW from critical 
reviews or empirical qualitative data from those who know about the field and can 
make judgements on whether the test appears to cover key aspects of the field 
(Bowling 2009) (in this case, whether the DRS-R-98 includes the measurements of key 
symptoms commonly associated with delirium). Due to this, content validation may be 
subjective to those who are critiquing it. However, as content validity can be 
demonstrated with thorough research into the field, thoughtful planning and with pre-
testing, it could be argued that such a process can show how representative a scale is 
to the concept it purports to measure and as well as being important during scale 
development.  
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3.2.1 Face validity: This is related to, and overlaps with, content validity. Face 
validity can also be used to assess how the test is relevant when measuring a trait or 
symptoms, and whether it contains the items that one would expect (Steiner and 
Norman 2008). This measure of validity is not robust, as it is based on the assessments 
of the investigators themselves and may be subject to bias; however it can allow 
potential users to assess the usability of the scale. 
3.3 CRITERION VALIDITY: This is the extent to which the scale is associated with, or 
relates to, another test, which measures the same phenomenon (for example the same 
set of symptoms). The test against which the scale is measured is ideally one that is 
LQGHSHQGHQWRIWKHVFDOHDQGLVDFFHSWHGDVDµJROGVWDQGDUG¶LQWKHILHOG (McDowell and 
Newell 1996)7KHµJROGVWDQGDUG¶LVFDOOHGWKHFULWHULRQ and should be seen as a true 
indicator of the topic (in this case, diagnosis).  
Criterion validity is usually split up into two distinct types: 
3.3.1 Concurrent validity: Concurrent validity is established when the scale and the 
criterion are conducted at the same time, and the different scores are assessed to see 
how much they correlate (Bowling 2009).  
 
3.3.2 Predictive validity: Predictive validity is established when the scale is used to 
predict future outcomes. These are often categorical, for example whether participants 
died or survived and are measured some time after the scale (measuring the original 
trait) is used.  
For both measures of criterion validity, if both the scale and the criterion are 
continuous, the Pearson correlation coefficient may be used to clearly demonstrate a 
VWURQJDVVRFLDWLRQEHWZHHQWKHµJROGVWDQGDUG¶FULWHULRQDQGWKHWHVWHGVFDOH,IWKLVLV
the case then the concurrent and predictive validity may be supported and the new 
scale may be said to be measuring similar traits (or symptoms) to that oIWKHµJROG
VWDQGDUG¶ (Bowling 2009).  
31 
 
3.4 CONSTRUCT VALIDITY: This is used to measure attributes for which there is no 
one specific measure and no one criterion on which to assess validity. Construct validity 
can be used to show whether a theory (or construct) is being supported and that the 
test being used reflects this (Banyard and Grayson 2000).  
In order to analyse this, the theory must be clearly defined. Construct validity can help 
to show whether the scale behaves in a way that one might expect. This can be 
VXSSRUWHGE\WHVWLQJWKHLQWHUQDOFRQVLVWHQF\RIWKHVFDOHXVLQJ&URQEDFK¶VDOSKDRU
factor analysis. Construct validity may also be assessed by measuring the convergent 
and discriminate validity.  
3.4.1 Convergent validity: This may be assessed by analysing how closely the tested 
scale correlates to measures of other things that are likely to be related to the scale. 
While the correlation between the tested and similar scales should be higher, in order 
to demonstrate construct validity, they should not be too high (as this indicates that 
they measure the same thing) (Walsh and Betz 2000).  
3.4.2 Discriminant validity: This may be assessed by analysing whether the scale 
does not correlate with scales or variables of a different construct. A strong correlation 
between two scales reporting to measure different, independent topics should not be 
found. If it is, this could mean that the scale is measuring something unexpected, or 
that the test items should be reviewed (McDowell and Newell 1996). 
3.5 ASSESSMENT OF VALIDITY - Test performance: Sensitivity and specificity may 
also be used to test validity of a scale or test. These are often used to test the validity 
of GLDJQRVWLFWRROVDJDLQVWDµJROGVWDQGDUG¶ (Bowling 2009).   
3.5.1 Sensitivity: This refers to the ability of a test to detect when a condition (for 
example delirium) is present. Calculated as a percentage, it helps to identify the 
number of participants with the condition for whom the scale reports they do not (the 
false negative or 1-senstivity) (Bowling 2009). 
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3.5.2 Positive Predictive Values:  In testing for specificity a positive predictive value 
may be calculated to measure how many of the participants scoring positivity on a test 
for a condition were correctly diagnosed (Kirkwood and Sterne 2003).  
 
3.5.3 Specificity:  Specificity refers to the ability of a test to detect when a condition 
is not present.  
3.5.4 Negative Predictive Values: In testing for specificity, negative predictive 
values can be used to indicate how many participants with a negative test result are 
correctly diagnosed as not having the condition (McDowell and Newell 1996).  
3.5.5 Sensitivity to change: Also known as responsiveness, sensitivity to change 
refers to the ability of a scale to detect any changes which may occur over time in an 
individual or sample (Bowling 2009).  
3.5.6 Receiver Operating Characteristic (ROC) curves: ROC curves may be used 
to investigate the ability of a test to discriminate who does from who does not have a 
condition. A ROC curve can be used to represent graphically all the potential cut-off 
scores for a continuous scale by plotting the true-positive probability (sensitivity) 
against the false-positive probability (1-specificity). The scale performance can be 
qualified using the area under the curve (Steiner and Norman 2008).  
3.6 LIKELIHOOD RATIOS: Likelihood ratios may also be used to allow us to see the 
comparisons of the probability of a participant screening positively for a condition (and 
actually having) against the probability of someone who does not have the condition 
(McDowell and Newell 1996). It is a measure of the information value added by a test 
result.  
There are two equations for the likelihood ratio. The likelihood of a positive test result 
(LR+) is calculated as such:  
    LR+ =sensitivity 
                  1-specificity 
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The likelihood of a negative test result (LR-) is calculated as: 
    LR - =1-sensitivity 
     specificity 
           
3.7 RELIABILITY: Reliability (or repeatability) refers to how consistent a test is when 
measures are taken. This means that if different raters use the scale at different times 
under different circumstances the results will remain consistent and may be replicated 
(Porter 2008).  
3.7.1 Test-rest reliability: Test-retest reliability can be used to investigate the 
repeatability of a scale. This is conducted by looking at the agreement of scores from 
repeated administrations by different raters on the same sample over a period of time 
where the underlying condition has not changed. Kappa values may be calculated for 
categorical scales, where a value of 1 indicates true agreement and 0 indicates that any 
agreement has come about only by chance. Intraclass correlation coefficients (ICC) 
may be calculated for continuous scales (Bowling 2009). 
3.7.2 Inter-rater reliability: This refers to agreement of scores when a scale is used 
by different raters on the same sample. As above, Kappa value or ICC may be 
calculated to review the proportion of agreements between different raters¶ scores 
(McDowell and Newell 1996).  
Whilst scale validity is an important way to assess the accuracy and consistency of a 
scale, it must be noted that scales can only be said to be validated in specific contexts, 
these being the environment and population (including their diagnoses) in which the 
YDOLGDWLRQ VWXG\ WRRN SODFH $ VFDOH PD\ QRW EH VHHQ WR EH WUXO\ µYDOLGDWHG¶ VR D
potential user must first judge whether the scale is adequate for their purpose, for 
example detecting delirium in inpatients on a general hospital ward. 
Having defined validity and how it can be measured, the evidence that supports the 
validity of the DRS-R-98 can be examined and used to determine whether the DRS-R-
98 is a valid tool which can be used to identify delirium and distinguish it from other 
mental health problems.  
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4 VALIDITY OF THE DRS-R-98 AND WHAT IT MEASURES: A Systematic 
Review 
 
4.1 AIMS: To critically examine the evidence of the validity of the DRS-R-98.  
                To determine if the DRS-R-98 can distinguish people with and without 
delirium, including those suffering from other psychiatric disorders including dementia, 
on general hospital wards. 
           
4.2 METHOD:  
A systematic approach was taken to review the available literature.  
The journals included were all from 1998 onwards as this was the date that the DRS-R-
98 was introduced. 
4.2.1 Databases: The following databases were searched (timeframe from 1998 to 
present); 
x Ovid Medline (1996+) 
x Embase (1980+) 
x Psych Info (1806+) 
x Web of Science (1955+) 
4.2.2 Search terms: The following search terms were used; 
1. µ'HOLULXP5DWLQJ6FDOH¶RUµ'56-R-¶LQRUGHUWRLGHQWLI\WKHVFDOH 
2. µ'HOLULXP¶RUµ'HPHQWLD¶RUµ3V\FKRWLF¶RUµ3V\FKRVLV¶WRLGHQWLI\WKHPHQWDOLOOQHVV 
3. µ$JHG¶RUµ$JHGDQGRYHU¶RUµ(OGHU¶RUµ2OGHUSHUVRQV¶WRLGHQWLI\WKH
population. 
4. µ,QSDWLHQW¶RUµ$FXWHGLVHDVH¶RUµ$FXWHLOOQHVV¶RUµ+RVSLWDO¶WRLGHQWLI\WKH
setting. 
5. µ6HQVLWLYLW\¶RUµ9DOLGLW\¶RU µ6SHFLILFLW\¶RUµ(IILFDF\¶RUµ5HOLDELOLW\¶WRLGHQWLI\
measurements of quality and validity by which the DRS-R-98 can be assessed. 
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 The search terms were adapted for each database in order to conform with the 
searching strategy required for each system. 
4.2.3 Inclusion criteria: Studies were selected if they met the following search 
criteria; 
x Published studies. 
x Primary research 
x Included participants aged 65 or above. 
x Used the DRS-R-98 in all cases. 
x Included participants with and without other mental illnesses or cognitive 
impairments. 
x Included participants recruited from general hospital settings. 
x 8VHGDµ*ROG6WDQGDUG¶WRGHWHUPLQHZKHWKHUWKH'56-R-98 is measuring delirium 
and is able to distinguish between that and other mental health illnesses (including 
Dementia). 
x Specificity and sensitivity to be cited or calculable. 
4.2.4 Exclusion Criteria: Studies were not selected if they met the following 
exclusion criteria; 
x Participants exclusively younger than 65 years of age. 
x Studies drawing exclusively from non-general hospital settings. 
x Studies involving predominantly alcohol, brain injury and/or cancer related 
delirium. 
x Non-English language publications. 
x Studies in which the DRS-R-98 was not utilised. 
x Reviews. 
x Participants not recruited from general hospital wards. 
 Duplicates of papers were then removed, inclusion and exclusion criteria applied 
to the remainder and relevant studies identified. In addition references of selected 
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papers were searched and papers know to the author considered, in order to ensure 
that key papers were not missed.  
4.2.5 Data extracted: For each study identified and read the following were recorded; 
x The study setting. 
x The sample population including age and mental illness, including which mental 
illnesses (if any) the comparison groups suffered from. 
x Population size. 
x Methods used to collect data, for example; whether researchers executed the 
assessments simultaneously, whether Dµ*ROG6WDQGDUG¶GLDJQRVLVZDVPDGHZKHWKHU 
researchers were blinded, etc. 
x What comparative tools were used. 
x  Overall findings. 
x The types of validity of the DRS-R-98 that the study supported, including levels of 
sensitivity and specificity noted in the study. 
x Methodological issues of each study were also noted in order to recognise 
potential bias or confounding variables (such as other mental illnesses) which could 
have influenced results. 
x Identification of any gaps or weaknesses in the existing literature which may 
provide a focus for further study. 
 For the papers that met the inclusion criteria and were not discarded due to the 
exclusion criteria, a proforma was created and used to extract data from each of the 
papers selected by the systematic literature search. This ensured that data extraction 
was standardised, methodical and easy to conduct.  
4.3 RESULTS:  
In the search stage 56 references or citations, all of which had abstracts were 
identified, one of which found through hand searching references of articles identified 
from the  
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electronic search. Twenty five were duplicates and four were excluded as they were 
published prior to 1998. A further two studies were excluded because they did not use 
the DRS-R-98 but other delirium measurement scales instead and four studies were 
excluded as they utilised the older version of the DRS rather in its revised form. 
4.3.1 Selection of papers: 
Web Of science search terms:   
DRS-R-98 OR Delirium Rating Scale ± R ± 98  
AND  
Delirium OR Dementia OR Psychotic OR psychiatric disorders  
AND 
$JHG25µ$JHGDQGRYHU¶25(OGHU252OGHUSHUVRQ 
AND 
Sensitivity OR Specificity OR Efficacy OR Reliability OR Validity 
Papers found: 19 
 
 
 
 
 Search Terms MEDLINE EMBASE PSYCHINFO 
1 Delirium Rating Scale OR DRS- R -98 102 174 160 
2 Delirium OR Dementia OR Psychotic 
OR Psychosis 
69254 182944 91697 
3 $JHG25µ$JHGDQGRYHU¶25
Elder$ OR Older person$ 
1604509 403307 74075 
4 Impatient$ OR Acute Disease OR 
Acute Illness OR Hospital$ 
573540 1276395 109794 
5 Sensitivity OR Validity OR Specificity 
OR Efficacy OR Reliability 
1000247 1971115 272144 
6 1 and 2 and 3 and 4 and 5 17 11 8 
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Figure 2: Identification and selection of papers 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The 13 remaining studies were read and the relevant data extracted. (See appendix 2). 
4.3.2 Sample: The samples in the studies reviewed were between 30 and 161 
participants. The age ranges within the papers varied greatly as well. Whilst attempting 
to limit the age range of participants to those 65 years or older, the age ranges in the 
papers chosen started as young as 16 but did not exclude older participants, so 
PSYCH INFO MEDLINE EMBASE WEB of SCIENCE HAND SEARCH 
8 17 11 19 1 
56 references 14 discarded after abstract review: 
x 5 use older version of DRS 
x 1 used in paediatric setting only 
x 3 did not use any version of the DRS 
x 4 published before 1998 
x 1 published in Dutch only 
42 retained 
 18 duplicates 
24 full papers reviewed 
8 Discarded after detailed review: 
x 2 only recruited from palliative care 
x  ?ďǇƐĐĂůĞ ?ƐĂƵƚŚŽƌ ?ŝŶƚƌŽĚƵĐŝŶŐZ^-R-
98, but no findings or results 
x 2 from recruited post-op patients only 
x 1 on recruited patients suffering from 
brain injury 
x 1 from psychiatric setting only 
x 1 only recruited in ICU setting 
 
13 papers in final set 
3 systematic 
reviews 
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incorporating a large range of ages. Five studies included participants who were 
exclusively aged 65 years and older, eleven papers included participants of 20 years 
and older, and one study had participants who were 40 years and older. 
4.3.3 Recruitment: Of the thirteen papers, all participants were recruited from in-
patient settings. Twelve were based on using those diagnosed with a psychiatric 
condition according to the Diagnostic and Statistical Manual of Mental Disorders ± DSM 
III-R or DSM IV criteria, and all bar three papers reported that the users of the DRS-R-
98 were blinded to this prior diagnosis. The remaining papers do not state whether 
raters were or were not blinded to the DSM IV diagnosis. Twelve of the papers only 
started the recruiting process and used the DRS-R-98 after a diagnosis of delirium had 
already been made. Only two studies screened for potential participants within 48 
hours of them being admitted, to see whether they met the criteria for participation. 
4.3.4 Execution of the Scale: In eight of the thirteen papers, the DRS-R-98 was used 
by a psychiatrist to identify delirium or measure its symptoms, in two it was by 
geriatrician, in two a research assistant whose qualifications were not stated and in the 
final paper it was conducted by a registered nurse. 
4.3.5 Psychiatrists as Raters: In ten of the papers the DSM III-R or DSM IV was 
used by a psychiatrist for the initial diagnosis. Only one of the papers stated that the 
psychiatrist in question was a third party to the study itself and not involved directly. 
4.3.6 Mental Illness: Four of the papers included participants suffering from 
schizophrenia or other psychiatric diagnoses (including depression and bi-polar 
disorders). Five included a control group with no diagnosis of mental illness. 
 Nine of the papers did include participants suffering from dementia: of these, seven 
had participants with dementia as part of a comparison group with little or no reference 
made to the co-morbidity which may exist between dementia and delirium.  
One of the papers did not include any comparative groups and participants were 
recruited only if they had a clinical diagnosis of delirium. This paper was designed to 
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illustrate the validity and reliability of the DRS-R-98 but could not report any values for 
sensitivity or specificity so did not examine whether the scale can distinguish delirium 
from other mental illnesses. 
 Four papers excluded recruit participants with a known diagnosis of dementia and 
three of the studies included a sub-group in which the participants were suffering from 
both delirium and dementia at the time of recruitment. 
4.3.7 Comparator Scales: Many of the papers included the use of comparative scales 
and the most commonly used was the Mini Mental State Examination (foreign language 
translations) which was used to measure levels of cognitive dysfunction in eight of the 
studies. A variety of other tools were used including the Confusion Assessment Method 
(CAM), IQCODE, and the original version of the DRS. However the use of such tools 
was so varied between papers, as to which ones were employed and how many were 
used, that the results between the papers were highly heterogeneous and therefore 
non comparable. In one paper the DRS-R-98 was used DVDµJROGVWDQGDUG¶ to assess 
the DOM scale.   
4.3.8 Prior Formal Diagnosis: In two of the papers participants were given a formal 
diagnosis before the tool was used. As delirium can be undiagnosed in general 
hospitals, this pre-screening may have led to the identification of milder cases which 
clinical identification was more likely to miss. In one of the papers it is also mentioned 
that researchers were not blinded to the diagnosis prior to using the DRS-R-98. If the 
rater is already aware of the nature of the mental illness of the patient this could have 
led to information bias, as the items would have been scored with prior knowledge of 
the final diagnosis. 
4.3.9 Co-Morbidity: In only three of the papers were diagnoses of delirium 
superimposed on dementia measured and analysed. Due to the incidence of their co-
morbidity in older populations, the three papers which included these items may be 
able to provide true values for specificity and sensitivity in the general hospital 
population due to the inclusion of this category. However, in one of these three studies 
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the specificity and sensitivity were not reported. In one of the papers participants with 
delirium superimposed on dementia was noted and compared with dementia and 
delirium only groups.  
4.4 SETTINGS IN WHICH THE DRS-R-98 HAS BEEN USED: Twelve of these papers 
were conducted in general hospitals, although four of them also included participants 
recruited from the psychiatric wards of these hospitals and three included recruitment 
from rehabilitation and outpatient wards as well. One recruited from geriatric medical 
wards. 
4.5 EVIDENCE OF VALIDITY:  
4.5.1 Content validity: Nine of the thirteen papers support the face and content 
validity that the DRS-R-98 may have.  
4.5.2 Concurrent validity: The association between the DOM and DRS-R-98 was 
analysed using Spearman¶s rho and found to be 0.80. The Pearson correlation between 
the DOS and DRS-R-98 was 0.61. Negative correlations between MMSE and the DRS-R-
98 were shown in six papers and Pearson correlations were shown to be between 0.64 
and 0.70 thus indicating that the DRS-R-98 was identifying impairment in cognitive 
function.  
4.5.3 Sensitivity and specificity: The specificity and sensitivity of the DRS-R-98 was 
compared with clinical diagnosis, and was noted in eight of the papers. Six papers 
noted a sensitivity ranging from 86% to 98% and specificity ranging from 72% to 77% 
when the DRS-R-98 was used to distinguish delirium from other mental health 
problems. When a sample consisting of only those suffering from delirium, dementia 
and delirium superimposed on dementia was used, sensitivity ranged from 56% to 93% 
and specificity ranged from between 75% and 95%.  
In one study, items of the DRS-R-98 were used to identify sub-types of delirium. Here 
it was found that when combined, the sensitivity and specificity for items 4 (lability of 
affect) and 7 (motor agitation) for non-hypoactive delirium were 89% and 57% 
respectively.  
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4.5.4 Construct validity:  In seven of the studies the internal consistency of the DRS-
R-98 was analysed using Cronbach¶s alpha to measure the intercorrelations among the 
test items. The scores were found to be between 0.76 and 0.94 indicating that there 
was high degree of internal consistency and the items in the DRS-R-98 were measuring 
the same thing.  
4.5.5 Sensitivity to change: In two of the studies the DRS-R-98 was used to 
measure the improvement of delirium throughout treatment. In both cases where 
delirium had resolved there was a significant change in DRS-R-98 score. In one of 
these studies the mean score was noted to change from 21.5 at baseline to 5.2 once 
resolved (P<0.001).  
4.5.6 Reliability: The inter-rater reliability (IRR) was recorded in seven of the studies. 
Intra Class Correlation Coefficients (ICCs) were documented in seven papers to assess 
this and were reported as ranging between 0.92 and 0.98 showing that there was a 
high degree of agreement between WKHUDWHUV¶VFRULQJ.  
4.6 DISCUSSION: 
The literature search found thirteen papers which were relevant to the aims of the 
review.  
4.6.1 Validity: The papers identified by the search indicate that there is evidence that 
the DRS-R-98 is a sensitive and specific tool. Although some of the literature suggests 
that the DRS-R-98 might lose some of its specificity and sensitivity when the 
participant sample includes those suffering from delirium and dementia there remains 
some evidence that the DRS-R-98 scores are still significantly higher in those with 
delirium, despite prior cognitive impairment. 
This is pertinent to the search as papers that show the DRS-R-98 was able to 
demonstrate high sensitivity and specificity in patients suffering from both conditions 
(both of which can alter cognitive ability) and provide evidence to suggest that the 
scale is not only valid and capable of measuring delirium but can also differentiate it 
from other mental illnesses. 
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4.6.2 Applicability: All the papers were selected on the basis that participant 
recruitment was conducted in general hospital and not exclusive to psychiatric, 
palliative or intensive care wards. This should mean that the reported findings are 
applicable to general hospital wards.  
4.6.3 Users: Many of the scale users in the papers selected were either psychiatrists 
or geriatricians who are likely to be familiar with identifying the features described in 
the DRS-R-98. While not directly biasing the results, the prior training received by 
these raters could have implications for how the scale may be used to identify delirium 
for non-research purposes. Not all general hospital wards may offer much patient 
contact with such specialists and other members of a multidisciplinary team may not be 
able to use the DRS-R-98 to identify symptoms of delirium, or the syndrome with the 
same level of accuracy. 
4.6.4 Sensitivity to change: By including two studies in which the DRS-R-98 was 
used to rate delirium throughout a course of treatment, this supports WKHVFDOH¶V
criterion validity. As the DRS-R-98 scores reduce during the treatment, it shows that 
the DRS-R-98 is measuring the severity of the delirium as it was intended.  
4.6.5 Concurrent Validity: One of the papers used the DRS-R-98 as a scale by which 
to validate a different scale. There was a significant correlation between the DOS and 
the DRS-R-98. As both scales were designed to measure delirium this supports the 
concurrent validity of the DRS-R-98.  
4.6.6 Discriminant Validity: Two of the papers identified by the search analysed the 
data from not only patients with and without delirium but also included in their 
participant sample those who also had a diagnosis of another mental health problem.  
4.6.7 Franco et al. (2009): conducted a factor analysis of the DRS-R-98. Data from 
three groups was analysed. The patient participants were distinguished by their DRS-R-
VFRUHVDµQRQ-GHOLULXP¶JURXSVFRULQJEHWZHHQDQGRQWKH'56-R-98), a 
µVXEFOLQLFDOSURGURPDOGHOLULXP¶JURXSVFRULQJEHWZHHQDQGDQGDµGHOLULXP¶
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group (scoring 14 or more) within the first 24 hours of their hospital admission. There 
was a diagnosis of dementia in 5 of the patients in the subclinical/prodromal group, 6 
of the delirium group and 2 of the non-delirium group. The different items of the DRS-
R-98 were analysed and the scores of 9 of the 16 items of the scale were found to be 
significantly different across all 3 groups, with scores being higher in the delirium group 
than the other groups. This study supports the construct validity of the DRS-R-98, as 
demonstrated by the factor analysis conducted (in which all 16 items were significantly 
different between the delirium and non-delirium groups) and shows that the DRS-R-98 
measures core symptoms (such as sleep/wake abnormalities) and that these had high 
correlations with associated symptoms (such as temporal onset). The scores for each 
FULWHULDZHUHKLJKHULQWKRVHSDUWLFLSDQWVZKRZHUHVSOLWLQWRWKHµGHOLULXP¶JURXSWKDQLQ
WKRVHLQWKHµSURGURPDO¶RUµQRQ-GHOLULXP¶JURXSV'XHWRWKHVLJQLILFDQWGLIIHUHQFHVLQ
scores between the groups, evidence was provided to support the criterion validity of 
the DRS-R-98.  
The authors reported that no specific evaluation of dementia in participants was 
conducted at recruitment nor was a pre-GHOLULXPHYDOXDWLRQRISDWLHQWV¶FRJQLWLYH
function performed. Instead, those accompanying participants into hospital on 
admission were asked if any history of dementia or dementia symptoms had been 
noted. However, it is not reported as to whether these informants were asked to 
provide any evidence on delirium or symptoms of delirium which may have occurred.  
4.6.8 Andrew et al. (2009): split patient participants into groups according to 
cognitive diagnoses as well as having a diagnosis of delirium or not. Dementia and 
GHOLULXPZHUHGLDJQRVHGDQGSDWLHQWVZHUHLGHQWLILHGDVKDYLQJHLWKHUµFRJQLWLYH
LPSDLUPHQWQRGHPHQWLD¶&,1')µQRFRJQLWLYHLPSDLUPHQW¶1&,GHPHQWLDGHOLULXP
delirium superimposed on CIND and delirium superimposed on dementia. The 
evaluations were conducted by two independent raters (within 1 hour of each other) 
one of whom was a geriatrician with prior experience of diagnosing delirium so clinical 
co-morbities of patients with delirium could be taken in to account independently. 
Patients with NCI had the lowest scores, while patients with delirium had the highest 
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scores. However, the DRS-R-98 was found to have low sensitivity (0.59) and specificity 
(0.67) between the dementia and delirium groups. Eleven patients with no delirium 
were found to have DRS-R-98 scores of above the cut-off of 17.75. Of these patients 
three had suffered from a stroke, three had $O]KHLPHU¶V disease and three had other or 
unspecified dementia. This could indicate that the scale may not be able to distinguish 
delirium from other mental health problems and does not have criterion validity. 
However, it was noted that the mean DRS-R-98 scores did differ between the delirium 
superimposed on dementia group (20.2 with 95% confidence interval of 16.1±24.3) 
and the dementia group (14.1 with 95% confidence interval of 10.7±17.4). This 
illustrates that the DRS-R-98 may be used to identify delirium in a patient suffering 
from dementia as well as distinguish between the two conditions, however as the 
confidence intervals overlap this is not certain.   
Andrew et al reported that the specificity and sensitivity of the scale were moderate, 
highlighting the difficulty of distinguishing delirium from other mental health problems. 
However, the authors noted that the clinical assessments which were used to identify 
dementia, and the identification and measurement of delirium symptoms using the 
DRS-R-98 were not always carried out on the same day. They also reported that 
despite some loss of sensitivity and specificity, the DRS-R-98 had high IRR and good 
construct validity (shown by the significant correlations between items rating 
symptoms using SDWLHQWV¶EHKDYLRXUand items rating symptoms XVLQJSDWLHQWV¶
histories and medical notes). 
4.7 WEAKNESSES IN THE LITERATURE: The validity of the DRS-R-98 has not been 
widely studied. The main barriers to establishing the validity of the DRS-R-98 appeared 
to be that only few studies included sample groups that contained patients suffering 
from delirium and mental health problems, with the main focus being on patients who 
were suffering from delirium only. Patient participants with dementia appeared to be 
recruited into FRPSDULVRQJURXSVUDWKHUWKDQLQWKHµGHOLULXP¶JURXSVGHVSLWH
associations and known risk of comorbidity of the two conditions. In 7 of the papers, 
users of the DRS-R-98 were psychiatrists, who would have received specialist training. 
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Only 2 of the papers included non-clinician scale users. The DRS-R-98 itself includes 
standard instructions to guide assessment, which could be validated if assessors did not 
have prior psychiatric training to assist them in identifying symptoms on the scale.  
 
4.8 LIMITATIONS OF THE STUDY: The search found a small number of papers. This 
could be due to the search terms being too restrictive and the subject being too 
narrowly defined, or to the possibility that there are not many papers which directly 
explore the validity of the DRS-R-98. References of selected papers were analysed and 
papers known to the author considered, ensuring that key papers were not missed.  
4.9 CONCLUSION:  
Findings of the systematic review suggest there is a range of evidence available which 
report that the DRS-R-98 is a valid scale and therefore suitable for identifying and 
measuring delirium. However, further research is needed in which: 
- Formal diagnoses of other mental health problems, as well as delirium and control 
groups should be recorded for the entire participant population. Few validation studies 
for the DRS-R-98 appear to use patient participants suffering from both delirium and 
dementia, despite associations identified in previous research. 
-Patient participants should be selected systematically from a general hospital 
population, as cases of delirium may go undetected and use of DRS-R-98 in this 
participant group may highlight issues with sensitivity and specificity.  
-Patient participants should have informants who are able to report delirium or delirium 
symptoms prior to the admission. The papers identified do not report the use of 
informants despite the scales author noting the use of caregivers and visitors during 
data collection. 
- Studies need to be done which identify patients early in their admission, when 
screening or diagnostic scales are likely to be of most use clinically. 
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As the DRS-R-98 appears to be an appropriate tool to diagnose delirium and distinguish 
it from other mental health problems, the next stage of this thesis was to analyse data 
where it had been used to detect delirium in a cohort of older people with mental 
health problems. From this, the features and outcomes associated with having delirium 
were identified.  
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5 METHOD: 
 
5.1 PRIMARY OBJECTIVE: To establish whether the DRS±R±98 is able to distinguish 
delirium from other mental health problems in a general hospital population. 
5.1.1 Secondary Objectives:  
 -To examine the association between DRS-R-98 scores, demographic variables 
and health problems in older people admitted to general hospital as an emergency. 
-To examine if DRS-R-98 scores are associated with outcomes. 
5.2 STUDY DESIGN: 
 The research questions were answered drawing from data from the MCOP-BMH 
study, conducted between 2009 and 2010. As the aim of this thesis was to assess the 
use of the DRS-R-98 in a population of older people with mental health problems and 
analyse the associated factors and outcomes of older patients with delirium, this data 
was to seen to be appropriate. The aim of MCOP-BMH was to measure the prevalence 
and severity of mental health problems, including delirium as measured by the DRS-R-
98 in older people admitted to general hospital as an emergency (Gladman et al. 
2012).  
The MCOP-BMH study measured health status of patient participants at baseline, 
including the DRS-R-98, (two to five days after admission) and a range of outcomes 6 
months later.  
A two-stage assessment procedure was used. The first stage identified and excluded 
people who were unlikely to suffer from mental health problems. The second stage 
involved patients and their carers completing a battery of questionnaires designed to 
measure both their physical and mental health status.  
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5.2.1 Screening: 
Consecutive admissions to study wards were approached between two and five days of 
their hospital admission. The screening was conducted by three researchers (a 
geriatrician, psychologist and nurse) on twelve wards (two trauma orthopaedic, three 
acute geriatric medical and seven general medical) in the Queens Medical Centre and 
Nottingham City Hospitals Campuses of Nottingham University Hospitals NHS Trust. 
These wards were visited in rotation. Verbal consent to answer questions was taken 
from the potential patient participants.  The screening battery included: 
 - The abbreviated mental test score (AMTS) (used to identify cognitive 
impairment) (Hodkinson 1972). 
 -GDS 4 questions (to identify patients exhibiting symptoms of depression) 
(Kurlowicz and Greenberg 2007).   
 -PRIME-MD anxiety screen (Spitzer et al. 1999). 
 - CAGE questions (identifying alcohol abuse) (Ewing 1984). 
 - A bespoke question was used in cases where the patient had already been 
diagnosed with a psychiatric diagnosis or if there was any other reason (such as 
behaviour) to suggest a mental health problem (see appendix 3). 
Finally, patients were asked if they would be willing to take part in a further research 
study regarding mental health problems on hospital medical wards.   
5.2.2 Inclusion criteria for the MCOP-BMH study: 
x Patients aged 70 years or older. 
x Patients admitted to hospital as an emergency to 12 specific wards: 3 acute 
geriatric medical, 2 trauma orthopaedic and 7 general medical in the Queens Medical 
Centre and Nottingham City Hospital campuses of Nottingham University Hospitals NHS 
Trust. 
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x Patients who screened positive for mental health problems between days 2 and 5 
of their admission. 
x Patients consented to take part if they had capacity. 
x Patients who had a willing carer/family member to provide consultee agreement 
in cases where participants lacked capacity. 
5.2.3 Exclusion criteria for the MCOP-BMH study: 
x Non-English speakers without translators. 
x Nursing/residential home residents with no unpaid carers to act as an 
independent consultee or informant. 
x Patients where consent or consultee agreement was not obtainable. 
x Those with no carers over the age of eighteen years. 
x Patients not admitted as an emergency (for example elective surgery). 
x Patients who were unconscious. 
x Patients not admitted to the pre-specified wards. 
x Patients whose clinical team did not believe they would survive the admission 
(death within 12 days). 
5.2.4 Patient and carer participants: 
After screening, patients who screened positive for one or more mental health 
problems were approached to take part in the MCOP-BMH study. 
Next, the capacity of the patient to give informed consent was assessed. 
 -In cases in which patients were deemed to have capacity, information sheets 
regarding the  study and its aims were given to patients and they were asked if 
they were willing to take  part and complete the consent forms. Permission was 
soughWWRFRQWDFWWKHSDWLHQW¶VFDUHU If permission was given by the patient 
participant, the closest family member or carer to the patient was identified and 
attempts were made to contact them by telephone or in person.   
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 -If capacity was not present, information sheets were given to carers and if 
willing consultee agreement was sought.  
Carers were also approached to be recruited as carer participants.  
 The MCOP-%0+SURWRFROGHILQHGDFDUHUDVµVRPHRQHZKRVHHVWKHSDWLHQWDWOHDVW
once a week for a minimuPRIRQHKRXU¶7KLVGHILQLWLRQDOORZHGWKHLQFOXVLRQRI
spouses, siblings, children and close friends. In cases where there was more than one 
carer the most available or willing was chosen.  
5.2.5 Data collection at baseline:  
Demographic data regarding patients were collected from both medical records and 
interviews and included their age, living arrangements, marital status and the type of 
ward they had been admitted to (see appendices 4 and 5). 
For patient participants at baseline the following scales were completed: 
x Delirium Rating Scale -revised version -98 (DRS-R-98) (Trzepacz et al. 1998): to 
measure the prevalence and severity of symptoms of delirium. 
x Modified early warning score (MEWS) (Subbe et al. 2001): measuring the severity 
of acute illness on admission. 
x Study of osteoporotic fractures frailty scale (SOF) (Ensrud et al. 2008): to 
measure frailty. 
x Charlson Index (Charlson et al. 1987): to measure co-morbidities. 
x An adapted version of the Neuropsychiatric Inventory (NPI) (Cummings et al. 
1994): to ascertain the presence of behavioural and psychological features associated 
with mental health problems. 
x Cornell Scale for Depression in Dementia (CSDD) (Alexopoulos et al. 1988): to 
diagnose symptoms of depression and measure its severity. 
x Mini mental state examination (MMSE) (Folstein et al. 1975): to measure 
cognitive function. 
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x Barthel index (Mahoney and Barthel. 1965): to measure functional ability in 
activities of daily living at admission and prior to illness. 
x EQ5D (Brazier et al. 1996): to measure quality of life. 
 
5.2.6 Structured assessment by a psychiatrist or geriatrician: 
 
Using the same participant population a sub-study was carried out and further 
assessments were made (see appendices 6 and 7): 
x 3 geriatricians (1 consultant, 2 senior trainees) and 3 psychiatrists (1 consultant 
and 2 trainees). 
x Patient selection: a convenience sample was taken depending on the availability 
of the assessors, but was essentially random.  
x 49 psychiatric evaluations were made. 53 geriatric evaluations were made. 9 of 
the evaluations were conducted using the same patient.   
x The assessments were carried out in the same hospital admission that the cohort 
baseline data was collected, but not on the same day.  
x Assessors were asked to make a clinical assessment, at a level consistent with a 
thorough ward consultation, using notes, questioning of the patient or carers and 
examination.  
x Assessors were asked to research problems, drugs were stopped or started, other 
interventions undertaken and outstanding needs for intervention. 
x Diagnoses of delirium according to DSM IV criteria were made. 
5.2.7 Data collection at 180 day follow-up: 
Patient and carer participants were included in the study for a maximum of 180 days. 
Data were collected either: 
x During a home-visit (the arrangement of which was attempted for each patient 
participant). 
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x By telephone with carer of patient. 
x By WHOHSKRQHZLWKWKHSDWLHQW¶VGeneral Practitioner. 
x Through the NUH NOTIS computer system to collect data regarding hospital 
admissions during the 180 days or up to date of death. 
Data collection at 180days: 
x Ascertainment of death. 
x Length of stay in hospital. 
x Number of hospital admissions. 
x Number of days at home. 
x Institutionalisation. 
   
Data collection conducted by a researcher during a home visit included: 
x Mortality. 
x MMSE (Folstein et al. 1975). 
x Quality of life using the DEMQoL (Smith et al. 2005)  
x Quality of life using EQ5D scales (Brazier et al. 1996). 
x Basic ADL: Barthel Index (Mahoney and Barthel. 1965). 
x An adapted version of the Neuropsychiatric Inventory (NPI)  (Cummings et al. 
1994) 
x Social and health care: Client Services Receipt Inventory (including                                             
 readmission to hospital) (Beecham and Knapp. 1992).   
(See appendix 8) 
5.2.8 Withdrawal: 
Patient and carer participants were informed in the information sheets that they had 
the option to withdraw from the study at any time but that any data collected prior to 
the withdrawal would not be destroyed and could still be used in the data analysis after 
the rest of the data collection was complete. 
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Figure 3: Recruitment procedure 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.2.9 Training of researchers: 
-Training in the use of the scales was provided by the consultant geriatrician.   
-Consistent training and performance reviews were conducted to ensure both initial and 
180 day outcome questionnaires were carried out in a reliable, uniform manner.  
5.2.10 Confidentiality:  
-All patient and carer participants were allocated a study ID number so that their 
anonymity could be maintained.  
-Hard copies of data were stored in locked filing cabinets. 
-All electronic data were stored in a password protected Access database. 
Patients screened 
No mental health 
problems 
Mental health problems 
Patients recruited 
Outcomes at 180 days 
Patients meeting 
exclusion criteria 
-Patient declines 
-Consultee declines 
-Researcher unavailable. 
Patient withdrawing 
before 180 days 
55 
 
5.3 DATA MANAGEMENT: Data was entered onto an Access database and extensively 
checked manually and using range and consistency checks. In keeping with the scoring 
manual missing or unavailable items for the DRS-R-98 were scored as 1.5.  
5.4 DATA ANALYSIS:  
5.4.1 General considerations: Analyses were carried out using STATA version 11. As 
part of the data analysis, DRS-R-98 scores were used as a continuous variable but a 
pre-specified sub-group analysis was also considered. The population was split 
according to the recommended DRS-R-98 cut-off of 17.75 (Trzepacz et al. 2001) to 
identify those likely to have delirium or not. The DRS-R-98 scores were also divided 
into quartiles creating an ordered categorical variable.  This enabled tests for trend to 
be performed, as well as allowing the comparison of the highest and lowest quartiles.  
 
5.4.2 Baseline data: Descriptive statistics of the data were presented including an 
item response analysis and associations between this data and DRS-R-98 scores 
identified. This explored what the DRS-R-98 may measure and the associations of what 
these scores may mean for an older patient.  
For each categorical variable, uni-variate analysis was carried out, producing crude 
odds ratios. Logistic regression was then carried out in order to produce 95% 
confidence intervals, and allowed the odds ratio to be adjusted for confounding 
variables (identified during data analysis).  
Continuous variables were described using means if the data was normally distributed 
and medians if it was not. Where these variables were normally distributed linear 
regression was performed. If not, the data was either transformed, or the median of 
the variable taken and used instead.  
5.4.3 Outcome data: From the outcome datasets, all outcome variables were 
analysed. Descriptive statistics were presented on the outcomes data, including 
variables such a mortality rate, new care home placement and length of any hospital 
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admissions after recruitment. The reassessment of functional and cognitive ability 
allowed the analysis of whether there is an association between DRS-R-98 score and 
disability. Differences in Barthel scores and MMSE totals between baseline and outcome 
were noted as separate variables.   
Categorical variables were subject to uni-variate analysis producing crude odds ratios. 
Logistic regression was then carried out in order to produce 95% confidence intervals, 
and adjusted odds ratios. 
 Continuous variables were described using means or medians according to whether the 
variable was normally distributed or not. Where variables were normally distributed 
linear regression was performed. If not, the data was transformed.  
5.4.4 Participants with incomplete data: Once the analysis of the baseline data was 
complete, and before exploratory analysis of the outcome data was conducted, 
comparisons were made between those participants who were not available to collect a 
full dataset at follow up (due to ill health, refusal to follow-up or death) and those who 
were.  Baseline characteristics were compared to see if there were any significant 
differences between the groups. Due to some of the data being made available over the 
telephone participants at this stage were split into groups: 
- Participants from whom a full data set was collected. 
- Participants from whom only part of the dataset was collected. 
- Participants from whom there is no data except that regarding hospital 
admissions to Nottingham University Hospitals, mortality status and CSRI. 
- Participants for whom, at outcome, no data could be collected. 
 
5.4.5 Population: The characteristics of the full participant population were described 
and both baseline and outcome data analysed. Once this was done the descriptive 
statistics were stratified according to presence of delirium as identified by the DRS-R-
98.  Associations between demographics or health problems and DRS-R-98 scores were 
explored, including any associations between the DRS-R-98 and participant¶VOLYLQJ
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arrangements, age, gender, functional disability, frailty and other mental health 
problems. 
5.4.6 Scale performance: Item analysis was conducted. The number of missing items 
was noted and distributions of the scores analysed.  The internal consistency of the 
DRS-R-98 was calculated using Cronbach¶s alpha coefficients. A high score would 
indicate that the DRS-R-98 has good internal consistency and that all the items were 
measuring the presence or absence of delirium.  
5.4.7 Validity: A primary objective was to establish whether the DRS-R-98 was a valid 
scale, able to distinguish delirium from other mental health problems in older patients 
in a general hospital population. 
5.4.7.1 Criterion validity:  The criterion validity was investigated by comparing DRS-
R-VFRUHVRISDUWLFLSDQWVDJDLQVWDµJROGVWDQGDUG¶,QGHSHQGHQWSV\FKLDWULFDQG
medical assessments were conducted on a sample of the cohort population, including 
diagnoses or absence of delirium. It is from these that the sensitivity and specificity of 
the DRS-R-98 was calculated. A ROC curve was also produced to show whether the 
DRS-R-98 was able to differentiate between delirium and no delirium and the cut-off 
points examined. The published cut-off of 17.75 was tested using ROC curves.  
We assumed that patients with an improvement in their cognitive function over 6 
months were likely to have had delirium (Meagher 2001) and tested the DRS-R-98 with 
this as the gold standard comparator. MMSE scores of those who were identified as 
having delirium or not by the DRS-R-98 were analysed. Recoverable cognitive function 
has been previously defined as an increase of 3 or more on the MMSE (Inouye et al. 
2006). 
5.4.7.2 Predictive validity:  This was investigated by analysing the mortality rates 
according to DRS-R-98 score. MMSE scores at baseline and outcome were analysed. As 
the cognitive impairment caused by delirium can be reversible, a higher DRS-R-98 
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score and an increase in MMSE at outcome could help to identify in which cases the 
scale may have demonstrated predictive validity. 
5.4.7.3 Construct validity: Construct validity was assessed by analysing the 
associations between DRS-R-98 scores with other scales measuring related variables.  
 The Study of Osteoporotic Fractures frailty scale (SOF) was used as a measure of 
frailty. Delirium may be linked to frailty in older people. An association between high 
DRS-R-98 and high SOF scores may have shown that the DRS-R-98 may be detecting 
delirium and a predisposing factor.    
The Modified Early Warning Score (MEWS) was used as a measure of severity of acute 
illness on admission. Delirium is associated with an acute physical illness. If cognitive 
deficits perhaps caused by delirium (as measured by the DRS-R-98) have developed 
due to levels of illness (as measured by the MEWS), it may help to show that the DRS-
R-98 has a concurrent validity with the MEWS and that the DRS-R-98 is associated with 
a key factor of the syndrome.  
The Charlson Index was used to measure co-morbidities. Older people may be more 
vulnerable to the development of a delirium due to more frequent levels of physical 
illness. As the Charlson Index measures previously diagnosed illnesses (prior to the 
index admission), an association with the Charlson may have shown that the DRS-R-98 
may be measuring delirium, which due to previously diagnosed illnesses have left the 
patient more susceptible to the syndrome. The Charlson also records a previous 
diagnosis of dementia and thus allowed comparisons to be made between patients with 
dementia, with delirium, with delirium and dementia and with neither delirium nor 
dementia.  
The Neuropsychiatric Inventory (NPI) was used to capture any data regarding the 
presence of behavioural and psychological features associated with mental health 
problems. As the DRS-R-98 has items which also measure behavioural and 
psychological symptoms associated with delirium such as perceptual disturbances, 
delusions, disturbances to motor function and sleep-wake patterns, an association 
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between the two scales could indicate that these symptoms are being detected by the 
DRS-R-98. 
The number of medications was recorded at baseline. As delirium has been associated 
with polypharmacy an association between the two variables could have supported the 
construct validity of the DRS-R-98.  
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 6 RESULTS 
 
6.1 RECRUITMENT: The three researchers recruited 250 participants between the 4th 
April 2009 and 3rd November 2009. 1004 patients were screened, 361 (36%) were 
unlikely to have mental health problems. From the remaining 643 (64%) 250 were 
recruited. One participant withdrew before the baseline data could be collected. At 180 
day follow-up, an outcome questionnaire was completed by 121 (49%) participants. Of 
the outcomes questionnaires which were not completed, 78 (31%) participants had 
died, data regarding 20 (8%) participants could only be collected by-proxy from carers, 
GDWDUHJDUGLQJZDVLQFRPSOHWHGXHWRSDWLHQWV¶LOOKHDOWKRUUHIXVDOWRDIROORZ-
up visit, 8 (3%) were lost to follow-up and a further 2 participants (1%) had 
withdrawn.  
Figure 4: Recruitment 
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recruitment with no 
baseline data 
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6.2 BASELINE DATA:  
6.2.1 Demographics: The median (IQR) age of patients recruited was 84 (79-89), 
66% were female and had been admitted to hospital from either their own home (79%) 
or a care home (21%). 47% of the participants were recruited from acute geriatric 
medical wards, 34% from acute medical wards and 18% from trauma orthopaedic 
wards.  
6.2.2 Physical health problems: Table 1 shows the levels of functional disability of 
the cohort, as measured by the Barthel index. Prior to the admission participants with 
delirium (according to the DRS-R-98) had significantly lower levels of functional ability 
than participants who did not (P<0.001): 64% of participants with delirium had Barthel 
scores of 0-5, versus 36% who did not. Of the more functionally able participants, with 
Barthel scores of 16-20, 29% had delirium, versus 71% who did not.  
Table 1 shows that the functional ability in the participants was worse by the time of 
admission and that participants with delirium continued to be more dependent than 
those who did not. 64% of participants with a Barthel score of 0-5 also had delirium. Of 
the more functionally able participants, 15% had delirium, versus 85% who did not.  
There no was significant association between the number of medical conditions the 
participants suffered from and whether they had delirium (P=0.36).  
There was no relationship between frailty (measured by the SOF) and delirium as 52% 
of those in the least frail category had delirium but 52% in the frailest category also 
had delirium.  
The number of medications was recorded and the median (IQR) number of medications 
the patients were prescribed to take was 7 (4-9) (6 for those with delirium as opposed 
to 7 for those without).  
There was no relationship between levels of acute illness on admission and delirium. 
Median (IQR) early warning scores taken on admission were 1 (1-2) (1 for participants 
with delirium and 1 for those without).  
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There was no significant association between quality of life and delirium. The median 
EQ5D (IQR) score was 0.18 (-0.4 ± 0.3) (0.2 for those with delirium and 0.17 for those 
without).  
Table 1: Characteristics of full study population  
  Total Delirium 
N=107 
No delirium 
N=142 
P 
value 
Age (n=249) Median (IQR) 84 (79-89) 86 (80-89) 83 (78-87) 0.36 
Female (n=249) n (%) 165 (66) 63 (68) 93 (66) 0.76 
Accommodation 
(n=249) 
n (%) 
Care home  52 (21) 43 (40) 9 (6) <0.001 
 Own home n 118 (47) 34 (31) 84 (59)  
 Own home with 
carer 
79 (32) 30 (28) 49 (35)  
Prior Barthel Index 
(n=244) 
n (%) 
0-5 n  14 (6) 9 (9) 5 (4) <0.001 
 6-10  33 (14) 23 (22) 10 (7)  
 11-15  58 (24) 32 (31) 26 (19)  
 16-20  139 (57) 40 (38) 99 (70)  
Admission Barthel Index  
(n=249) n (%) 
0-5 n (%) 66 (27) 45 (42) 21 (15) <0.001 
 6-10 74 (30) 35 (33) 39 (27)  
 11-15 68 (27) 21 (20) 47 (33)  
 16-20 41 (16) 6 (6) 35 (25)  
Charlson Comorbidity 
(n=249) n (%) 
0-1 n (%) 76 (31) 31 (29) 45 (32) 0.36 
 2-3 104 (42) 50 (47) 54 (38  
 4+ 69 (28) 26 (24) 43 (30)  
SOF frailty (n=248) n 
(%) 
0-1  50 (20) 26 (25) 24 (17) 0.05 
 2  144(58) 52 (49) 92 (65)  
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 3  54 (22) 28 (26) 26 (18)  
Medications (n=241) Mean (IQR) 7 (4-9) 6 (5-9) 7 (5-10) 0.177 
MEWS (n=249) Median (IQR) 1 (1-2) 1 (1-2) 1 (1-2) 0.65 
EQ5D (n=248) Median (IQR) 0.18 (-0.4 - 
0.3) 
0.79 (-0.1 -
0.3) 
0.2 (0.04-
0.6) 
0.177 
IQR Inter quartile range 
SOF Study of osteoporotic fractures frailty scale 
MEWS Modified early warning score 
 
There was no significant correlation between DRS-R-98 scores and levels of physical 
illness on admission as measured by the MEWS. 
There was no significant association between DRS-R-98 scores and the number of 
medications the patients were prescribed on admission.  
Chi squared tests were conducted and showed that a positive score for delirium on the 
DRS-R-98 was significantly associated with admission to hospital from a care home 
being functionally disabled and having increased levels of frailty.  
6.2.3 Mental health problems at baseline: Table 2 shows the mental health 
problems experienced by the population. In this thesis delirium was identified using the 
recommended DRS-R-98 cut-off of 17.75. 107 (43%) patients scored positively for 
delirium according to the DRS-R-98.  
106 (43%) of the patients had a diagnosis of dementia (68% of whom had scored 
positively for delirium on the DRS-R-98).  
There was a significant association (P<0.001) between cognitive impairment (as 
measured by the MMSE) and DRS-R-98 score. Of the participants with severe cognitive 
impairment (MMSE of 0-9), 88% had delirium. All of the participants (100%) who had 
GHOLULXPKDGDFRJQLWLYHLPSDLUPHQW006(  
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There was a relationship between depression and delirium. 40% of the patients 
suffered from mild depression (as measured Cornell scale for depression) (of which 
44% had delirium). 13% suffered from marked depression (of who 67% had delirium).  
The median neuro-psychiatric inventory (IQR) score was 24 (14-35) (33 for those also 
scoring positively for delirium and 20 for those scoring negatively).  
Table 2: Mental health problems at baseline 
  Total Delirium 
N=107 
No delirium 
N=142 
P value 
Diagnosed dementia 
 (n=249) n (%) 
Yes  106 (43) 72 (68) 34 (32) <0.001 
MMSE (n=248) n (%) 0-9  67 (27) 59 (55) 8 (6) <0.001 
 10-20  92 (37) 44 (41) 48 (34)  
 21-24  47 (19) 4 (4) 43 (30)  
 A? ? ? 42 (17) 0 (0) 42 (30)  
DRS-R-98 (>17.75) 
(n=249) n (%) 
Delirious  107 (43)    
Dementia and delirium  
(n=249) n (%) 
 72 (29)    
CSDD (>10) (n=249) 
n(%) 
Mild Depression  
CSDD (11-18) 
99 (40) 44 (41) 55 (39) 0.003 
 DĂũŽƌĞƉƌĞƐƐŝŽŶ ?A? ? ? ? 33 (13) 23 (22) 11 (8)  
NPI (severity  W 
moderate to marked) 
(n=249) n (%) 
Delusions  31 (12) 27 (25) 4 (3) <0.001 
 Hallucinations  25 (10) 17 (16) 8 (6) <0.001 
 Agitation and aggression  35 (14) 32 (30) 3 (2) <0.001 
 Depression  85 (34) 45 (42) 40 (28) 0.022 
 Anxiety  85 (34) 44 (41) 41 (29) 0.048 
 Elation 3 (1) 2 (2) 1 (1) 0.4 
 Apathy  83 (33) 54 (51) 29 (20) <0.001 
 Disinhibition  19 (8) 16 (15)  3 (2) <0.001 
 Irritability  44 (18) 29 (27) 15 (11) <0.001 
 Psychomotor activity  42 (17)  31 (29) 11 (8) <0.001 
 Sleep problems 83 (33) 39 (37) 44 (31) 0.34 
 Appetite or eating 
problems 
113 (46) 55 (52) 58 (41) 0.08 
NPI total (n=249) Median (IQR) 24 (14-35) 33 (20-52) 20 (11-27) 0.02 
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MMSE Mini Mental State Examination 
DRS Delirium Rating Scale ±Revised ± 98 
CSDD Cornell Scale for Depression in Dementia 
NPI Neuro psychiatric inventory 
 
The NPI was used to measure psychiatric symptoms and behavioural problems, some 
of which the DRS-R-98 also measured. Chi 2 tests were performed and NPI items for 
delusions, hallucinations and psychomotor behaviours as well as the total NPI scores 
were significantly associated with scoring positively for delirium.  
6.3 OUTCOMES AT 180 DAYS: At 180 days 78 (31%) of the patients had died. The 
median (IQR) number of days spent in hospital was 15 (6-35) and the median (IQR) 
number of re-admission was 0 (0-1). 19% of participants had moved into a care home 
after their index admission. Mortality, days spent in hospital and institutionalisation 
were not found to be significantly associated with delirium. 
On 180 day outcome 39 (28%) of the patients had a Barthel score of 0-5, 29 (21%) 
had a Barthel score of 6-10, 33 (23%) had a Barthel of 11-15 and 40 (28 %) had a 
Barthel of 16-20.  It was found that between baseline and outcome 22% of the patients 
had a decrease in Barthel score of 3 points or more. A relationship between functional 
ability and delirium at outcome was found but there was no significant association 
between a change in dependency between admission and outcome. 
Table 3: Outcomes at 180 days 
  Total Delirium No 
delirium 
P value 
Mortality at 6 months n (%) (n=249) Alive 169 
(68) 
66 (62) 103 (73) 0.19 
 Dead 78 (31) 40 (37) 38 (27)  
Length of stay in hospital (n=249) Median (IQR) 
(days) 
15 (6-
35) 
14 (7-
32) 
16 (6-39) 0.56 
Hospital re-admissions (n=247) Yes (%) 104 
(42) 
45 (42) 59 (42) 0.92 
 No (%) 143 
(58) 
61 (58) 82 (58)  
Moved to Care Home from community 
(n=247) 
Yes (%) 46 (19) 20 (19) 26 (28) 0.93 
 No (%) 201 
(81) 
86 (81) 115 (82)  
Outcome Barthel Index n(%)  
(n=141) 
0-5 39 (28) 22 (40) 17 (20) <0.001 
 6-10 29 (21) 17 (31) 12 (14)  
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 11-15 33 (23) 12 (22) 21 (24)  
 16-20 40 (28) 4 (7) 36 (42)  
Decrease Barthel /ŶĚĞǆŽĨA䠃? (n=141) Yes (%) 30 (22) 15 (50) 15 (50) 0.16 
Increase Barthel Index of A? 3 (n=141) Yes (%) 45 (32) 14 (25) 31 (36%) 0.19 
 No (%) 96 (68) 41 (75) 55 (64)  
 
There were no significant associations between DRS-R-98 score and mortality or length 
of stay during index admission.  
Barthel score at outcome was significantly associated with delirium but no relationship 
in the recovery or worsening of dependency.  
6.3.1 Mental health problems at 180 days: At 180 days it was found that cognitive 
impairment (as measured by the MMSE) was significantly associated with delirium.  
Table 4: Mental health problems at 180 days 
  Total Delirium 
 
No 
delirium 
P 
value 
Outcome MMSE (n=121) n (%) 0-9  31 (26) 22 (47) 9 (12) <0.001 
 10-20  37 (31) 15 (32) 22 (30)  
 21-24  17 (14) 5 (11) 12 (16)  
 A? ? ? 36 (30) 5 (11) 31 (42)  
Increase of MMSE by 3+ (n =121) 
n (%) 
Yes  40 (33) 20 (43) 20 (27) 0.07 
 No  81 (67) 27 (57) 54 (73)  
NPI (severity  W moderate to 
marked) (n=121) n (%) 
Delusions  15 (13) 11 (19) 4 (6) 0.03 
 Hallucinations  8 (7) 7 (12) 1 (2) 0.02 
 Agitation and aggression 19 (16) 12 (21) 7 (11) 0.12 
 Depression 17 (14) 10 (17) 7 (11) 0.32 
 Anxiety 21 (18) 13 (23) 8 (13) 0.16 
 Elation 2 (2) 2 (4) 0 (0) 0.13 
 Apathy 37 (31) 20 (36) 17 (27) 0.28 
 Disinhibition 5 (4) 3 (5) 2 (3) 0.54 
 Irritability  14 (12) 10 (18) 4 (6) 0.05 
 Psychomotor activity  13 (11) 10 (18) 3 (5) 0.02 
 Sleep problems 19 (16) 12 (21) 7 (11)  0.14 
 Appetite or eating 
problems 
27 (23) 11 (20) 16 (25) 0.49 
NPI total Median (IQR) 11 (5-25) 13 (7-29) 9.5 (4-
22) 
0.09 
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The association between recoverable MMSE and delirium was not significant suggesting 
that the DRS-R-98 was measuring a more long-term cognitive impairment rather than 
one that was specific to delirium. As cognitive impairment caused by delirium is 
resolvable, and there was relationship between cognitive impairment at both baseline 
and outcome this suggests that the cognitive impairment was present even after the 
syndrome had resolved.  
Four of the twelve NPI scores (delusions, hallucinations, irritability and psycho-motor 
activity) at outcome continued to have a significant association with baseline DRS-R-98 
score. As there was a stronger association between the DRS-R-98 and psychiatric and 
behavioural problems during index admission than at outcome, this suggests that some 
of these symptoms may have resolved. This could suggest that the DRS-R-98 detected 
only psychiatric and behavioural problems associated with delirium. Once the syndrome 
resolved so did the symptoms, indicating that the problems were resolvable and not 
long-term. 
6.4 THE INTERNAL CONSISTENCY OF THE DRS-R-98: Item analysis was 
conducted. Missing items for each variable of the DR-R-98 were analysed. 4% of the 
data for the item µWKRXJKWSURFHVV¶ZHUHPLVVLQJ7KHUHZDVPLVVLQJYDOXHIRUWKH
LWHPµYLVXR-VSDWLDOSUREOHPV¶EXWIRUWhe remaining 14 items there was none. Therefore 
there do not appear to be any redundant items in the scale. Cronbach¶s alpha scores 
were calculated and it was found that the items were correlated to each other. The 
diagnostic items and severity items were also analysed separately (table 6) and even 
used alone the diagnostic items were consistent.   
Table 5 Item Analysis and Internal Consistency: 
DRS on admission  N (%) Cronbach ?s 
alpha 
Item  Scores   
Sleep/wake cycle  Not present                                                         0           56 
(22) 
0.87 
 Mild sleep disturbance                                      1            91 
(37) 
 
 Moderate sleep disturbance                            2            89 
(36) 
 
 Severe sleep disturbance                                  3         13 (5)  
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 Missing 0 (0)  
Perceptual disturbances Not present                                                          0          180 
(72) 
0.87 
 Mild perceptual disturbances                           1             7 (3)  
 Illusions present                                                  2          1 (0)  
 Hallucinations present                                       3           61 
(25) 
 
 Missing 0 (0)  
Delusions Not present                                                          0          147 
(59) 
0.86 
 Mildly suspicious                                                1            25 
(10) 
 
 Unusual ideation                                                2            6 (2)  
 Delusional                                                            3           71 
(29) 
 
 Missing 0 (0)  
Lability of affect Not present                                                          0          177 
(72) 
0.87 
 Affect altered                                                      1           47 
(19) 
 
 Affect inappropriate to situation                     2           18 (7)  
 Severe disinhibition of emotions                     3         3 (1)  
 Missing 0 (0)  
Language Normal                                                                  0 157 
(63) 
0.86 
 Mild impairment                                                 1 37 
(15) 
 
 Moderate impairment                                       2 28 
(11) 
 
 Severe impairment                                             3            27 
(11) 
 
 Missing 0 (0)  
Thought process Normal processes                                                              
0 
129 
(51) 
0.85 
 Tangential thought processes                          1           47 
(19) 
 
 Associations loosely connected occasionally     
                                                                               2         
36 
(14) 
 
 Associations loosely connected most of the 
time                                                                       3 
26 
(10) 
 
 Missing 11 (4)  
Motor agitation No restlessness                                                   0              178 
(71) 
0.86 
 Mild restlessness                                                1            40 
(16) 
 
 Moderately motor agitation                             2           28 
(11) 
 
 Severe motor agitation                                      3          3 (1)  
 Missing 0 (0)  
Motor retardation No slowness in movements                              0           135 
(54) 
0.86 
 Mildly reduced frequency of movements      1         49 
(20) 
 
 Moderately motor retardation                        2 49 
(20) 
 
 Severe motor retardation                                 3       16 (6)  
 Missing 0 (0)  
Orientation Orientated                                                           0           48 
(19) 
0.86 
 Disorientated to either time or place             1            71 
(29) 
 
 Disorientated to time and place                      2           112 
(45) 
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 Disorientated to person                                    3              18 (7)  
 Missing 0 (0)  
Attention Alert                                                                      0         96 
(39) 
0.85 
 Mildly distractible                                               1             65 
(26) 
 
 Moderate inattention                                        2          50 
(20) 
 
 Severe difficulty in focusing/sustaining 
attention                                                              3 
38 
(15) 
 
 Missing 0 (0)  
Short term memory  Short term memory intact                                0          38 
(15) 
0.86 
 Recalls 2/3 items                                                 1           34 
(14) 
 
 Recalls 1/3 items                                                 2           37 
(15) 
 
 Recalls 0/3 items                                                 3           140 
(56) 
 
 Missing 0 (0)  
Long term memory Long-term memory intact                                 0         82 
(33) 
0.86 
 Recalls 2/3 items                                                 1           42 
(17) 
 
 Recalls 1/3 items                                                 2           47 
(19) 
 
 Recalls 0/3 items                                                 3           78 
(31) 
 
 Missing 0 (0)  
Visuospatial ability No impairment                                                    0           75 
(30) 
0.85 
 Mild impairment                                                 1           62 
(25) 
 
 Moderate impairment                                       2           56 
(22) 
 
 Severe impairment                                             3            55 
(22) 
 
 Missing 1 (0)  
Temporal onset of 
symptoms 
No change from usual behaviour                    0           155 
(62) 
0.87 
 Onset of symptoms over weeks to a month 1              33 
(13) 
 
 Acute change over days to a week                 2          28 
(11) 
 
 Abrupt change over hours to a day                3           33 
(13) 
 
 Missing 0 (0)  
Fluctuation of symptom 
severity 
No fluctuation                                                     0           182 
(73) 
0.87 
 Fluctuation over hours                                      1            42 
(17) 
 
 Fluctuation over minutes                                  2           24 
(10) 
 
 Missing 1 (0)  
Physical presence None present                                                       0          58 
(23) 
0.87 
 Presence of any physical disorder                   1           61 
(25) 
 
 Drug/medical problem altering behaviour    2 130 
(52) 
 
 Missing 0 (0)  
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Table 6 Internal Consistency of diagnostic items, severity items and total:  
 
 
 
 
This indicates that despite the apparent heterogeneity of the different items the scale 
measures a single unidimensional concept.  
6.5 THE SENSITIVITY AND SPECIFICITY OF THE DRS-R-98:  
The sensitivity and specificity of the DRS-R-98 were calculated. Psychiatric and clinical 
UHSRUWVZHUHXVHGWRSURYLGHDµJROGVWDQGDUG¶IRUWKHLGHQWLILFDWLRQRIPHQWDOKHDOWK
problems in a sub-sample of the population. 20 cases were diagnosed clinically with 
delirium. By using the cut-off of 17.75 (as recommended by the scale¶s author) 
participants who scored as positive or negative for delirium were compared with the 
psychiatric and medical diagnoses. The positive predictive value and negative predictive 
values were also calculated. 
Table 7: Sensitivity and Specificity: 
 Gold standard: Clinical evaluation by psychiatrist and 
geriatrician 
 
 Diagnosis of delirium No diagnosis of delirium Total 
DRS-R-98 score 
>17.75 
a) True positive 
15 
b) False positive 
21 
36 
DRS-R-98 score 
<17.75 
c) False negative 
5 
d) True negative 
52 
57 
Total 20 73 93 
 
Sensitivity is a/ (a+c) = 75% (95%CI = 56% - 93%) 
Specificity is d/ (b+d) = 71% (95%CI = 66% - 76%) 
 
Positive predictive value= a/(a+b) = 42% (95%CI = 27% - 57%) 
Negative predictive value = d/(c+d) = 91% (95%CI = 83% - 98%) 
 
Items Cronbach ?s alpha 
Diagnostic items 
only 
0.66 
Severity scale only 0.88 
Total scale 0.87 
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Both sensitivity and specificity were moderate, however as the sample was small and 
the confidence intervals very wide this may not be precise. The positive and negative 
predictive values were calculated and showed the proportion of those scoring as 
positive who were truly positive and those scoring negative who were truly negative. 
The positive predictive value was low indicating that there is a moderate chance that 
those scoring positive on the DRS-R-98 did not have delirium.  
6.5.1 ROC Analysis:  ROC analysis using clinical evaluations as a gold standard 
showed that the DRS-R-98 was able to differentiate delirium or no delirium.  
Figure 5: ROC curve of the DRS-R-98 
 
 
From this the DRS-R-98 demonstrated a moderate ability to differentiate delirium from 
no delirium. The area under the curve is 0.76 (95% CI of 0.63 ± 0.88).  
Cut-off points for the DRS-R-98 were examined in order to identify which allowed the 
greatest sensitivity and specificity: 
0.
00
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00
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1 - Specificity
Area under ROC curve = 0.7630
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Table 8 Analysis of DRS-R-98 cut-offs:      
 
Cut-off point Sensitivity Specificity Correctly  classified 
A? ? ? 85% 37% 47% 
A? ? ? 85% 40% 49% 
A? ? ? 80% 41% 49% 
A? ? ? 80% 47% 54% 
A? ? ? 80% 55% 60% 
A? ? ? 75%         55% 59% 
A?16 75% 59% 62% 
A?17  75% 64% 67% 
A? ? ?         75% 71% 72% 
A? ? ?           70% 73% 72% 
A? ? ? 70% 78% 76% 
A? ? ? 60% 78% 74% 
A? ? ? 60% 82% 77% 
A? ? ? 55% 85% 78% 
A? ? ? 50% 88% 80% 
A? ? ? 40% 89% 78% 
 
From the ROC analysis the cut-off point which seemed to allow the highest sensitivity 
and specificity was 18, which was similar to the recommended cut-off of 17.75 
(Trzepacz et al. 2001).  
6.5.2 Sensitivity and specificity analysis of the DRS-R-98 as determined by 
recoverable cognitive function: 
Delirium distinguishes itself from dementia and long-term cognitive impairments as it 
should possible for cognitive function to be recovered after the delirium has been 
resolved. Changes of 3 or more in MMSE scores (based on previous work by Inouye et 
al. 2006), from the baseline to 180 day outcome, were analysed and used to further 
assess the sensitivity and specificity of the DRS-R-98. 
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Table 9: Sensitivity and Specificity as determined by recoverable cognitive 
function: 
 Gold standard: Recovery of cognitive function from baseline to 
outcome 
 
 MMSE increased by A䠃? MMSE did not increase Total 
DRS-R-98 score 
>17.75 
a) True positive 
20 
b) False positive 
27 
47 
DRS-R-98 score 
<17.75 
c) False negative 
20 
d) True negative 
54 
74 
Total 40 81 121 
 
Sensitivity is a/ (a+c) = 50% (95%CI = 28% - 72%) 
Specificity is d/ (b+d) = 67% (95%CI = 46% - 88%) 
 
Positive predictive value= a/(a+b) = 42% (95%CI = 27% - 57%) 
Negative predictive value = d/(c+d) = 73% (95%CI = 54% - 92%) 
 
Both sensitivity and specificity were found to be moderate. From this analysis it 
appeared that 50% of the population who suffered from delirium may not have scored 
as positive on the DRS-R-98, and 33% of the population were reported as having 
delirium when they did not. However the confidence intervals were very wide meaning 
that this may not be conclusive. The positive and negative predictive values were 
calculated and showed the proportion of those scoring as positive who were truly 
positive and those scoring negative who were truly negative. The positive predictive 
value was low indicating that there is a modest chance that those scoring positive on 
the DRS-R-98 may not have had delirium. 
 
6.6 DATA AS DEFINED BY DRS-R-98 QUARTILES: The baseline and outcomes data 
were split according to quartiles of the DRS-R-98. The associations were recorded and 
allowed for trends between the quartiles to be analysed.   
6.6.1 Baseline data as defined by DRS-R-98 quartiles: As shown in table 10, with 
each increase of DRS-R-98 quartile there was an increase in the odds of the participant 
being older, having been admitted to hospital from a nursing or residential home and 
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being more functionally disabled on index admission. There was an increase in the odds 
ratios showing that participants with higher DRS-R-98 scores are more likely to suffer 
from dementia and cognitive impairment.  Table 10 also shows that with each increase 
in DRS-R-98 quartile there is an increase in the odds of a participant experiencing 
neuro-psychiatric behaviours, with the exception of difficulties in sleeping and eating, 
and elation.   
Table 10: Baseline characteristics as defined by DRS-R-98 quartiles: 
 DRS-R-98 Quartiles 
Q1 
Scores 1-
7 
(Lowest) 
Q2 Scores 
8-15 
 
Q3 Scores 
16-23 
Q4 Scores 
24-39 
(Highest) 
P value 
Age (Median, IQR) 
(n=249) 
 82 (77-
86) 
84 (79-88) 85 (80-88) 88 (81-93) P<0.001 
(Sp) 
Female (%) (OR) 
(n=249) 
 66.1 (1) 65.2 (1.02 
CI=0.48-
2.15) 
67.2 (0.97 
CI=0.46-
2.05) 
66.3 (0.97 
CI=0.46-
2.05) 
P=0.96 
Accommodation (%) 
(n=249)  
Own home 
alone  
40 29 20 12 P<0.001  
 Own home with 
relative/carer  
20 32 30 18  
 Nursing home  0 20 7 73  
  Residential 
home  
0 8 28 64  
 Mixed home  0  25 8 67  
Admission Barthel 
Index (%) (n=249) 
0-5  8 17 26 50 P<0.005 
 6-10  24 24 26 26  
 11-15  19 44 24 13  
 16-20  63 20 12 5  
Prior Barthel Index 
(%) (n=244) 
0-5  0 36 7 57 P=0.08 
 6-10  0 24 36 39  
 11-15  17 21 28 35  
 16-20  37 29 20 14  
Decrease in Barthel 
from Prior to Index 
(%) (OR) (total=244) 
Yes 55 (1) 49 (1.76 
CI=0.63-
4.9) 
58 (0.54 
CI=0.15-
1.95) 
52 (1.20 
CI=0.40-
3.56) 
P=0.23 
Charlson Co 
morbidity (%) (n=249) 
0-1 26 28 25 21 P=0.4 
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 2-3 18 28 23 31  
 4+ 33 25 20 28  
SOF frailty (%) 
(n=248) 
0 or1 23 28 23 26 P=0.9 
 2 28 30 22 20  
 3 19 19 26 36  
Medications (n=241) 1 to 5 23 25 24 29 P=0.2 
 6 or 7 16 34 31 19  
 8 or 9 21 29 19 31  
 10 + 47 20 20 14  
MEWS (%) (n=249) 0 or 1 25 25 28 22 P=0.8 
 2 16 40 9 35  
 3 or more 33 21 18 28  
Dementia (%) (OR) 
(n=249) 
Yes  
 
8 (12.90) 
(1) 
16 (26.23) 
(1.14 
CI=6.12) 
31 (49.21) 
(6.53 
CI=2.6-
15.9) 
51 (80.95) 
(28.68 
CI=10.84 -
75.90) 
P<0.0001 
MMSE  (%) (n=248) 0-9  0 8 24 69 P<0.0001 
 10-20 9 35 38 19  
 21-24  51 36 13 0  
 A? ? ? 71 26 2 0  
CSDD (>10) (%) 
(n=249) 
Mild Depression  
(CSDD 11-18) 
23 23 27 26 P=0.003 
 Major 
Depression 
(CSDD A? ? ? ?
9 21 18 52  
CSDD  WAny 
depression  
N (%) (OR) 26 
(41.94) 
(1) 
27 (44.26) 
(1.09 
CI=0.53-
2.24) 
36 (57.14) 
(1.84 
CI=0.90-
3.75) 
43 (68.25) 
(2.97 
CI=1.43 -
6.18) 
(P=0.009) 
NPI (moderate to 
marked) (%) (n=249) 
Delusions 0 10 48 42 P<0.001 
 Hallucinations 0 32 24 44 P=0.01 
 Agitation and 
aggression 
0 3 34 63 P<0.001 
 Depression 22 18 26 34 P=0.04 
 Anxiety 26 17 21 37 P=0.01 
 Elation 0 0 33 67 P=0.3 
 Apathy 10 22 22 47 P<0.001 
 Disinhibition 0 5 32 63 P<0.001 
 Irritability 14 16 36 34 P=0.02 
 Psychomotor 
activity 
5 14 24 57 P<0.001 
 Sleep problems 25 22 19 34 P=0.1 
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 Appetite or 
eating problems 
21 24 23 32 P=0.2 
NPI total  Median (IQR) 17 (10-
25) 
21 (12-28) 25 (19-40) 38 (27-62) P<0.001 
 
 
6.6.2 Outcomes data as defined by DRS-R-98 quartiles: As shown in table 11, 
with each increase in DRS-R-98 quartile there was an increase in the odds of the 
participant being functionally disabled at outcome (as measured by the Barthel Index), 
though the change in functional status from admission to outcome was not significant.  
DRS-R-98 scores were significantly associated with recoverable cognitive impairment 
(an increase in MMSE score of 3 or more) indicating that the DRS-R-98 was measuring 
more acute cognitive impairments. 
There was no significant association between mortality, hospital readmissions or length 
of stay and DRS-R-98 quartile. There were also no associations between DRS-R-98 
quartile and quality of life at outcome. 
Table 11: 180 day outcome data as defined by DRS-R-98 quartiles 
  DRS-R-98 Quartiles 
  Q1 
Scores 1-
7 
(Lowest) 
Q2 Scores 
8-14 
 
Q3 Scores 
15-23 
Q4 Scores 
24-39 
(Highest) 
P value 
Mortality at 6 
months (n=249) (%) 
(OR) 
Dead 45 
(21.79)  
(OR=1) 
16 (20.51) 
(OR =0.96 
CI= 0.43  W 
2.14) 
18 (23.1) 
(OR=1.08 
CI=0.49-
2.36) 
27 (34.62) 
(OR=1.98 
CI=0.93-
4.1) 
P=0.17  
 
Length of stay in 
hospital 
Mean (days) 23 29 25 21 P=0.46 
Length of stay 
during index 
admission 
Mean (days) 14 17 16 15 P=0.9 
Hospital re-
admissions 
Mean (days) 8 12 9 7 P=0.38 
Moved to Care 
Home (n=247) 
(OR) 
Yes (%) 
 
11 (23.9) 
1 
10 (21.7) 
(0.92 
CI=0.36-
2.37) 
14 (30.43) 
(1.35 
CI=0.55-
3.26) 
11 (23.9) 
(0.98 
CI=0.39-
2.46) 
P=0.8  
Outcome Barthel 
Index (n=141) 
0-5 5 31 26 39 P<0.001  
 6-10 10 17 41 31  
 11-15 30 27 30 12  
 16-20 48 35 15 3  
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Decrease in Barthel 
from Index to 
Outcome (n) (OR) 
(n=141) 
Yes  10 (1) 14 (0.71 
CI=0.26-
1.9) 
14 (0.77 
CI=0.28-
2.06) 
13 (0.51 
CI=0.18-
1.44) 
 
P=0.65 
Decrease Barthel 
Index of 3+  (n)(OR) 
(n=141)  
Yes  3 (1) 9 (0.31 
CI=0.76 -
1.26) 
9 (0.33 
CI=0.82-
1.34) 
 
9 (0.21 
CI=0.05-
0.89) 
P=0.16 
Increase Barthel 
Index to Outcome 
(n) (OR) (n=141) 
Yes  20 (1) 21 (0.77 
CI=0.31-
1.95) 
19 (0.7 
CI=0.31-
1.94) 
13 (0.57 
CI=0.21-
1.55) 
P=0.23 
Increase in Barthel 
from Index of 3+ (n) 
(OR) (n=141) 
Yes  12 (1) 14 (0.99 
CI=0.37-
2.57) 
11 (0.75 
CI=0.27-
2.01) 
8 (0.7 
CI=0.23-
2.04) 
P=0.86 
DEMQoL Median (IQR 81 84 84 81 P=0.83 
EQ5D Median (IQR) 0.46 0.32 0.30 0.23 P=0.06 
Outcome MMSE (%) 
(n=121) 
0-9  0 19 36 45 P<0.001  
 10-20  16 38 24 22  
 21-24  29 35 29 6  
 A? ? ? 53 25 19 3  
Increase of MMSE 
by 3+ (%)(n=121) 
(OR) 
Yes  4 (10.0) 
 (1) 
9 (23) (2.4 
CI=0.66-
8.96) 
17 (43) 
(6.5 
CI=1.86-
22.6) 
10 (25) 
(4.64 
CI=1.22-
17.53) 
P=0.01 
 
Outcome NPI (%) Delusions (n=15) 7 13 40 40 P=0.3 
 
 Hallucinations 
(n=8) 
0 0 50 50 P=0.07 
 Agitation and 
aggression (n=19) 
5 26 42 26 P=0.4 
 Depression (n=17) 6 18 47 29 P=0.3 
 Anxiety (n=21) 14 14 52 19 P=0.1 
 Elation (n=2) 0 0 100 0 P=0.2 
 Apathy (n=37) 8 27 35 30 P=0.4 
 Disinhibition 
(n=5) 
20 20 20 40 P=0.8 
 Irritability (n=14) 0 21 50 29 P=0.2 
 Psychomotor 
activity (n=13) 
0 8 46 46 P=0.04 
 Sleep problems 
(n=19) 
11 16 42 32 P=0.4 
 Appetite or eating 
problems (n=27)  
26 30 22 22 P=0.3 
NPI total Median (IQR) 15 (4-19) 8 (3-25) 12 (8-30) 14 (5-29) P=0.17 
 
 
 
 
 
78 
 
7 DISCUSSION 
7.1 MAIN FINDINGS:  From the initial analysis there was high prevalence of mental 
health problems in older people on general hospital wards. 250 participants were 
recruited into the MCOP-BMH cohort population, of varying functional ability and 
suffering from a variety of physical and mental health problems. The predominant 
mental health problems were mild depression, cognitive impairment and delirium. 
Previous research indicates that delirium is unrecognised in general hospitals (Schofield 
2008). In this study it was found that out of the 249 patients recruited on general 
hospital wards, 43% had delirium according to the DRS-R-98, of whom 67% also had a 
diagnosis of dementia. At the 180 day outcome 31% of participants died, 19% had 
moved to a care home after their hospital admission and 22% had decrease in 
functional ability (a decrease in Barthel score of 3 or more).  
7.1.2 DRS-R-98 SCORES: The participants scoring within the highest quartile of the 
DRS-R-98 were more likely to be care home residents, experience long-term disability 
and have dementia. They were older, and be more likely to suffer from depression and 
behavioural problems. At 180 day outcome, scores within the highest quartile of the 
DRS-R-98 appeared to be associated with functional disability (though change in 
Barthel score from index admission was not significant). 
 An increase in the MMSE scores at outcome was noted, the odds of which increase in 
the higher quartiles of the DRS-R-98 scores (with the exception of the highest 
quartile). Neuro-psychiatric symptoms at baseline, as measured by the NPI, were 
higher in the patients with higher DRS-R-98 scores. This association was not present at 
outcome suggesting that neuro-psychiatric problems may have resolved by 180 days in 
patients suffering from delirium.  
However, further analysis shows that the ability of the DRS-R-98 to distinguish delirium 
from other mental health problems is only modest. 
7.1.3 VALIDITY OF THE DRS-R-98:  Based on the analysis using a gold standard, 
the DRS-R-98 appears to be moderately accurate as a diagnostic tool with reasonable 
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sensitivity and specificity when the cut-off of 17.75 was used; however the sample was 
small so this may not be conclusive. When calculating the sensitivity and specificity 
based on recovery of cognitive function the DRS-R-98 was shown to have modest 
validity and to be less accurate when distinguishing those with or without the 
syndrome. 
The face and content validity have been supported through the item analysis. There 
was also evidence of concurrent validity through the associations between the DRS-R-
98 and the MMSE, Barthel and NPI.  However, whilst there were associations between 
some of the neuro-psychiatric inventory items and delirium, for example 
µKDOOXFLQDWLRQV¶ there was no relationship with µGLIILFXOWLHVVOHHSLQJ¶$VUHVHDUFK
supports this being both a risk factor and symptom of delirium (Sanders and Maze 
2010) this does not support the validity of the DRS-R-98.  
Some unexpected findings arose from the data analysis as delirium (as identified by the 
DRS-R-98) was not associated with death, nor was it associated with the number of 
medications patients were taking on admission or severity of acute illness (as 
measured by the Modified Early Warning Score).  These results could also indicate a 
lack of validity of the DRS-R-98 as previous studies have shown direct causal 
relationships (Fong et al. 2009) (Inouye 2000) (Attard et al. 2008).  
7.2 STRENGTHS:  
7.2.1 Sample size at baseline: 250 older patients with mental health problems were 
recruited and 249 retained. From these participants, data was collected using a battery 
of scales measuring mental health and functional problems. This large sample allowed 
a greater amount of data to be collected from patients from varying backgrounds, with 
varying degrees of disability and cognitive status. This could allow the data to be seen 
as generalisable to older patient populations in hospital suffering from mental health 
problems.  
7.2.2 Systematic identification and screening: This ensured that patients were 
approached without bias, on a range of hospital wards meaning that data could be 
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collected from patients with different medical conditions, therefore also supporting the 
generalisability of the data to older patient on general hospital wards, as opposed to 
specialist wards.  
7.2.3 Consultee agreement: This was sought for patients who lacked capacity to 
consent for themselves to participate in the study. This allowed the collection of data 
from patients suffering from a range of severities of cognitive impairment. 
7.2.4 Informants: Carers of the patient participants were approached and in cases 
where participants were unable to provide information they acted as informants, 
SURYLGLQJLQIRUPDWLRQUHJDUGLQJWKHSDWLHQW¶VXVXDOFRJQLWLYHDELOLW\IXQFWLRQDODELOLW\
and mental health statXVGXULQJWKHSDWLHQW¶VDGPLVVLRQ 
7.2.5 8VHRISDWLHQW¶VPHGLFDOUHFRUGV These were used to provide a full history 
UHJDUGLQJWKHSDWLHQW¶VFR-PRUELGLWLHV7KLVDOORZHGDQDFFRXQWRIWKHSDWLHQW¶VSUH-
existing and concurrent medical problems to be recordHGDVZHOODWWKHSDWLHQW¶VKHDOWK
status on admission.  
7.2.6 Nursing notes and nursing staff: Information from both staff and notes 
DOORZHGIRUWKHFROOHFWLRQRIGDWDRQSDWLHQW¶VIXQFWLRQDODELOLW\GXULQJDGPLVVLRQDQG
also if any psychiatric problems were noted. During screening these proved helpful in 
judging the suitability of potential patient participants.  
7.3 WEAKNESSES:  
7.3.1 Screening at 2-5 days of the admission: As patient participants were 
approached at days 2 to 5 of their hospital admission, there was the possibility that if 
they had been suffering from a mental health problem such as delirium, the condition 
may have resolved by the time of screening. If this was the case and no evidence of 
mental health problems was recorded by staff members on the wards the patient may 
have been screened as not suitable for recruitment. This could mean that data would 
not have been collected from patients for whom the mental health problem resolved.  
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7.3.2 No consultee: In cases where the participants lacked the capacity to consent to 
their participation, attempts to contact family members or a significant next of kin were 
made. However, in some cases, no such person was available. This meant that patients 
in these circumstances could not be recruited, and the differences between groups with 
an involved next of kin and those without could not be explored.  It must also be noted 
that the researchers were confined to normal working hours (9am to 6pm). This meant 
that the differences between patients who had family members who were able to visit 
between these hours, and patients whose family members could not, was not explored.  
7.3.3 Missing values: At the 180 day follow-up, over half of the 249 participants were 
unavailable for outcome data collection. Due to the high mortality rate of the 
population (almost a third died), participants moving home or changing telephone 
numbers rendering them unreachable, and carers of the participants consenting only to 
answering questions  over the telephone meant that full data collection was not 
possible. Data analysis of outcomes data used a smaller amount of participants¶ data 
and lacked some of the power the baseline data may have had. 
7.3.4 Bias: Participants were aware of the nature of the MCOP-BMH cohort study. This 
may have caused patients and informants to feel obliged to over-report any symptoms 
or experiences of mental health problems that they had. On recruitment, the nature of 
the study may have contributed to potential participants declining to take part, due to 
the perceived stigma of having a mental health problem.  
7.3.5 Dates of clinical and psychiatric assessment: The structured assessments 
performed by the geriatrician assessors and psychiatrists were sometimes conducted up to 
ten days after the DRS-R-98 was used. This could mean that the delirium resolved by the time the 
assessment took place and unless evidence had been recorded by ward staff it would not have 
been detected.  
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7.4 DELIRIUM IN A GENERAL HOSPITAL: 
7.4.1 Delirium is common: As the DRS-R-98 has moderate sensitivity and specificity 
when distinguishing delirium from other mental health problems; it can be used to 
estimate the proportion of patients with delirium, dementia or both. Using the DRS-R-
98 cut-off of 17.75 delirium was common in older patients with mental health problems 
in general hospitals, as 43% of the cohort population scored positive for delirium. Due 
to the screening methods, and the sample of wards from which the participants were 
recruited, the cohort population appears to be representative of a wider hospital 
population (Goldberg et al. 2012). From this we can estimate that for all patients over 
70 on general hospital wards, 28% had delirium and 19% had both delirium and 
dementia.  
Delirium can cause distressing symptoms. According to the DRS-R-98 25% of the 
population suffered from hallucinations, 29% from delusions and 11% from language 
difficulties. Being frightened by visions and persecutory thoughts, without the ability to 
communicate or ask for help could be very frightening for patients in hospital. Also, as 
RISDWLHQWVVFRUHGKLJKHVWIRUWHPSRUDORQVHWPHDQLQJWKDWWKHSDWLHQWV¶
symptoms occurred within hours to a day) this alteration in normal abilities and sudden 
cognitive difficulties could also be very distressing to both patients and those who know 
them.  
 
7.4.2 Using the DRS-R-98: The DRS-R-98 appears to have both moderate sensitivity 
and specificity. However, false positive and false negative diagnoses were made. This 
implies that even when using a tool specifically designed to identify delirium, cases may 
still be missed and misdiagnoses of delirium may be made in patients suffering from 
other mental health problems.  
 
7.4.3 Poor prognosis: There were no significant associations between mortality, 
length of stay or decrease in functional ability. Patients with higher DRS-R-98 scores 
were more functionally disabled at both admission and outcome, but as there was no 
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relationship between changes in Barthel index and DRS-R-98 scores delirium did not 
appear to exacerbate this.  
 
7.4.4 Recoverability: As there is a significant association between an increase in 
cognitive ability and DRS-R-98 score, this indicates that cognitive impairment caused 
by delirium is recoverable. However, as the mortality rate and number of withdrawals 
were high, there was inadequate power to support this. Also, as initial questionnaires 
were carried out on general hospital wards and outcome questionnaires usually in the 
SDWLHQWV¶KRPHVWKHUHDUHHQYLURQPHQWDOLVVXHVZKLFKPD\KDYHOHGWRDQLQFUHDVHLQ
recovery of cognition. Firstly, patients were in hospital because they were ill, which 
could affect concentration. Secondly, hospital wards are often noisy, busy places and 
patients could be better orientated and relaxed in their own homes.  
 There was no relationship between delirium and recovery of functional ability, which 
would occur if delirium was resolvable. This could be due to poor identification by ward 
staff, a failure in rehabilitation, complications (such as falls or pressure sores), over-
sedation, deconditioning or immobility.  
7.5 CONCLUSION:  
Results from this thesis show that in this population there was a high prevalence of 
delirium and dementia, and a significant association between the two was found. As 
both affect patients¶ cognitive function this means that delirium is not easy to identify 
in patients already suffering from dementia related impairment. The DRS-R-98 has 
moderate levels of sensitivity and specificity in detecting delirium in a population all 
screened positive for mental health problems. The levels of sensitivity and specificity 
are lower than previously reported; this thesis shows the sensitivity and specificity to 
be 75% and 71% respectively, when compared to clinical diagnosis. These finding are 
not dissimilar those of Andrew et al. 2009, who reported that when using the DRS-R-98 
to distinguish delirium from dementia, the sensitivity and  specificity of the scale were 
reduced.  If the DRS-R-98 were to be used for detecting delirium in older patients 
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suffering from mental health problems on general hospital wards, delirium could be 
missed in 25% of patients and misdiagnosed in 29%. Therefore, in this context and 
population the DRS-R-98 does not perform sufficiently validly and if diagnoses are 
made using it they should be confirmed by clinical or mental state examinations. 
However, the DRS-R-98 appears to be sufficiently valid to be used in epidemiological 
studies, where non differential misclassification causes a loss of power, rather than 
directly affecting DSDWLHQW¶VFDUH 
7.8 IMPLICATIONS FOR FURTHER RESEARCH: 
If the validity of the DRS-R-98 is to be assessed the study should be replicated, using a 
greater sample and including patients with prior diagnoses of mental health problems 
and a control group. To fully assess the scale¶s criterion validity a psychiatric 
assessment should be performed for a larger sample of the study population (if not all) 
and a full clinical interview should take place at the same time that the DRS-R-98 is 
used. It may also be prudent to collect outcomes data at 90 days as well as 180 days, 
as mortality at 180 days was high.  
From this thesis it is also evident that new and better ways of diagnosing and 
measuring delirium in people with dementia are needed.  
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Appendix 1: DRS-R-98 (Trzepacz et al. 2001) 
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Appendix 2: Summary data from literature search 
Study Setting Population Method DSM IV        Criteria 
Gold 
standard. Validity 
Delirium subtype 
identification and the 
validation of the Delirium 
Rating Scale ? Revised-98 
(Dutch version) in 
hospitalised elderly patients.        
deRooj et al. (2006) 
General 
hospital 
Inpatients 65 years and 
over. First cohort: 65 
patients; consisted of 23 
patients with delirium, 22 
patients with dementia, 
and 20 
non-psychiatric 
comparison patients.  
First: validation and reliability 
study of the Dutch version of 
the DRS-R-98.                                  
Yes Yes 
Face validity and content validity 
(appears to measure delirium). IRR 
(0.97). Concurrent validity with MMSE. 
/ŶƚĞƌŶĂůĐŽŶƐŝƐƚĞŶĐǇ ?ɲA? ? ? ? ?ĂŶĚŝĨŽŶĞ
ŝƚĞŵǁĂƐĚĞůĞƚĞĚɲA? ? ? ?4 W0.95).Criterion 
validity (compared with psychiatric 
diagnosis using DSM IV, scores DRS-R-98 
-D significantly higher in delirium group.  
Delirium subtype 
identification and the 
validation of the Delirium 
Rating Scale ? Revised-98 
(Dutch version) in 
hospitalised elderly patients.        
deRooj et al. (2006) 
General 
hospital 
Inpatients 65 years and 
over. Second cohort: 54 
delirious patients. 
Second: Delirium subtype 
analysis DSM-IV criteria were 
assessed with the DRS-R-98 
Yes Yes 
Concurrent validity with IQCODE (nearly 
all delirious patients had had a prior 
cognitive decline). Further, hypoactive 
and non-hypoactive 
delirium could be discerned. Non-
hypoactive delirium was best predicted 
by a positive score on the DRS-R- 98 
ŝƚĞŵƐ ‘ĂĨĨĞĐƚůŝĂďŝůŝƚǇ ?ĂŶĚ ?Žƌ ‘ŵŽƚŽƌ
ĂŐŝƚĂƚŝŽŶ ? ?ƉŽƐƐŝďůĞƉƌĞĚŝĐƚŝǀĞǀĂůŝĚŝƚǇ ? 
Delirium-O-DĞƚĞƌ PĂŶƵƌƐĞƐ ?
rating scale for monitoring 
delirium severity in geriatric 
patients.                          
deJonghe et al. (2005) 
General 
hospital 
92 inpatients, 67 years 
and over; 56 with 
delirium, 24 with 
dementia or other 
cognitive disturbances 
(no delirium) and 12 with 
other psychiatric 
disorders or 
no mental disorder.  
Analysis of cross sectional 
and repeated assessments 
data 48hours after patient's 
admission to the hospital.  
Yes Yes 
DRS-R-98 concurrent validity with DOM. 
Paper states of the DRS-R-98 'reliability 
and validity of the DRS has been 
established' but not further details. 
Spanish version of the 
Delirium Rating Scale-
Revised-98: Reliability and 
validity.                        Fonseca 
et al. (2003) 
General 
hospital 
30 patients, 73 years and 
over; 18 women and 9 
men, with a mean age of 
81 (± 8) years with a 
DSM-IV diagnosis of 
delirium. 
Validation and reliability 
study. 
Yes Yes 
IRR = 0.96. Concurrent validity with 
MMSE, OS and MEC. Internal 
ĐŽŶƐŝƐƚĞŶĐǇ ?ɲA? ? ? ? ? ?/ĨĂŶŝƚĞm was 
ƌĞŵŽǀĞĚɲA? ? ? ? ?-0.81). 
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Study Setting Population Method DSM IV        Criteria 
Gold 
standard. Validity 
Japanese Version of the 
Delirium Rating Scale, 
Revised W98 (DRS-R98 WJ): 
Reliability and Validity.                    
Kato et al. (2010) 
General 
hospital 
81 inpatients, 40 years 
and over, were 
consecutively referred to 
the psychiatric 
consultation service. They 
were divided into two 
groups for 
this study: delirium 
(N=48) or non-delirium 
(including dementia) 
(N=33). 
Validation and reliability 
study.  
Yes Yes 
Face validity and content validity 
(appears to measure delirium). 
Concurrent validity with MMSE and CGI-
S W ?/ŚŝŐŚ ?ɲA? ? ? ? ? ? ?/ĨĂŶŝƚĞŵǁĂƐ
ƌĞŵŽǀĞĚɲA? ? ? ? ?ĂŶĚ ? ? ? ? ?ŝƐĐƌŝŵŝŶĂŶƚ
validity: using a cut-off of 14.5 resulted 
in 98% sensitivity and 94% specificity 
and comparing delirium and dementia 
groups: 98% sensitivity and 75% 
specificity, 
Factor Analysis of The 
Colombian Translation of The 
Delirium Rating Scale (DRS), 
Revised W98.                                     
Franco et al. (2009) 
General 
hospital 
161 adult surgical 
inpatients (not comatose, 
in obstetrics or intensive 
care units) 23 years or 
over. 32 had delirium (of 
which 7 also had 
dementia), and 129 did 
not have delirium (of 
which 6 had 
dementia)(according to 
DSM-IV WTR criteria).   
A factor analysis of the DRS-
R W98 (case control). Yes Yes 
Face validity and content validity (rank 
means for all individual items 
significantly higher in delirium groups 
than non-delirium group). Construct 
validity.  
Validation of the Delirium 
Rating Scale-Revised-98: 
Comparison With the 
Delirium Rating Scale and the 
Cognitive Test for Delirium.           
Trzepacz (2001) 
Medical, 
surgical, 
psychiatric, 
rehabilitation, 
and nursing 
home care 
inpatient 
units of  
Medical 
Centre. 
68 inpatients, 16 years 
and over. Medical, 
surgical, psychiatric, 
rehabilitation, and 
nursing home care 
inpatients. 24 delirious, 
13 demented, 9 
schizophrenic,  
12 depressed, and 10 
 “ŽƚŚĞƌ ? ? 
Validation and reliability 
study. 
Yes Yes 
Face and content validity (appears to 
measure delirium) on Kruskal-Wallis 
comparisons p<0.001. Concurrent 
validity with DRS and DSM-IV (and ability 
to measure change).Internal consistency 
 ?ɲA? ? ? ? ? ? ?/ĨĂŶŝƚĞŵƌĞŵŽǀĞĚɲA? ? ? ? ?
to 0.90.ICC = 0.99. Using a cut-off of 
17.75 sensitivity=92% and specificity = 
95%.  
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Study Setting Population Method DSM IV        Criteria 
Gold 
standard Validity 
Inter-rater reliability of the 
DRS-R-98 in detecting 
delirium in frail elderly 
patients.                            
Andrew at al. (2009) 
Geriatric 
medical ward. 
145 participants, aged 75 
years and over, recruited 
as inpatients from 
geriatric medical wards, 
or as outpatients from 
emergency department. 
33 no cognitive 
impairment (NCI), 21 
cognitive impairment no 
dementia (CIND), 36 with 
dementia, 23 with 
delirium, 10 delirium and 
CIND and 22 delirium and 
dementia. 
Case-control. Yes Yes 
Concurrent validity with MMSE 
(negĂƚŝǀĞůǇĐŽƌƌĞůĂƚĞĚ ?ƌA?AL ? ? ? ? ? ?'ŽŽĚ
IRR (r=0.93 and I.C.C= 0.92). Moderate 
inter-rater agreement (0.76). However, 
sensitivity low between dementia and 
delirium groups (<0.6) 
Chinese version of the 
Delirium Rating Scale-
Revised-98: reliability and 
validity.                                   
Huang et al. (2009) 
General 
hospital and 
psychiatric 
centre. 
59 patients, 20 years and 
over, with delirium(n = 
28), alcohol dependence 
(n = 9), dementia (n =11), 
and schizophrenia and 
bipolar disorder (n = 11). 
Case series.  Yes Yes 
Face and content validity. High IRR (ICC 
A? ? ? ? ? ? ?,ŝŐŚŝŶƚĞƌŶĂůĐŽŶƐŝƐƚĞŶĐǇɲA?
0.86.Concurrent validity with MMSE; 
ƐŝŐŶŝĨŝĐĂŶƚŝŶǀĞƌƐĞĐŽƌƌĞůĂƚŝŽŶ ?ƌA?AL ? ? ? ? ?
P > 0.001). With cut-off of 15.5 for total 
score, sensitivity = 89.3% and specificity 
= 96.8%. 
Portuguese version of the 
Delirium Rating Scale-
Revised-98: reliability and 
validity.                                   de 
Negreiros et al. (2008) 
Clinical, 
psychiatric, 
surgical and 
emergency 
wards of 
general 
hospital. 
64 inpatients, 23 years 
and over, from five 
diagnostic groups (27 
delirium, 11 demented, 
11 depressed, 8 
schizophrenic and 7 
 ‘ŽƚŚĞƌ ? ? ? 
Case series.  Yes Yes 
Face and content validity (mean and 
median DRS-R-98 total scores 
significantly distinguished delirium from 
the other groups (p<0.001) inc. 
dementia). High inter-rater reliability 
(ICC between 0.9 and 1) and internal 
ĐŽŶƐŝƐƚĞŶĐǇ ?ɲA? ? ? ? ? ? ?ŽŶĐƵƌƌĞŶƚ
validity between DRS-R-98 severity 
scores and CGI. With a cut-off value of 
20  sensitivity = 92.6% and specificity = 
94.6%. 
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Study Setting Population Method DSM IV        Criteria 
Gold 
standard Validity 
Assessing severity of delirium 
by the Delirium Observation 
Screening Scale. Scheffer et al. 
(2010) 
General hospital Part of larger study: 97 patients: 41 
admitted with hip fracture, 56 medical 
patients.  
Validation study of DOS 
(using delirium as 
identified by DRS-R-98 as 
 ‘ŐŽůĚƐƚĂŶĚĂƌĚ ?). 
Yes  No Criterion validity, 
concurrent 
validity with DOS. 
A randomized controlled trial of 
quetiapine versus placebo in 
the treatment of delirium. Tahir 
et al. (2010) 
Medical, surgical 
and orthopaedic 
wards 
42 participants recruited after meeting 
DSM IV criteria for delirium and scoring 
15 or higher on DRS-R-98. 
Double blind RCT. Yes  No Content validity 
Risperidone versus olanzapine 
for the treatment of delirium. 
Kim et al. (2011) 
General hospital 32 subjects (18 male and 14 female), 
aged 
36+ years (median, 70 years). Twenty-
three (71.9%) patients had malignant 
cancer, and nine had femur fracture, 
head trauma, or pneumonia. 
7 - day, rater blind, RCT At baseline No Content validity 
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Appendix 3: MCOP-BMH Screening questionnaire 
 
 
Study number _________________________   
Ward                 _______________________ 
Researcher ___________________________  Date  
 
1. Can the patient speak enough to communicate? If no, is this due to severe aphasia or 
tracheostomy? If so, exclude. If not, screen is positive. 
2. Is the patient unconscious, drowsy or too unwell to answer? If yes, go straight to question 4, 
or review to day five, and exclude if still unable. 
 
1. Ask: Will you do a short memory test for me? 1= correct, 0= 
wrong or unable 
Positive 
What is your age? (exact)   
 
 
 
Yes 
 
No 
 
 
 
 
What is the time? (nearest hour)  
3OHDVHUHSHDWWKHDGGUHVV¶:HVW6WUHHW¶DQGWU\WRUHPHPEHULW  
What is the year? (exact)  
What is the name of this hospital? (any generally accepted)  
Can you tell me these 2 people do? (show photographs)  
What was your date of birth? (month and year correct)  
What was the year of the first world war? (accept 1914 or 1914-18)  
What is the name of the current monarch?  
Please count backwards from 20-1 (all correct)  
Recall the address  
TOTAL: Less than or equal to 7 is positive 
 
 
2. May I now ask some questions about your mood?   Positive 
Are you basically satisfied with life? No=1, Yes=0 Yes 
 
No 
 
Do you feel that your life is empty   No=0, Yes=1 
Are you afraid that something bad is going to happen to you? No=0, Yes=1 
Do you feel happy most of the time? No=1, Yes=0 
TOTAL: One or more is positive 
 
 
In the past month: Yes=1, no=0 Positive 
Have you been bothered by nerves, feeling anxious, or being on edge?  Yes 
 
No 
 
Have you been bothered by worrying about a lot of different things?  
Had an anxiety or panic attack? (sudden feeling of panic)  
TOTAL: Two or more is positive 
 
 
1RZ,¶GOLNHWRDVNVRPHTXHVWLRQVDERXWGULQNLQJDOFRKRO. 
Do you ever drink alcohol? If no, screen negative. If yes, ask: Yes=1, no=0 Positive 
Have you ever felt you needed to cut down on your drinking?  Yes 
 
No 
 
Have people annoyed you by criticising your drinking?  
Have you ever felt guilty about drinking?  
Have you ever felt you needed a drink first thing in the morning to steady 
your nerves or to get rid of a hangover (an eye-opener)? 
 
TOTAL: Two or more is positive 
 
 
4. Is there any other reason to suspect that this person might 
have a mental health problem (e.g. agitated, confused, appearing 
WRKDOOXFLQDWHQXUVHVUHSRUWµVRPHWKLQJRGG¶ 
Yes   No Positive 
Yes 
No 
Mental Health Problems on Hospital Medical Wards 
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Study number _________________________   
 
 
Date _______________________ 
 
 
Screen positive? 
 
Ask: Would you consider taking part in a research study about mood or memory 
problems in hospital? Give information sheet and explain as necessary. 
 
 
Assess capacity 
 
Can the person (free from undue pressure) 
x Understand information about the study? 
x Retain the information (for long enough to make a decision)?  
x Use it to make a decision? 
x Communicate the decision? 
 
If yes to all ± patient has capacity. If no to any ± patient lacks capacity   
 
Patient has capacity: Yes   No 
 
If yes, ask patient if they are willing to take part, and take formal consent? Ask 
patient if you could talk to a family member or carer. Then contact carer for carer-
participant consent.  
 
If no, contact carer, seek assent and carer-participant consent.  
 
 
 
 
 
Reason for not including in trial 
 
Patient refused to be screened (CR)  
Unable to screen: off ward, care being given, asleep  
No carers / family member involved in care (NC)  
Discharge home imminent/transfer to non study ward (ND)  
No English or reliable interpreter (NE)  
Incorrectly put on screening log (LTP)  
Unable to contact carers (NR)  
Patient refused consent to study  
Carer refused consent to study  
 
 
Patient name and hospital number or sticker 
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Appendix 4: MCOP-BMH Initial Questionnaire 
 
6WXG\,'««««« 
                     
Date 
 
 
Gender Male           Female          
 
Consent / assent Consent      Carer consultee   
 
 
Questionnaire completed by: 
  Please tick one box 
 7KHSDWLHQWSDUWLFLSDQW«««««««  
 Jointly by the patient participant and carer  
 Someone else:   
Who
? 
 KXVEDQGRUZLIH««««««««««««««  
  DQRWKHUUHODWLYHSOHDVHVSHFLI\LQWKHER[EHORZ«  
   
 
 
  a IULHQG««««««««««««««««««««  
  DSDLGFDUHU««««««««««««««««««  
  DQ\RWKHUSOHDVHVSHFLI\LQWKHER[EHORZ«««  
   
 
 
 
A. Living arrangements. If someone is completing the questionnaire on behalf of the patient participant, 
please give THE ANSWERS THE PATIENT PARTICIPANT WOULD GIVE if they were able. 
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1. Is the patient participant currently 
  Please tick one box 
 married or have a partner? ? ? ? ? ? ? ? ?  
 divorced or separated? ? ? ? ? ? ? ? ? ? ? ?  
 ǁŝĚŽǁĞĚ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
 never ŵĂƌƌŝĞĚ ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
 
2. Does the patient participant currently: 
  Please tick one box 
 live alone?. ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
 live with a spouse, other relative, friend or companion?.. ? ? ? ? ?  
 live in a care home (nursing)? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? 
 live in a care home (residential)? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? 
 live in a care home (mixed nursing and residential)? ? ? ? ? ? ? ? ? ?  
 
3. What is the highest level of education the patient participant achieved? 
  Please tick one box 
 Primary school education.. ? ? ? ? ? ? ? ? ? ? ?  
 ^ĞĐŽŶĚĂƌǇƐĐŚŽŽůĞĚƵĐĂƚŝŽŶ ?ĂŐĞ ? ? ? ? ? ?  
Ask separately ^ĞĐŽŶĚĂƌǇƐĐŚŽŽů ?ŽůĚĞƌƚŚĂŶ ? ? ? ? ? ? ? ?  
sŽĐĂƚŝŽŶĂůĞĚƵĐĂƚŝŽŶ ? ? ? ? ? ? ? ? ? ? ? ? ? ? University/higher education ? ? ? ? ? ? ? ? ? ?  
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Sections to be completed by direct interview with the participant 
 
B. General health 
 
 
 [Econ] 1. In comparison with other 
people of the same age, how do you 
consider your health? 
Not as good   
As good   
Better   
Does not know  
 
[SOF] 6. Do you currently feel full of energy?  
  
Please tick one box 
 Yes ? ? ? ? ? ? ? ? ? ?  
 EŽ ? ? ? ? ? ? ? ? ? ? ? ?  
 
[EQ5D] 4. Pain / Discomfort: Do you currently have any pain or discomfort?  
  
Please tick one box 
 I have no pain or ĚŝƐĐŽŵĨŽƌƚ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
 /ŚĂǀĞŵŽĚĞƌĂƚĞƉĂŝŶŽƌĚŝƐĐŽŵĨŽƌƚ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
 /ŚĂǀĞĞǆƚƌĞŵĞƉĂŝŶŽƌĚŝƐĐŽŵĨŽƌƚ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
 
C. Cognition: Will you do a memory test for me? 
 
[MMSE] 
ORIENTATION 
What is the year, season, month, date, day (write down date response) / 5 
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Where are we: country, county, town, hospital, ward /5 
MEMORY REGISTRATION 
Examiner names 3 objects (apple, table, penny) 
Patient asked to repeat the 3 names  W score one for each correct answer 
Then patient to learn 3 names (i.e. repeat until correct) 
 
/3 
ATTENTION AND CALCULATION 
Subtract 7 from 100, then repeat from result etc. Stop after 5. 
100     93     86     79     72     65 
 ?ůƚĞƌŶĂƚŝǀĞůǇ ?ƐƉĞůů “ǁŽƌůĚ ?ďĂĐŬǁĂƌĚƐ ?>ZKt ? 
/5 
RECALL 
Ask for 3 objects learnt earlier /3 
LANGUAGE 
Name a pencil and watch /2 
ZĞƉĞĂƚ “EŽ ?ŝĨƐ ?ĂŶĚƐ ?ŽƌďƵƚƐ ? /1 
Give a 3-stage command. Score one point for each correct stage. 
 ?Ğ ?Ő ? “ƚĂŬĞƚŚĞƉĂƉĞƌŝŶǇŽƵƌƌŝŐŚƚŚĂŶĚ ?ĨŽůĚŝƚŝŶƚǁŽĂŶĚƉƵƚŝƚŽŶƚŚĞĨůŽŽƌ ? ?
 
 
/3 
ƐŬƚŚĞƉĂƚŝĞŶƚƚŽƌĞĂĚĂŶĚŽďĞǇĂǁƌŝƚƚĞŶĐŽŵŵĂŶĚŽŶĂƉŝĞĐĞŽĨƉĂƉĞƌ ?ƐƚĂƚŝŶŐ P “ĐůŽƐĞǇŽƵƌĞǇĞƐ ? ? /1 
Ask the patient to write a sentence. Score if it is sensible and has a subject and a verb. 
 
 
 
 
 
/1 
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COPYING 
Ask the patient to copy a pair of intersecting pentagons 
 
 
 
 
 
 
 
/1 
TOTAL SCORE /30 
 
CLOSE YOUR EYES 
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Score the following items from the MMSE results, and carer report (but note different 
criteria for scoring date)  
 
[DRS] 9. Orientation. (Note specific (and liberal) definition of orientation to person) 
 
Disorientation to person means not recognizing familiar persons and may be intact even if the person has naming 
difficulty but recognizes the person. Disorientation to person is most severe when one doesn't know one's own 
identity and is rare. Disorientation to person usually occurs after disorientation to time and/or place. Patients who 
cannot speak can be given a visual or auditory presentation of multiple choice answers. Allow patient to be 
wrong by up to 7 days instead of 2 days for patients hospitalized more than 3 weeks. 
 
Score  
Please tick one box 
0 Oriented to person, place and time  ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?..  
1 Disoriented to time (e.g., by more than 2 days or wrong month or wrong year) or to 
place (e.g., name of building, city, state), but ŶŽƚďŽƚŚ ? ? ? ? ? ? ? ? ? ? ? 
 
 
2 Disoriented to time and place  
3 Disoriented to person  
 
[DRS] 11. Short-term memory.  
 
Defined as recall of information (e.g. 3 items presented either verbally or visually) after a delay of about 2 to 3 
minutes. When formally tested, information must be registered adequately before recall is tested. The number of 
trials to register as well as effect of cueing can be noted on scoresheet. Patient should not be allowed to rehearse during 
the delay period and should be distracted during that time. Patient may speak or nonverbally communicate to the 
examiner the identity of the correct items. Short-term deficits noticed during the course of the interview can be used 
also. 
 
Score  
Please tick one box 
0 Short-term memory intact  
1 Recalls 2/3 items; maybe able to recall third item after category cueing  
2 Recalls 1/3 items; may be able to recall other items after category cueing  
3 Recalls 0/3 items  ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
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[DRS] 12. Long-term memory [DRS]. (Try current news items, children, medical history) 
 
Can be assessed formally or through interviewing for recall of past personal (e.g. past medical history or 
information or experiences that can be corroborated from another source) or general information that is 
culturally relevant. When formally tested, use a verbal and/or visual modality for 3 items that are 
adequately registered and recalled after at least 5 minutes. The patient should not be allowed to 
rehearse during the delay period during formal testing. Make allowances for patients with less than 
8 years of education or who are mentally retarded regarding general information questions. Rating of 
the severity of deficits may involve a judgment about all the ways long-term memory is assessed, 
including recent and/or remote long-term memory ability informally tested during the interview as well 
as any formal testing of recent long-term memory using 3 items. 
 
score  
Please tick one box 
0 No significant long-term memory deficits  ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
1 Recalls 2 /3 items and/ or has minor difficulty recalling details of other long-term information 
 ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? 
 
 
2 Recalls 1/3 items and/ or has moderate difficulty recalling other long-term information  
3 Recalls 0/3 items and/or has severe difficulty recalling other long-term information. 
 ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? 
 
 
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This section onwards is to be completed by direct interview with the patient 
participant and/or carer on their behalf  
 
D. Sleep. How do you sleep? Do you get up in the night? Is that only for the toilet or due to pain? Are you sleepy 
in the day? 
 
 
[NPI] 11. Sleep: Does the subject have 
difficulty sleeping?  Is he or she up at 
night (not including getting up once or 
twice to the toilet)?  Does he/she get up 
at night thinking it is day?  Is he /she 
sleepy during the day? 
Yes     No  
If yes, how often do these problems occur Occasionally (<once a week)  
Often (about once a week)       
Frequent (several times a week but less than every day)  
Very frequent (every night)   
And how severe are the problems? Mild (night time behaviours occur but are not particularly 
disruptive)  
 
Moderate (night time behaviours occur and disturb the 
subject and the sleep of the carer; more than one type of 
night time behaviour may be present)  
 
Marked (night time behaviour occurs; several types of 
night time behaviour may be present; the subject is very 
distressed during the night and the sleep of the carer very 
disturbed)  
 
[CSDD] D: CYCLIC FUNCTIONS;  RW rating 
 0= not present 1= mild or intermittent 2= severe 
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13. Difficulty falling asleep 
Later than usual for this individual 
   
14. Multiple awakenings during sleep    
15. Early morning awakenings 
Earlier than usual for this individual 
   
 
[DRS] 1. Sleep wake cycle disturbance.  
 
Rate sleep-wake pattern using all sources of information, including from family, ĐĂƌĞŐŝǀĞƌƐ ?ŶƵƌƐĞƐ ?ƌĞƉŽƌƚƐ ?ĂŶĚ
patient. Try to distinguish sleep from resting with eyes closed 
 
score  
Please tick one box 
0 Not present  ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
1 Mild sleep continuity disturbance at night or occasional drowsiness during the day ..  
2 Moderate disorganisation of sleep-wake cycle (e.g. falling asleep during conversations, 
napping during the day or several brief awakenings during the night with 
ĐŽŶĨƵƐŝŽŶ ?ďĞŚĂǀŝŽƵƌĂůĐŚĂŶŐĞƐŽƌǀĞƌǇůŝƚƚůĞŶŝŐŚƚƚŝŵĞƐůĞĞƉ ? ? ? ? ? ? ? ? ? 
 
 
 
3 Severe disruption of sleep wake cycle (e.g. day-night reversal of sleep wake cycle, or severe 
circadian fragmentation with multiple periods of sleep and wakefulness or severe 
sůĞĞƉůĞƐƐŶĞƐƐ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
 
 
 
 
[CSDD] C: PHYSICAL SIGNS; RW rating    
 0= not present 1= mild or intermittent 2= severe  
11. Lack of energy 
Fatigues easily, unable to sustain activities (score only if change 
occurred  acutely i.e. in less than 1 month) 
   
 
E. Appetite and weight loss (rate appetite, swallowing and physical feeding problems) 
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[NPI] 12. Appetite: ,ĂƐƚŚĞƐƵďũĞĐƚ ?Ɛ
appetite or eating habits changed?  
Has he/she lost of gained weight, or 
changed the foods he/she likes? 
Yes     No  
If yes, how often do these problems 
occur 
Occasionally (< once a week)  
Often (about once a week)       
Frequent (several times a week but less than every day)  
Very frequent (once a day or more)   
And how severe are the problems? Mild (change in appetite or eating habits is present but has not led 
to change in weight & is not disturbing)  
 
Moderate (change in appetite or eating habits is present & cause 
minor change in weight)  
 
Marked (obvious changes in appetite or eating habits are present 
and cause weight change; is embarrassing or otherwise disturbs 
the subject)   
 
[PCI, MNA] 7. Has your food intake declined over the past 3 months due to loss of appetite, digestive problems, 
chewing or swallowing difficulties?  
  
Please tick one box 
 Severe loss of appetite (eats less than ¼ of meal) ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
 Moderate loss of appetite (eats less than normal but more than ¼ of meal)  ? ? ? ?  
 No loss of appetite ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
 
[SOF, MNA] 8. Have you lost weight unintentionally in the last three months? 
  
Please tick one box 
 Yes««««««  
 1R««««««  
 
[PCI] 9. If you have lost weight during the last three months, how much weight have you lost?  
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Please complete one box 
 Weight loss (please state in kilograms: 1kg = 2.2 lb; 1 stone = 6.4 kg)  
 
 
  
Do not 
NQRZ««««««««««««««««««««««««««««««««««««« 
 
 
 
[CSDD] C: PHYSICAL SIGNS; RW rating 
 0= not present 1= mild or intermittent 2= severe 
9. Appetite loss 
Eating less than usual 
   
10. Weight loss 
(score 2 if greater than 2kg in one month) 
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F. Activities of daily living. Please score what the patient participant has actually done in the last week or so.  
 
 [Barthel index items]  
[PCI] How has the subject managed with their personal hygiene over 
the last 7 days? 
Independent             
Supervised               
Limited assistance     Extensive 
assistance  
Total Dependence      
How do they manage 
with grooming? 
Needs help with personal care 0  
Independent face/hair/teeth/shaving (implements provided) 1 
[PCI] With regards to eating over the last seven days in particular, how 
has the subject managed? 
Independent             
Supervised               
Limited assistance      
Extensive assistance  
              Total Dependence      
How do they manage with 
eating? 
Unable 0  
Needs help cutting, spreading butter etc. 1 
Independent (food provided in reach) 2 
How do they manage with 
dressing? 
Dependent 0  
Needs help but can do about half unaided 1 
Independent (including buttons, zips, laces etc.) 2 
How do they manage with 
bathing? 
Dependent 0  
Independent (or in shower) 1 
[PCI] How has the subject managed with using the toilet over the last 7 
days? 
Independent             
Supervised               
Limited assistance     Extensive 
assistance  
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Total Dependence      
How do they manage 
using the toilet? 
Dependent 0 
1 
2 
 
Needs some help but can do something alone 
Independent (on and off, dressing, wiping) 
How do they manage with 
their bladder? 
Incontinent or catheterised and unable to manage 0  
Occasional accident (max once per 24 hours) 1 
Continent (for over 7 days) 2 
How do they manage with 
their bowels? 
Incontinent (or needs to be given enema) 0  
Occasional accident (once per week) 1 
Continent 2 
 
[EQ5D] 2. Self care  
Please tick one box 
 /ĂŵƵŶĂďůĞƚŽǁĂƐŚŽƌĚƌĞƐƐŵǇƐĞůĨ ? ? ? ? ? ? ? ? ? ? ? ? ?  
 /ŚĂǀĞƐŽŵĞƉƌŽďůĞŵƐŝŶǁĂƐŚŝŶŐŽƌĚƌĞƐƐŝŶŐ ? ? ? ? ? ? ?  
 I have no-problems with looking after ŵǇƐĞůĨ ? ? ? ? ? ? ? ? ?  
 
[EQ5D] 3. Usual activities (e.g. housework, leisure, family)?   
Please tick one box 
 /ĂŵƵŶĂďůĞƚŽƉĞƌĨŽƌŵŵǇƵƐƵĂůĂĐƚŝǀŝƚŝĞƐ ? ? ? ? ? ? ? ? ? ?  
 /ŚĂǀĞƐŽŵĞƉƌŽďůĞŵƐƉĞƌĨŽƌŵŝŶŐŵǇƵƐƵĂůĂĐƚŝǀŝƚŝĞƐ ? ? ? ? ?  
 I have no problems performing ŵǇƵƐƵĂůĂĐƚŝǀŝƚŝĞƐ ? ? ? ? ? ? ?  
 
  
 120 
 
G. Mobility. 
  
 
[Barthel index items]  
[MNA] With regard to mobility, 
is the subject? 
Bed or chair bound      
Able to get out of bed/chair but does not go out   
Goes out  
[PCI] Over the last seven days 
in particular, how has the 
subject been with regard to 
mobility? 
Independent             
Supervised               
Limited assistance      
Extensive assistance  
Total Dependence      
How do they manage 
with transferring? 
Unable - no sitting balance 0  
Major help (one or two people, physical) can 
sit 
1 
Minor help (verbal or physical) 2 
Independent 3 
How do they manage 
with mobility? 
Immobile 0  
Wheelchair independent including corners etc. 1 
Walks with help of one person (verbal or 
physical) 
2 
Independent (but may use any aid e.g. stick) 3 
How do they manage 
with stairs? 
Unable 0  
Needs help (verbal, physical, carrying aid) 1 
Independent up and down 2 
 
[EQ5D] 1. Mobility  
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Please tick one box 
 I am ĐŽŶĨŝŶĞĚƚŽďĞĚ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
 /ŚĂǀĞƐŽŵĞƉƌŽďůĞŵƐŝŶǁĂůŬŝŶŐĂďŽƵƚ ? ? ? ? ? ? ? ? ? ? ?  
 /ŚĂǀĞŶŽƉƌŽďůĞŵƐǁĂůŬŝŶŐĂďŽƵƚ ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
 
 
H. Mood and anxiety  
 
 
[NPI] 4. Depression: does the subject 
seem sad or depressed? Does he or 
she say that he or she feels sad or 
depressed? Or a burden, a failure or 
a bad person? Or say he/she wishes 
to die or harm him/herself? 
Yes     No  
If yes, how often do these problems 
occur? 
Occasionally (<once a week)  
Often (about once a week)      
Frequent (several times a week but less than every day)  
Very frequent (once a day or more)   
And how severe are the problems? Mild (depression is distressing but usually responds to distraction or 
reassurance)  
 
Moderate (depression is distressing, depressive thoughts are 
spontaneously spoken by the subject and difficult to alleviate)  
 
Marked (depression is very distressing, & a major source of suffering for 
the subject)  
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[NPI] 5. Anxiety: Is the subject 
nervous, anxious, worried or 
frightened? Is he/she shaky, tense or 
fidgety? Is he/she afraid to be in 
particular places or apart from 
familiar people?  
Yes     No  
If yes, how often do these problems 
occur? 
Occasionally (<once a week)  
Often (about once a week)      
Frequent (several times a week but less than every day)  
Very frequent (once a day or more)   
And how severe are the problems? Mild (anxiety is distressing but usually responds to distraction or 
reassurance)  
 
Moderate (anxiety is distressing, anxiety symptoms are spontaneously 
voiced by the subject and difficult to alleviate)  
 
Marked (anxiety is very distressing & a major source of suffering for the 
subject)  
 
[EQ5D] 5. Anxiety / Depression 
  
Please tick one box 
 ,DPQRWDQ[LRXVRUGHSUHVVHG«««««««««««««  
 ,DPPRGHUDWHO\DQ[LRXVRUGHSUHVVHG«««««««««  
 ,DPH[WUHPHO\DQ[LRXVRUGHSUHVVHG«««««««««  
 
[CSDD] A: MOOD RELATED SIGNS; RW rating 
 0= not 
present 
1= mild or intermittent 2= severe  
1. Anxiety 
Anxious expression, ruminations, worrying 
   
2. Sadness 
Sad expression, sad voice, tearfulness 
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3. Lack of reactivity to pleasant events    
16. Suicide 
Feels life is not worth living, has suicidal wishes, or made 
suicide attempt 
   
17. Poor self esteem 
Self blame, self depreciation, feelings of failure  
   
18.Pessisism 
Anticipation of the worst 
   
 
[NPI] 7. Apathy and indifference: has the subject 
lost interest in the world around him/her? Does 
he or she seem less interested in his/her usual 
activities and in other people? Or become less 
likely to start a conversation? Or seems not to 
have any motivation or not to care about things 
any more? 
Yes     No  
If yes, how often do these problems occur? Occasionally (<once a week)  
Often (about once a week)      
Frequent (several times a week but less than every day)  
Very frequent (once a day or more)   
And how severe are the problems? Mild (apathy is noticeable but produces little interference with 
daily life; only slightly different from usual behaviour; subject 
responds to suggestions to do things)  
 
Moderate (apathy is very evident; may be overcome with 
coaxing and encouragement; responds spontaneously only to 
powerful events such as family visits)  
 
Marked (apathy is very evident and usually fails to respond to 
any encouragement or external events)  
 
[CSDD] B: BEHAVIOURAL DISTURBANCE; RW rating 
 0= not present 1= mild or intermittent 2= severe  
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8. Loss of interest 
Less involved in usual activities (score only if change 
occurred  acutely i.e. in less than 1 month) 
   
 
[DRS] 4. Lability of affect (do mood and emotions vary, are they under control and appropriate?).  
Rate the patient's affect as the outward presentation of emotions and not as a description of what the patient feels. 
score  
Please tick one box 
0 Not present   ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
1 Affect somewhat altered or incongruent to situation; changes over the course of hours; 
emotions are mostly under self-ĐŽŶƚƌŽů ? ? ? ? ? ? ? ? ? ? 
 
 
2 Affect is often inappropriate to the situation and intermittently changes over the course of 
minutes; emotions are not consistently under self-control, though they respond to redirection 
ďǇŽƚŚĞƌƐ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? 
 
 
 
3 Severe and consistent disinhibition of emotions; affect changes rapidly, is inappropriate to 
context, and does not respond to rediƌĞĐƚŝŽŶďǇŽƚŚĞƌƐ ? ? 
 
 
 
[CSDD] D: CYCLIC FUNCTIONS; RW rating 
 0= not present 1= mild or intermittent 2= severe 
12. Diurnal variation of mood 
Symptoms worse in the morning 
   
 
 [NPI] 6. Elation: does the subject seem 
abnormally cheerful or happy for no 
reason? Does he/she find things funny 
ƚŚĂƚŽƚŚĞƌƐĚŽŶ ?ƚ ?KƌƚĞůů silly jokes, or 
play tricks or pranks? Or boast about 
abilities or wealth? 
Yes     No  
If yes, how often do these problems 
occur 
Occasionally (<once a week)  
Often (about once a week)      
Frequent (several times a week but less than every day)  
Very frequent (once a day or more)   
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And how severe are the problems? Mild (elation is noticeable by friends and family but is not disruptive)  
 
Moderate (elation is noticeably abnormal)  
 
Marked (elation is very pronounced; subject is euphoric and finds 
everything to be funny)  
 
[NPI]: 8. Disinhibition: does the subject 
seem to act impulsively without 
thinking about the consequences? 
Does he/she talk to strangers as if he or 
she knows them? Or say or do things 
that are rude or embarrassing? Or hurt 
ƉĞŽƉůĞ ?ƐĨĞĞůŝŶŐƐ ?
Yes     No  
If yes, how often do these problems 
occur? 
Occasionally (<once a week)  
Often (about once a week)      
Frequent (several times a week but less than every day)  
Very frequent (once a day or more)   
And how severe are the problems? Mild (behaviour is noticeable but usually responds to distraction or 
reassurance)  
 
Moderate (behaviour is very evident and difficult to overcome by carer) 
 
 
Marked (behaviour usually fails to respond to any intervention by carer 
and is a source of embarrassment or social distress)  
 
H. Agitation, irritability, increased or decreased motor activity 
 
 
[NPI] 9. Irritability and temper: does 
the subject get irritated easily? Or 
impatient? Do his/her moods change 
quickly? Does he/she get bad 
Yes     No  
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tempered? Or angry or argumentative?  
If yes, how often do these problems 
occur? 
Occasionally (<once a week)  
Often (about once a week)      
Frequent (several times a week but less than every day)  
Very frequent (once a day or more)   
And how severe are the problems? Mild (irritability or moodiness is noticeable but usually responds to 
distraction or reassurance)  
 
Moderate (irritability or moodiness is very evident and difficult to 
overcome by carer)  
 
Marked (irritability or moodiness is very evident, usually fails to respond 
to any intervention by carer and they are a major source of distress)  
 
[CSDD] A: MOOD RELATED SIGNS; RW rating 
 0= not present 1= mild or intermittent 2= severe  
4. Irritability.  
Easily annoyed, short tempered 
   
 
[NPI] 3. Agitation and Aggression: 
does the subject have periods when 
he/she is agitated or aggressive? Or 
refuses to co-ŽƉĞƌĂƚĞ ?KƌǁŽŶ ?ƚůĞƚ
people help him/her with washing or 
dressing? Or shout or swear? 
Yes     No  
If yes, how often do these problems 
occur? 
Occasionally (<once a week)  
Often (about once a week)      
Frequent (several times a week but less than every day)  
Very frequent (once a day or more)   
And how severe are the problems? Mild (behaviour is disruptive but can be managed with distraction or 
reassurance)  
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Moderate (behaviour is disruptive and difficult to distract or control)  
 
Marked (agitation is very disruptive and a major source of difficulty; 
there may be a threat of personal harm)  
 
[NPI] 10. Motor behaviour: does the 
subject pace around or wander? Or 
engage in repetitive activities, such as 
opening cupboards or drawers, or 
picking at things, or winding threads? 
Yes     No  
If yes, how often do these problems 
occur 
Occasionally (<once a week)  
Often (about once a week)      
Frequent (several times a week but less than every day)  
Very frequent (once a day or more)   
And how severe are the problems? Mild (behaviour is noticeable but produces little interference with daily 
life)  
Moderate (behaviour is very evident but can be overcome by carer)  
Marked (behaviour is very evident and usually fails to respond to any 
intervention by carer & is a major source of distress)  
 
[DRS] 7. Motor agitation.  
Rate by observation, including from other sources of observation such as by visitors, family and clinical 
staff. Do not include dyskinesia, tics, or chorea. 
score  
Please tick one box 
0 No restlessness or agitation  ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
1 Mild restlessness of gross motor movements or mild fidgetiness  
2 Moderate motor agitation including dramatic movements of the extremities, pacing , 
fidgeting, removing intravenous lines, etc 
 
3 Severe motor agitation, such as combativeness or a need for restraints or seclusion   
 
[DRS] 8. Motor retardation. ` 
Rate movement by direct observation or from other sources of observation such as family, visitors, or clinical staff. Do 
not rate components of retardation that are caused by parkinsonian symptoms. Do not rate drowsiness or sleep. 
score  
Please tick one box 
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0 No slowness of voluntary movements  ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
1 Mildly reduced frequency, spontaneity or speed of motor movements, to the degree 
that may interfere somewhat with the assessment. 
 
2 Moderately reduced frequency, spontaneity or speed of motor movements to the 
degree that it interferes with participation in activities or self-care 
 
3 Severe motor retardation with few spontaneous movements. ? ? ? ? ? ? ? ? ? ? ?  
 
[CSDD] B: BEHAVIOURAL DISTURBANCE; RW rating 
 0= not present 1= mild or 
intermittent 
2= severe 
5. Agitation 
Restlessness, hand-wringing, hair-pulling 
   
6. Retardation 
Slow movements, slow speech, slow reactions  
   
7. Multiple physical complaints 
(score 0 if GI symptoms only) 
   
 
I. Delusions and hallucinations 
 
 
[NPI] 1. Delusions: does the 
subject have beliefs that you 
know are not true? 
Yes     No  
If yes, how often do these 
problems occur? 
Occasionally (<once a week)  
Often (about once a week)      
Frequent (several times a week but less than every day)  
Very frequent (once a day or more)   
And how severe are the 
problems? 
Mild (beliefs present but seem harmless and produce little distress)  
 
Moderate (beliefs are distressing and disruptive) 
 
Marked (beliefs are very disruptive & are a major source of disturbed behaviour)  
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[CSDD] E. IDEATIONAL DISTURBANCE; RW rating 
 0= not present 1= mild or intermittent 2= severe  
19. Mood congruent (depressive, manic) 
delusions  
Delusions of poverty, illness, or loss 
   
 
[DRS] 3. Delusions.  
Delusions can be of any type, but are most often persecutory. Rate if reported by patient, family or caregiver. Rate as 
delusional if ideas are unlikely to be true yet are believed by the patient who cannot be dissuaded by logic. Delusional 
ideas cannot be explained otherwise by the patient's usual cultural or religious background.  
score  
Please tick one box 
0 Not present   ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
1 DŝůĚůǇƐƵƐƉŝĐŝŽƵƐ ?ŚǇƉĞƌǀŝŐŝƚĂŶƚ ?ŽƌƉƌĞŽĐĐƵƉŝĞĚ ? ? ? ? ? ? ? ? ? ? ? ? ?  
2 Unusual or overvalued ideation that does not reach delusional proportions or could 
ďĞƉůĂƵƐŝďůĞ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? 
 
 
3 Delusional   ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
 
[NPI] 2. Hallucinations: does the 
subject have hallucinations, such as 
false visions or voices? 
Yes     No  
If yes, how often do these problems 
occur? 
Occasionally (<once a week)  
Often (about once a week)      
Frequent (several times a week but less than every day)  
Very frequent (once a day or more)   
And how severe are the problems? Mild (hallucinations present but seem harmless and produce little 
distress)  
Moderate (hallucinations are distressing and disruptive)  
 
Marked (hallucinations are very disruptive & are a major source of 
disturbed behaviour)  
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[DRS] 2. Perceptual disturbances and hallucinations.  
Illusions and hallucinations can be of any sensory modality. Misperceptions are "simple" if the y are 
uncomplicated, such as a sound, noise, colour, spot, or flashes and "complex" if they are multidimensional, such as 
voices, music, people, animals, or scenes. Rate if reported by patient or caregiver, or inferred by observation  
score  
Please tick one box 
0 Not present  ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
1 Mild perceptual disturbances (e.g., feelings of derealization or depersonalization; or 
patient may not be able to discriminate dreams ĨƌŽŵƌĞĂůŝƚǇ ? ? ? ? ? ? ? ? ? ?
 
 
2 Illusions present  ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
3 Hallucinations present   ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
 
 
J. Delirium diagnostic items. 
 
 
[DRS] 14. Temporal onset of symptoms (Rate change in mental state or behaviour).   
Rate the acuteness of onset of the initial symptoms of the disorder or episode being currently assessed, not their 
total duration. Distinguish the onset of symptoms attributable to delirium when it occurs concurrently with a different 
preexisting psychiatric disorder. For example, if a patient with major depression is rated during a delirium episode due 
to an overdose, then rate the onset of the delirium symptoms. 
score  
Please tick one box 
0 No significant change from usual or longstanding baseline behaviour ...  
1 Gradual onset of symptoms, occurring over a period of several weeks to a month   
 
2 Acute change in behaviour or personality occurring over days to a week   
3 Abrupt change in behaviour occurring over a period of several hours to a day  ?  
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[DRS] 15. Fluctuation of symptom severity. (Apply to any mental or psychological symptoms or behaviour)  
Rate the waxing and waning of an individual or cluster of symptom(s) over the time frame being rated. Usually 
applies to cognition, affect, intensity of hallucinations, thought disorder, language disturbance. Take into 
consideration that perceptual disturbances usually occur intermittently, but might cluster in period of greater 
intensity when other symptoms fluctuate in severity,  
score  
Please tick one box 
0 No symptom fluctuation  
1 Symptom intensity fluctuates in severity over hours   
2 Symptom intensity fluctuates in severity over minutes  
 
[DRS] 16. Physical disorder (any drug, infection, metabolic or brain disorder or other  medical problem).  
Rate the degree to which a physiological, medical or pharmacological problem can be specifically attributed to have 
caused the symptoms being assessed. Many patients have such problems but they may or may not have causal 
relationship to the symptoms being rated. 
score  
Please tick one box 
0 None present or active ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
1 Presence of any physical disorder that might affect mental state  
2 Drug, infection, metabolic disorder, CNS lesion or other medical problem that 
specifically can be implicated in causing the altered behaviour or mental state 
 
 
K. Observations from interview. 
 
 
[DRS] 10. Attention.  
Attention can be assessed during the interview (e.g., verbal perseverations, distractibility, and difficulty with 
set shifting) and /or through use of specific tests, e.g., digit span. Patients with sensory deficits or who are 
intubated or whose hand movements are constrained should be tested using an alternate modality besides 
writing.  
Score  
Please tick one box 
0 Alert and attentive  ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
1 Mildly distractible or mild difficulty sustaining attention, but able to refocus with 
cueing. On formal testing makes only minor errors and is not significantly slow in 
ƌĞƐƉŽŶƐĞƐ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
 
 
 
2 Moderate inattention with difficulty focusing and sustaining attention. On formal testing,  
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makes numerous errors and either requires ƉƌŽĚĚŝŶŐƚŽĨŽĐƵƐŽƌĨŝŶŝƐŚƚŚĞƚĂƐŬ ? ?  
3 Severe difficulty focusing and/or sustaining attention, with many incorrect or 
incomplete responses or inability to follow instructions. Distractible by other noises or 
events in the environment  ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? 
 
 
 
 
[DRS] 5. Language.  
Rate abnormalities of spoken, written or sign language that cannot be otherwise attributed to dialect or stuttering. 
Assess fluency, grammar, comprehension, semantic content and naming. Test comprehension and naming 
nonverbally if necessary by having patient follow commands or point. 
score  
Please tick one box 
0 Normal language  ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
1 Mild impairment including word-ĨŝŶĚŝŶŐĚŝĨĨŝĐƵůƚǇŽƌƉƌŽďůĞŵƐǁŝƚŚŶĂŵŝŶŐŽƌĨůƵĞŶĐǇ ?  
2 Moderate impairment including comprehension difficulties or deficits in meaningful 
ĐŽŵŵƵŶŝĐĂƚŝŽŶ ?ƐĞŵĂŶƚŝĐĐŽŶƚĞŶƚ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? 
 
 
3 Severe impairment including nonsensical semantic content, word salad, muteness, or 
severely reduced comprehension  ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? 
 
 
 
[DRS] 6. Thought process abnormalities (do thoughts flow logically one to the next, coherence of thought). 
Rate abnormalities of thinking processes based on verbal or written output. If a patient does not speak or write, do 
not rate this item. 
score  
Please tick one box 
0 Normal thought processes  ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
1 dĂŶŐĞŶƚŝĂůŽƌĐŝƌĐƵŵƐƚĂŶƚŝĂů ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
2 ƐƐŽĐŝĂƚŝŽŶƐůŽŽƐĞůǇĐŽŶŶĞĐƚĞĚŽĐĐĂƐŝŽŶĂůůǇ ?ďƵƚůĂƌŐĞůǇĐŽŵƉƌĞŚĞŶƐŝďůĞ ? ? ? ?  
3 Associations loosely connected most of the time  ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?..  
  
[DRS] 13. Visuospatial ability (use intersecting pentagons, and reports of navigation on ward  or at home) 
Assess informally and formally. Consider patient's difficulty navigating one's way around living areas or environment 
(e.g. getting lost). Test formally by drawing or copying a design, by arranging puzzle pieces, or by drawing a map and 
identifying major cities, etc. Take into account any visual impairments that may affect performance  
Score  
Please tick one box 
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0 No impairment  ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
1 Mild impairment such that overall design and most details or pieces are correct; 
and/or little difficulty navigating in his/her ƐƵƌƌŽƵŶĚŝŶŐƐ ? ? ? ? ? ? ? ? ? ? ? ? 
 
 
2 Moderate impairment with distorted appreciation of overall design and/or several 
errors of details or pieces; and/or needing repeated redirection to keep from getting 
lost in a newer environment despite, trouble locating familiar objects in immediate 
ĞŶǀŝƌŽŶŵĞŶƚ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? 
 
 
 
 
3 Severe impairment on formal testing; and/or repeated wandering or getting lost in 
environment  ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? 
 
 
 
 
L. Help and support received, OVER THE LAST FEW WEEKS.  
 
 
[Econ] 1. How financially well off do you feel in general? 
  
Please tick one box 
 Very well off.««««««««««««««««««««  
 :HOORII««««««««««««««««««««  
 1RWZHOORII«««««««««««««««««««  
 
[Econ] 2. Do you receive pension credit? 
  
Please tick one box 
 Yes««««««  
 1R««««««  
 
[PCI] 3. Have you been admitted to a nursing/care home in the past three months? 
  
Please tick one box 
 Yes««««««  
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 1R««««««  
 
[Econ]4. How many different people provide personal or domestic care for you? 
(do not answer if in care home) 
 
[Econ] 7. Do you attend: 
 Please tick one 
box 
Name of place you attend 
 
If yes, how 
many times per 
week 
Day centre/hospital Yes   No   
«««««««««« 
 
«««««« 
Others (please list) 
 
«««««««««««««« 
 
 
«««««««««« 
 
 
«««««« 
 
««««««««««««««« 
 
«««««««««« 
 
«««««« 
   
 
«««««««««««««« 
 
«««««««««« 
 
«««««« 
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[Econ] 5. Do any of the following come in to see you? 
 
 Please tick one box 
If yes, how many times 
per day and times per 
week 
Community care assistant          Yes    No  ««««««««««««««««
.. 
Privately organised carer  Yes    No  ««««««««««««««««
.. 
Cleaner  Yes    No  ««««««««««««««««
.. 
Community Matron  Yes    No  ««««««««««««««««
.. 
District Nurse  Yes    No  ««««««««««««««««
.. 
Specialist nurse  Yes    No  ««««««««««««««««
.. 
Other (please list) 
««««««««««««««««««««««««««««««««««««
« 
 
««««««««««««««««
.. 
««««««««««««««««««««««««««««««««««««
« 
««««««««««««««««
.. 
««««««««««««««««««««««««««««««««««««
« 
««««««««««««««««
.. 
««««««««««««««««««««««««««««««««««««
« 
««««««««««««««««
.. 
 
[Econ] 6. How often do you talk to neighbours, friends/relatives, at home/elsewhere? 
 (subjective perception only) 
Please tick one box 
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 Very often.««««««««««««««««««««  
 Often.««««««««««««««««««««««  
 1RWYHU\RIWHQ««««««««««««««««««  
 1HYHU««««««««««««««««««««««  
 
 
 
 
M. Prior activities of daily living. Please score what the patient participant actually did prior to 
the current illness, or 3 months ago if current illness longer than this.  
 
How do they manage 
with eating? 
Unable 0 
1 
2 
 
Needs help cutting, spreading butter etc. 
Independent (food provided in reach) 
How do they manage 
with grooming? 
Needs help with personal care 0  
Independent face/hair/teeth/shaving (implements provided) 1 
How do they manage 
with dressing? 
Dependent 0  
Needs help but can do about half unaided 1 
Independent (including buttons, zips, laces etc.) 2 
How do they manage 
with bathing? 
Dependent 0  
Independent (or in shower) 1 
How do they manage 
using the toilet? 
Dependent 0  
Needs some help but can do something alone 1 
Independent (on and off, dressing, wiping) 2 
How do they manage 
with their bladder? 
Incontinent or catheterised and unable to manage 0  
Occasional accident (max once per 24 hours) 1 
Continent (for over 7 days) 2 
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How do they manage 
with their bowels? 
Incontinent (or needs to be given enema) 0  
Occasional accident (once per week) 1 
Continent 2 
How do they manage 
with transferring? 
Unable - no sitting balance 0  
Major help (one or two people, physical) can sit 1 
Minor help (verbal or physical) 2 
Independent 3 
How do they manage 
with mobility? 
Immobile 0  
Wheelchair independent including corners etc. 1 
Walks with help of one person (verbal or physical) 2 
Independent (but may use any aid e.g. stick) 3 
How do they manage 
with stairs? 
Unable 0  
Needs help (verbal, physical, carrying aid) 1 
Independent up and down 2 
 
N. Measurements 
 
 
Weight (from notes /nursing record if 
done, estimate if unable to weigh) 
 
Demispan 
 
 
Mid-arm circumference (cm) Right arm  
      
Left arm 
Calf circumference (cm) 
 
Right calf Left calf 
Grip strength Right Left  
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Ability to rise from a chair 5 times 
without using his/her arms 
Yes        No  Time 
 
The end, thank you! 
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Appendix 5: MCOP-BMH Medical Data Form 
 
6WXG\,'««««« 
 
This section is to be completed from the medical 
notes of the participant by the researcher 
 
 
Has the participant ever had any of the following medical conditions? 
Myocardial infarct Yes           No  
Congestive heart failure Yes           No  
Peripheral vascular disease Yes           No  
Cerebrovascular disease Yes           No  
Dementia Yes           No  
Chronic pulmonary disease Yes           No  
Short of breath Yes           No  
Connective tissue disease Yes           No  
Ulcer disease Yes           No  
Mild liver disease Yes           No  
Moderate or severe liver disease Yes           No  
Diabetes Yes           No  
Hemiplegia Yes           No  
Moderate or severe renal disease Yes           No  
Renal failure Yes           No  
Diabetes with end organ damage Yes           No  
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Any tumour Yes           No  
Leukaemia  Yes           No  
Lymphoma Yes           No  
Metastatic solid tumour Yes           No  
AIDS Yes           No  
 
 
Neuropsychological problems Severe dementia or depression  
Mild dementia or depression     
No psychological problems  
  
 
Did the participant present with any of the following: 
 
Fall 
 
Yes           No  
Reduced mobility 
 
Yes           No  
New or increased continence disorder 
  
Yes           No  
Current pressure sores Yes           No  
 
Dehydration Yes           No  
 
Deteriorated cognitive skills or status in the 
past 3 months 
Yes           No  
Psychological stress or acute disease in the 
past 3 months (e.g. bereavement, moved 
Yes           No  
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home, been sick)  
 
Admission medications 
 
Drug 
 
Dose Frequency BNF chapter 
number 
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Total number of different 
prescription medications taken each 
day 
   
 
Admission/initial modified early warning score. From observations chart. Please circle. 
 
score 3 2 2 0 1 2 3 
Systolic BP (mmHg) <70 71-80 81-100 101-
199 
- >200 - 
Heart rate (bpm) - <40 41-50 51-100 101-
110 
111-
129 
>130 
Respiratory rate - <9 - 9-14 15-20 21-29 >30 
Temperature (deg C) - <35 - 35-38.4 - >38.5 - 
Conscious level (AVPU) - - - A V P U 
Urine output (ml/kg/h) anuric <0.5 <1 1-2.5 - >3  
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Appendix 6: MCOP-BMH Psychiatric Assessment Form 
                  
 
 
Mental Health Problems on Hospital Medical Wards 
Psychiatric Assessment Proforma 
Study number __________ Ward_______________     Date ______________  
 
Researcher ________________   Days since 
admission_________ 
 
Current and past psychiatric history, cognitive history (free text, not for coding; 
see Psychiatric  Diagnostic Study History Schedule ) 
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Study number ____________________ Date _______________________ 
 
Please complete following ICD-10 diagnoses 
 
1. Delirium present:   
 
definitely ; probably ; possibly ; not present ; not known ; not applicable  
 
Superimposed on dementia: definitely ; probably ; possibly ; not  
 
Cause(s) of delirium evident: yes  no   Specify 
 
Induced by alcohol or other psycho active substance: yes  no   Specify 
 
Significant behaviour problem posed in present care setting:  
mild  moderate  severe  none    
Specify: 
 
 
Hallucinations: yes  no  ; Delusions: yes  no   
Specify: 
 
 
 
 
2. Dementia present:     
definitely ; probably ; possibly ; not present ; not known ; not applicable  
 
MCI  
 
Potentially reversible cause (specify and justify):  
 
Significant behaviour problem posed in present care setting:  
mild  moderate  severe   none   
Specify: 
 
 
 
Hallucinations: yes  no  ; Delusions: yes  no   
Specify: 
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Study number ____________________ Date _______________________ 
 
3. Dementia Subtype 
 
$O]KHLPHU¶VGLVHDVHSUHVHQW 
Definitely ; probably ; possibly ; not present ; not known ; not applicable  
 
Vascular dementia disease  present:   
Definitely ; probably ; possibly ; not present ; not known ; not applicable  
 
Dementia with Lewy Bodies present:   
Definitely ; probably ; possibly ; not present ; not known ; not applicable  
 
FTD disease  present:   
Definitely ; probably ; possibly ; not present ; not known ; not applicable  
 
Mixed dementia present: Specify:    
Definitely ; probably ; possibly ; not present ; not known ; not applicable   
 
Other dementia present: Specify:    
Definitely ; probably ; possibly ; not present ; not known ; not applicable   
 
 
 
4. Depression present:       
 
Definitely  ;     probably   ;     possibly  ; not present ; not known ; not applicable 
 
 
Severity: mild  ;          moderate  ;          severe  ;      psychotic symptoms  ; 
 
Somatic syndrome: present ;    absent ; 
 
Subtype:   
 
Depressive episode  ; dysthymia ;  Recurrent depressive disorder ;  other (specify)  
 
Hypomania ; Manic episode ;   psychotic symptoms   
 
Bipolar affective disorder   
 
5. Anxiety present:  
 
definitely  probably   possibly  not present   not known   not applicable          
 
Subtype:   generalised anxiety disorder     phobic  ;  panic ;   
 
Agoraphobia ; social phobia ;  specific (isolated) phobia ;   Specify 
 
Mixed anxiety and depressive disorder ;  anxiety disorder, unspecified  
 
Obsessive-compulsive disorder ;  somatoform disorder , specify  
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Study number ____________________ Date _______________________ 
 
 
6. Delusional disorders present: 
definitely  probably   possibly  not present   not known   not applicable    
 
 
Paraphrenia; 
definitely  probably   possibly  not present   not known   not applicable    
 
 
Significant behaviour problem posed in present care setting:  
mild  moderate  severe  none    
Specify: 
 
 
 
7. Adjustment disorder present: 
definitely  probably   possibly  not present   not known   not applicable    
 
 
Somatisation disorder present: 
definitely  probably   possibly  not present   not known   not applicable    
 
 
 
 
8. Mental and behavioural disorders due to psychoactive substance use (including 
alcohol),  present:   
definitely  probably   possibly  not present   not known   not applicable  
 
Specify 
 
 
 
 
9. Other disorder present:  
Definitely  probably   possibly  not present   not known   not applicable    
 
Specify and justify : 
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Study number ____________________  Date ____________________ 
 
10. Current interventions 
5HFRUGSHUFHSWLRQRIZKDWDUHWKHWUHDWLQJWHDP¶VFXUUHQW³SV\FKLDWULFLQWHUYHQWLRQV´LI
any?) 
Drug therapy for mental health condition  yes  no   
Appropriate drug   Appropriate dose   Evidence of assessment for effectiveness   
 
 
Behavioural interventions 
Evidence of restraint:  bedrails   other   specify 
Evidence of restriction yes  no   specify 
Other yes  no   specify 
 
 Other specific interventions; specify 
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Study number ____________________  Date ____________________ 
 
11. Psychiatric Needs Assessment. Needs = potential to benefit from an 
intervention. Psychiatrist recommendations for ongoing and further care (all 
plausible).  
 
These are assessments of the immediate state of need for specialist old age psychiatric 
service made at the end of the psychiatric diagnostic assessment, taking account of the 
clinical data therein gained and of already available information otherwise gathered by the 
study. There are twin foci:  
x firstly on need for service intervention and  
x secondly on need for one of (or a variety of) possible therapeutic interventions, including 
medication prescription.  
These judgements are made by service clinicians in normal service conditions, with the 
standard expectations of service availability and resourcing to which they have been used. 
 
Service Interventions 
1] patient needs psychiatric assessment ward admission 
now (this includes MHA detention options and DoLs) 
1=yes, 2=no, 8=DK,9=N/A 
2] patient needs psychiatric assessment ward admission 
when physically fit for transfer and must have psychiatric 
nursing supplied from the psychiatric assessment ward in 
the interim until that is possible1 (includes MHA detention 
options and DoLs) 
1=yes, 2=no, 8=DK,9=N/A 
3] patient needs psychiatric assessment ward admission 
when physically fit for transfer and can  wait for this without 
such nursing (includes MHA detention options and DoLs) 
1=yes, 2=no, 8=DK,9=N/A 
4]  patient needs 2nd. or further psychiatric review in order to 
determine need for psychiatric assessment ward admission 
(includes MHA detention options and DoLs) 
1=yes, 2=no, 8=DK,9=N/A 
5] patient does not need psychiatric assessment ward 
admission now but needs further psychiatric review on ward 
further to assess progress and such possible need later 
1=yes, 2=no, 8=DK,9=N/A 
6] patient needs psychiatrist follow up by the service post 
general hospital discharge (& this does not exclude 6], 
below) 
1=yes, 2=no, 8=DK,9=N/A 
7] patient needs non-psychiatrist follow up/further/additional 
intervention by the service (e.g. CPN, clinical psychologist, 
OT, Physio.) post general hospital (GH) discharge. If so, 
1=yes, 2=no, 8=DK,9=N/A 
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specify which and more than one may be specified 
8] GP needs positively to review need for further psychiatric 
involvement post GH discharge 
1=yes, 2=no, 8=DK,9=N/A 
9] patient does not need follow up by the specialist 
psychiatric service post general hospital discharge 
1=yes, 2=no, 8=DK,9=N/A 
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Study number ________________          Date _______________ 
 
Therapeutic Interventions 
1] Suggest start or continue (without dose modification) 
antipsychotic drug 
1=yes, 2=no, 8=DK,9=N/A 
If yes, specify BNF group, drug and route of administration: BNF 
Group (Group code), BNF name, Administration route  
Code: 
Name: 
Route: oral solid/ oral liquid / im /depot /iv /pr 
2] Suggest modification of present antipsychotic drug  1=yes, 2=no, 8=DK,9=N/A 
specify BNF group, drug and route of administration: BNF Group 
(Group code), BNF name, Administration route 
Code: 
Name: 
Route: oral solid/ oral liquid /im /depot /iv /pr 
3] as 1] & 2] for Hypnotic, Anxiolytics, or Antidepressant drugs, 
drugs used for prophylaxis of bipolar disorder, drugs used in 
parkinsonism for prophylaxis or treatment of drug side effects of 
antipsychotics, drugs used for dementia, any other BNF CNS 
drugs.  
1=yes, 2=no, 8=DK,9=N/A 
Specify BNF group, drug and route of administration: BNF 
Group (Group code), BNF name, Administration route 
Code: 
Name: 
Route: oral solid/ oral liquid /im /depot /iv /pr 
 Code: 
Name: 
Route: oral solid/ oral liquid /im /depot /iv /pr 
 Code: 
Name: 
Route: oral solid/ oral liquid /im /depot /iv /pr 
4] Refer or list for team CMHT psychiatrist follow up 1=yes, 2=no, 8=DK,9=N/A 
5] Refer for team CMHT CPN follow up 1=yes, 2=no, 8=DK,9=N/A 
6] Refer for team CMHT follow up by non-CPN member 
(specify) 
1=yes, 2=no, 8=DK,9=N/A 
7] Refer for clinical psychologist assessment/intervention 1=yes, 2=no, 8=DK,9=N/A 
8] Refer for specialist psychiatric day therapy intervention 
(based in former psychiatric Day Hospital) 
1=yes, 2=no, 8=DK,9=N/A 
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Study number ________________          Date _______________ 
 
Social Interventions 
1] Refer for JackDawe team support (special multiagency 
social services-led home support for people with dementia) 
1=yes, 2=no, 8=DK,9=N/A 
2] Refer for intermediate care 1=yes, 2=no, 8=DK,9=N/A 
3] Refer for general social services support 1=yes, 2=no, 8=DK,9=N/A 
4] Suggest Care Home admission for respite/assessment 
(specify type) 
 
1=yes, 2=no, 8=DK,9=N/A 
NH   RH 
General   Dementia 
registered 
5] Suggest Care Home admission expected to be 
permanent (specify type) 
1=yes, 2=no, 8=DK,9=N/A  
NH   RH 
General   Dementia 
registered 
 
Service Improvement option 
1] Is there a modification of the present psychiatric service 
which would enable earlier or more likely discharge home? If 
so, specify 
1=yes, 2=no, 
8=DK,9=N/A 
2] Is there a modification of the present social services or of 
integrated support which would enable earlier or more likely 
discharge home? If so, specify 
1=yes, 2=no, 
8=DK,9=N/A 
3] Is there a modification of the present psychiatric service 
which would enable earlier or more likely positive therapeutic 
progress? If so, specify 
1=yes, 2=no, 
8=DK,9=N/A 
4] Is there a modification of the present general hospital 
service which would enable earlier or more likely positive 
therapeutic progress? If so, specify 
1=yes, 2=no, 
8=DK,9=N/A 
 
 
Other suggested mental health intervention 
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Appendix 7: MCOP-BMH Medical Assessment Form 
 
Study number ____________Ward___________  Day of admission assessed 
_________ 
 
Researcher ___________________________  Date ___________ 
 
1. Diagnostic assessment (include psychiatric). Include all diagnosable 
conditions of any clinical relevance. 
Certainty based on clinical judgment of evidence; active = causing problem now; potential = may 
cause problems; inactive= no current or potential problem  
Diagnosis Definite/probable/possibl
e 
Active/potential/inactive 
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Study number ____________________   
 
2. Problem list. ,QFOXGHUHOHYDQWDQGµDFWLYH¶LVVXHVLQFOXGLQJV\PSWRPV
impairments, disabilities, risks, risk factors, predispositions, behaviours, abnormal 
investigations. Broadly medical (social and environmental is next). 
Explained means credible and sufficient explanation for problem. 
Problem Explained/ diagnosed? 
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Study number ____________________  Date 
_______________________ 
 
3. Social, environmental and contextual issues. Relationships, carer strain, 
available family and external help, accommodation, prior adaptations, use of aids, 
broad financial situation 
 
Issue 
Accommodation/adaptations/ physical environment 
 
 
 
 
 
 
 
 
 
 
Social and family support, including statutory 
 
 
 
 
 
 
 
 
Finance and resources, including aids, appliances, car 
 
 
 
 
 
 
 
 
 
 
Other 
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Study number ____________________   
 
4. Current interventions. Multi professional. Include evidence of 
communication/explanation/decision making/discharge planning 
 
Intervention 
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Study number ____________________   
 
4a. Interventions. List drugs started and stopped. 
 
Drugs started 
Drug Dose frequenc
y 
Length of course 
(estimate, state if 
ongoing) 
    
    
    
    
    
    
    
    
    
 
 
Drugs stopped 
Drug Dose frequenc
y 
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Study number ____________________   
 
5. Needs. Geriatrician recommendations for ongoing and further care. Include 
communication /explanation/decision making/discharge planning 
 
Proposed intervention Who 
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Appendix 8: MCOP-BMH Outcome Questionnaire 
 
6WXG\,'««««« 
 
 
dŽĚĂǇ ?ƐĚĂƚĞ P? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? 
 
Is this form being completed by interview with the patient participant directly? 
  
Please tick one box 
 Yes ?ďǇŝŶƚĞƌǀŝĞǁǁŝƚŚƉĂƚŝĞŶƚƉĂƌƚŝĐŝƉĂŶƚĂůŽŶĞ ? ?  
 Yes, by ŝŶƚĞƌǀŝĞǁǁŝƚŚƉĂƚŝĞŶƚƉĂƌƚŝĐŝƉĂŶƚĂŶĚĐĂƌĞƌũŽŝŶƚůǇ ? ?  
 No, it is being completed by interview with:   
  WĂƚŝĞŶƚ ?Ɛ ŚƵƐďĂŶĚŽƌǁŝĨĞ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
  AŶŽƚŚĞƌƌĞůĂƚŝǀĞ ?ƉůĞĂƐĞƐƉĞĐŝĨǇŝŶƚŚĞďŽǆďĞůŽǁ ? ? ? ? ?  
   
 
 
  A ĨƌŝĞŶĚ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
  A ƉĂŝĚĐĂƌĞƌ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
  AŶǇŽƚŚĞƌ ?ƉůĞĂƐĞƐƉĞĐŝĨǇŝŶƚŚĞďŽǆďĞůŽǁ ? ? ? ? ? ? ? ? ?  
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This section is to be completed by direct interview with the patient 
participant only 
 
A. Cognition: Will you do a memory test for me? 
 
[MMSE] 
ORIENTATION 
What is the year, season, month, date, day  / 5 
Where are we: country, county, town, hospital, ward /5 
MEMORY REGISTRATION 
Examiner names 3 objects (apple, table, penny) 
Patient asked to repeat the 3 names  W score one for each correct answer 
Then patient to learn 3 names (i.e. repeat until correct) 
 
/3 
ATTENTION AND CALCULATION 
Subtract 7 from 100, then repeat from result etc. Stop after 5. 
100     93     86     79     72     65 
 ?ůƚĞƌŶĂƚŝǀĞůǇ ?ƐƉĞůů “ǁŽƌůĚ ?ďĂĐŬǁĂƌĚƐ ?>ZKt ? 
/5 
RECALL 
Ask for 3 objects learnt earlier /3 
LANGUAGE 
Name a pencil and watch /2 
ZĞƉĞĂƚ “EŽ ?ŝĨƐ ?ĂŶĚƐ ?ŽƌďƵƚƐ ? /1 
 160 
 
Give a 3-stage command. Score one point for each correct stage. 
 ?Ğ ?Ő ? “ƚĂŬĞƚŚĞƉĂƉĞƌŝŶǇŽƵƌƌŝŐŚƚŚĂŶĚ ?ĨŽůĚŝƚŝŶƚǁŽĂŶĚƉƵƚŝƚŽŶƚŚĞĨůŽŽƌ ? ?
 
 
/3 
ƐŬƚŚĞƉĂƚŝĞŶƚƚŽƌĞĂĚĂŶĚŽďĞǇĂǁƌŝƚƚĞŶĐŽŵŵĂŶĚŽŶĂƉŝĞĐĞŽĨƉĂƉĞƌ ?ƐƚĂƚŝŶŐ P “ĐůŽƐĞǇŽƵƌ
ĞǇĞƐ ? ?
/1 
Ask the patient to write a sentence. Score if it is sensible and has a subject and a verb. 
 
 
 
 
 
/1 
 
COPYING 
Ask the patient to copy a pair of intersecting pentagons 
 
 
 
 
/1 
TOTAL SCORE /30 
 
 
 161 
 
 
B. DEMQoL Quality of life. Now I would like to ask about how you find life at present. Look at 
the card to choose which answer describes how you feel. 
 
 
First, / ?ŵŐŽŝŶŐƚŽĂƐŬǇŽƵĂďŽƵƚyour feelings ?/ŶƚŚĞůĂƐƚǁĞĞŬ ?ŚĂǀĞǇŽƵĨĞůƚ ? ? ? 
 
,ĂǀĞǇŽƵĨĞůƚ ? 
1. Cheerful?** A 
lot 
ප Quite a 
bit 
ප A 
little 
ප Not at 
all 
ප 
2. Worried or anxious?  A 
lot 
ප Quite a 
bit 
ප A 
little 
ප Not at 
all 
ප 
3. That you are enjoying life? ** A 
lot 
ප Quite a 
bit 
ප A 
little 
ප Not at 
all 
ප 
4. Frustrated? A 
lot 
ප Quite a 
bit 
ප A 
little 
ප Not at 
all 
ප 
5. Confident?** A 
lot 
ප Quite a 
bit 
ප A 
little 
ප Not at 
all 
ප 
6. Full of energy?** A 
lot 
ප Quite a 
bit 
ප A 
little 
ප Not at 
all 
ප 
7. Sad? A 
lot 
ප Quite a 
bit 
ප A 
little 
ප Not at 
all 
ප 
8. Lonely? A 
lot 
ප Quite a 
bit 
ප A 
little 
ප Not at 
all 
ප 
9. Distressed? A 
lot 
ප Quite a 
bit 
ප A 
little 
ප Not at 
all 
ප 
10. Lively? ** A 
lot 
ප Quite a 
bit 
ප A 
little 
ප Not at 
all 
ප 
11. Irritable? A 
lot 
ප Quite a 
bit 
ප A 
little 
ප Not at 
all 
ප 
12. Fed-up? A ප Quite a ප A ප Not at ප 
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lot bit little all 
13. That there are things that you 
ǁĂŶƚĞĚƚŽĚŽďƵƚĐŽƵůĚŶ ?ƚ ?
A 
lot 
ප Quite a 
bit 
ප A 
little 
ප Not at 
all 
ප 
 
Now ?/ ?ŵŐŽŝŶŐƚŽĂƐŬǇŽƵĂďŽƵƚyour memory. In the last week, how worried have you been 
ĂďŽƵƚ ? 
How worried hĂǀĞǇŽƵďĞĞŶĂďŽƵƚ ? 
1
4. 
Forgetting things that happened 
recently?    
A 
lot 
ප Quite a bit ප A 
little 
ප Not at 
all 
ප 
1
5. 
Forgetting who people are? A 
lot 
ප Quite a bit ප A 
little 
ප Not at 
all 
ප 
1
6. 
Forgetting what day it is? A 
lot 
ප Quite a bit ප A 
little 
ප Not at 
all 
ප 
1
7. 
Your thoughts being muddled? A 
lot 
ප Quite a bit ප A 
little 
ප Not at 
all 
ප 
1
8. 
Difficulty making decisions?   A 
lot 
ප Quite a bit ප A 
little 
ප Not at 
all 
ප 
1
9. 
Poor concentration? A 
lot 
ප Quite a bit ප A 
little 
ප Not at 
all 
ප 
 
EŽǁ ?/ ?ŵŐŽŝŶŐƚŽĂƐŬǇŽƵĂďŽƵƚǇŽƵƌeveryday life. In the last week, how worried have you been 
ĂďŽƵƚ ? ? 
How worried hĂǀĞǇŽƵďĞĞŶĂďŽƵƚ ? 
20. Not having enough money? A 
lot 
ප Quite a 
bit 
ප A 
little 
ප Not at 
all 
ප 
21. How you get on with people 
close to you? 
A 
lot 
ප Quite a 
bit 
ප A 
little 
ප Not at 
all 
ප 
22. Getting the affection you 
want? 
A 
lot 
ප Quite a 
bit 
ප A 
little 
ප Not at 
all 
ප 
23. People not listening to you? A 
lot 
ප Quite a 
bit 
ප A 
little 
ප Not at 
all 
ප 
24. Making yourself understood? A 
lot 
ප Quite a 
bit 
ප A 
little 
ප Not at 
all 
ප 
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25. Getting help when you need it? A 
lot 
ප Quite a 
bit 
ප A 
little 
ප Not at 
all 
ප 
26. Getting to the toilet in time? A 
lot 
ප Quite a 
bit 
ප A 
little 
ප Not at 
all 
ප 
27. How you feel in yourself? A 
lot 
ප Quite a 
bit 
ප A 
little 
ප Not at 
all 
ප 
28. Your health overall? A 
lot 
ප Quite a 
bit 
ප A 
little 
ප Not at 
all 
ප 
 
tĞ ?ǀĞalready talked about lots of things: your feelings, memory and everyday life. Thinking about 
ĂůůŽĨƚŚĞƐĞƚŚŝŶŐƐŝŶƚŚĞůĂƐƚǁĞĞŬ ?ŚŽǁǁŽƵůĚǇŽƵƌĂƚĞ ? ? 
2
9. 
Your quality of life overall?               
**    
Very good ප Goo
d 
ප Fair ප Poor ප 
**items that need to be reversed before scoring 
 
C. Some questions about things that make life worthwhile (use cue cards) 
[ICECAP] 
1.  Thinking about love & friendship, which describes you?     
I can have all of the love and friendship that I want    
4 
 
 ?a lot of the love and friendship that I want   3  
  ?a little of the love and friendship that I want    2  
I cannot have any of the love and friendship that I want   1  
 
    
2. Thinking about the future, which describes you?     
I can think about the future without any concern   4  
 ? with only a little concern   3  
 ? with some concern   2  
 ? with a lot of concern   1  
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3. Are you able to do things that make you feel valued?     
I am able to do all of the things that make me feel valued   4  
  ? many of the things that make me feel valued   3  
 ? a few of the things that make me feel valued    2  
I am unable to do any of the things that make me feel valued    1  
     
4. Thinking about enjoyment and pleasure, which describes you?     
I can have all of the enjoyment and pleasure that I want   
4 
 
 ? a lot of the enjoyment and pleasure that I want   
3  
 ? a little of the enjoyment and pleasure that I want   
2  
I cannot have any of the enjoyment and pleasure that I want    
1  
   
  
     
5. Thinking about independence, which describes you?     
I am able to be completely independent   
4 
 
 ? independent in many things   
3  
 ? independent in a few things   
2  
I am unable to be at all independent    
1  
     
 
© Joanna Coast & Terry Flynn 
 
This section is to be completed by interview with the patient participant 
and/or carer on their behalf 
 
 
D. Activities of daily living. Some questions about everyday activities. Please score what the 
person has actually done in the last week or so.  
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 [Barthel index]  
How do they manage 
with grooming? 
Needs help with personal care 0  
Independent face/hair/teeth/shaving (implements 
provided) 
1 
How do they manage 
with eating? 
Unable 0  
Needs help cutting, spreading butter etc. 1 
Independent (food provided in reach) 2 
How do they manage 
with dressing? 
Dependent 0  
Needs help but can do about half unaided 1 
Independent (including buttons, zips, laces etc.) 2 
How do they manage 
with bathing? 
Dependent 0  
Independent (or in shower) 1 
How do they manage 
using the toilet? 
Dependent 0 
1 
2 
 
Needs some help but can do something alone 
Independent (on and off, dressing, wiping) 
How do they manage 
with their bladder? 
Incontinent or catheterised and unable to manage 0  
Occasional accident (max once per 24 hours) 1 
Continent (for over 7 days) 2 
How do they manage 
with their bowels? 
Incontinent (or needs to be given enema) 0  
Occasional accident (once per week) 1 
Continent 2 
How do they manage 
with transferring? 
Unable - no sitting balance 0  
Major help (one or two people, physical) can sit 1 
Minor help (verbal or physical) 2 
Independent 3 
How do they manage 
with mobility? 
Immobile 0  
Wheelchair independent including corners etc. 1 
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Walks with help of one person (verbal or physical) 2 
Independent (but may use any aid e.g. stick) 3 
How do they manage 
with stairs? 
Unable 0  
Needs help (verbal, physical, carrying aid) 1 
Independent up and down 2 
 
 
E. EQ5D quality of life. Some more questions about everyday activities. Rate as far as possible 
using information already collected. 
  
 
 
1. Mobility  
Please tick one box 
 /ĂŵĐŽŶĨŝŶĞĚƚŽďĞĚ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
 I have some problems in walking ĂďŽƵƚ ? ? ? ? ? ? ? ? ? ? ?  
 /ŚĂǀĞŶŽƉƌŽďůĞŵƐǁĂůŬŝŶŐĂďŽƵƚ ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
2. Self care  
Please tick one box 
 /ĂŵƵŶĂďůĞƚŽǁĂƐŚŽƌĚƌĞƐƐŵǇƐĞůĨ ? ? ? ? ? ? ? ? ? ? ? ? ?  
 /ŚĂǀĞƐŽŵĞƉƌŽďůĞŵƐŝŶǁĂƐŚŝŶŐŽƌĚƌĞƐƐŝŶŐ ? ? ? ? ? ? ?  
 I have no-problems with looking after ŵǇƐĞůĨ ? ? ? ? ? ? ? ? ?  
 
3. Usual activities (e.g. housework, leisure, family)?   
Please tick one box 
 /ĂŵƵŶĂďůĞƚŽƉĞƌĨŽƌŵŵǇƵƐƵĂůĂĐƚŝǀŝƚŝĞƐ ? ? ? ? ? ? ? ? ? ?  
 /ŚĂǀĞƐŽŵĞƉƌŽďůĞŵƐƉĞƌĨŽƌŵŝŶŐŵǇƵƐƵĂůĂĐƚŝǀŝƚŝĞƐ ? ? ? ? ?  
 I have no problems performing my usual ĂĐƚŝǀŝƚŝĞƐ ? ? ? ? ? ? ?  
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4. Pain / Discomfort: Do you currently have any pain or discomfort?  
  Please tick one box 
 /ŚĂǀĞŶŽƉĂŝŶŽƌĚŝƐĐŽŵĨŽƌƚ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
 /ŚĂǀĞŵŽĚĞƌĂƚĞƉĂŝŶŽƌĚŝƐĐŽŵĨŽƌƚ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
 I have extreme ƉĂŝŶŽƌĚŝƐĐŽŵĨŽƌƚ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  
 
5. Anxiety / Depression 
  Please tick one box 
 /ĂŵŶŽƚĂŶǆŝŽƵƐŽƌĚĞƉƌĞƐƐĞĚ ? ? ? ? ? ? ? ? ? ? ? ? ?  
 /ĂŵŵŽĚĞƌĂƚĞůǇĂŶǆŝŽƵƐŽƌĚĞƉƌĞƐƐĞĚ ? ? ? ? ? ? ? ? ?  
 /ĂŵĞǆƚƌĞŵĞůǇĂŶǆŝŽƵƐŽƌĚĞƉƌĞƐƐĞĚ ? ? ? ? ? ? ? ? ? ? ?  
 
 
F. Questions about the effect of health problems on everyday life 
 
 
I am going to ask some questions about how health problems affect your everyday life.  
I want to know about:  
x what you do in practice, 
x with any kind of help you usually have available, 
x compared with other people of your age and background. 
 
[Tick one level for each section, stop when you have identified the right level. If necessary, ask 
supplementary questions to clarify. A proxy can answer if the subject is unable to do so. In that 
casĞ ‘ǇŽƵ ?ƐŚŽƵůĚďĞƌĞĂĚĂƐ ‘ŚĞ ?ƐŚĞ ? ?tĞĂƌĞŝŶƚĞƌĞƐƚĞĚŝŶ ‘ƵƐƵĂů ?ƌĞĐĞŶƚĂďŝůŝƚǇ ?ǁŚŝĐŚĐĂŶďĞ
taken as over the last month] 
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[London Handicap Scale; mobility] 
1. How well are you able to go where you want to go, using any help or means of transport you usually 
have available? Exclude journeys to hospital. 
Please tick one box 
A
. 
Can you go everywhere you want to, no matter how far away? Yes, Level 1  
 If no, ask question B  
B
. 
Do you get out of the house? Yes, Level 2  
  No, Level 3  
 
[Physical independence] 
2. How well are you able to look after yourself? Include things like shopping, housework, cooking, 
getting to the toilet and getting dressed. 
Please tick one box 
A
. 
Do you do almost everything to look after yourself that someone like you 
would be expected to do? You need no more than a little help now and 
again. 
Yes, Level 1  
 If no, ask question B  
B
. 
Do you need help to be available all the time? You cannot be left alone 
safely. 
No, Level 2  
  Yes, Level 3  
 
[Occupation]. 
3. Next, I am interested in work and leisure activities, which includes any paid work, housework, 
gardening, visiting people, hobbies, watching TV; anything you do to occupy your time. 
Please tick one box 
A
. 
Do you do everything you want or need to do, that someone like you 
would be able to do? 
Yes, Level 1  
 If no, ask question B  
 169 
 
B
. 
Are there are times, when you would like to be occupied, that you do 
nothing? 
No, Level 2  
  Yes, Level 3  
 
[Social integration].           
4. Next, I want to know if your health stops you getting on with people, including family, friends, and 
people you might meet during a normal day. 
Please tick one box 
A
. 
Do you get on well with people, see everyone you want to see, and meet 
new people? 
Yes, Level 1  
 If no, ask question B  
B
. 
ŽǇŽƵĨŝŶĚŝƚĚŝĨĨŝĐƵůƚƚŽŐĞƚŽŶǁŝƚŚƉĞŽƉůĞǁŚŽǇŽƵĚŽŶ ?ƚŬŶŽǁǁĞůů ?
Maybe you see no-one except close family or the people who look after 
you. 
No, Level 2  
  Yes, Level 3  
 
[Awareness] 
5. Next, awareness of your surroundings. Assume you are using your usual glasses or hearing aid 
Please tick one box 
A
. 
Do you see, hear, speak and think clearly, and have a good memory? Yes, Level 1  
 If no, ask question B  
B
. 
Do you have problems with hearing, speaking, seeing or your memory, 
which makes life difficult most of the time?   
No, Level 2  
  Yes, Level 3  
 
[Economic self sufficiency]  
6. Finally, affording things you need.  
Please tick one box 
A
. 
Can you afford everything you need, including anything you need to buy 
because of ill-health or disability?  
Yes, Level 1  
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 If no, ask question B  
B
. 
Do you find it difficult to afford your most basic needs? You cannot afford 
things you need because of ill health. 
No, Level 2  
  Yes, Level 3  
              
G. Client Service Receipt Inventory 
 
 
1. Have you been in hospital during the past 6 months? 
(include index admission) 
Yes           No  
If yes, please list the dates and hospital 
Dates Hospital 
From To   
   
   
   
   
 
2. Have you been in a care home, either for respite or permanent 
care during the past 6 months? 
Yes           No  
If yes, please list the dates, place and whether for respite or permanent care 
Dates Care Home Respite / Permanent 
From To    
    
    
    
    
 
Part One: Participant Schedule 
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A. PARTICIPANT ACCOMMODATION 
 
1. Usual place of residence during the last 
six months? 
Owner occupied house/flat 1 
Privately rented house/flat 2 
House/flat rented from housing 
associated/local authority 
3 
(Also complete Question 3) Sheltered housing/warden control 4 
Residential home 5 
Nursing home 6 
Acute psychiatric ward 7 
Rehabilitation ward 8 
General medical ward 9 
Other:_________________________ 10 
 
2. 
 
 
Has (participant) lived anywhere else 
during the last six months? 
No 0 
Yes  1 
 
If yes, Accommodation type: 
 
1=Owner occupied house/flat 
2=Privately rented house/flat 
3=House/flat rented from housing 
associated/local authority 
4=Sheltered housing/warden control 
5=Residential home 
6=Nursing home 
7=Other ______________________ 
 
Code Approximate number of nights spent 
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Only complete if Question 1 is coded 4 to 10 
3
a. 
Organisation managing facility Local authority social services 1 
NHS 2 
Private (for-profit) 3 
Voluntary (non-profit) 4 
Other: _________________________ 5 
 
3
b. 
(Participants) ?ƐƚŽƚĂůĐŽŶƚƌŝďƵƚŝŽŶƚŽ
weekly charge for facility 
  
£. 
 
 
3
c. 
Who contributes towards placement 
(circle all that apply) 
DSS 1 
NHS 2 
Local authority 3 
Voluntary organisation 4 
Participant 5 
WĂƌƚŝĐŝƉĂŶƚ ?ƐĨĂŵŝůǇ 6 
Insurance policy 7 
Other: _________________________ 8 
 
 
B. PARTICIPANT SERVICE RECEIPT 
 
4a. Hospital services used over the last six months 
(include normal accommodation given in Question 1) 
 Service Name of Reason for using Unit of Total 
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ward / 
clinic / 
hospital / 
centre 
service 
(eg nature of 
illness, regular 
respite 
arrangement) 
measurement number 
of units 
received 
 Day hospital   Day 
attendance 
 
 Accident and 
Emergency 
  Attendance  
 Outpatient services   Appointment 
 
 
 Psychiatric inpatient 
ward 
  Inpatient day  
 Other inpatient ward   Inpatient day 
 
 
 Other : 
________________ 
    
____________ 
 
 
4b. Day services used over the last six months 
(do not include any day service provided by the accommodation facility 
in which the participant is currently living) 
 Service  Name of 
centre/service  
Unit of 
measurement 
Total 
number 
of units 
received 
 Day care: 
  
Local authority 
social services 
department  
 Days  
 Day care: Voluntary 
organisation 
 Days  
      
 Lunch club  Visits   
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 Social club  Visits  
 
 
 Other : 
_______________________ 
   
____________ 
 
 
4c. Community  ? based services used over the last six months 
(do not include services provided by people employed directly by the accommodation facility in 
which the participant is currently living) 
Service 
(do not include 
outpatient 
services) 
Type of visit  Provider agency  Total 
number 
of 
contacts 
(Round 
to 
nearest 
whole 
number) 
Average 
duration 
of each 
contact 
(minutes) 
(Round to 
nearest 
whole 
number) 
D
o
m
ic
il
ia
ry
 
O
ff
ic
e
  
H
e
a
lt
h
 s
e
rv
ic
e
 
Lo
ca
l a
u
th
o
ri
ty
 
V
o
lu
n
ta
ry
 o
rg
a
n
is
a
ti
o
n
 
P
ri
v
a
te
 o
rg
a
n
is
a
ti
o
n
 
i) Consultant, non 
psychiatrist 
0  1 2 3 4   
ii) General 
practitioner 
0 1 1 2 3 4   
iii) Practice nurse 
(GP clinic) 
0 1 1 2 3 4   
iv) District Nurse 0 1 1 2 3 4   
v) Health visitor 0 1 1 2 3 4   
vi) CPN/CMHN 0 1 1 2 3 4   
vii) Cardiac nurse 0 1 1 2 3 4   
viii) Continence 
nurse 
0 1 1 2 3 4   
ix) Occupational 
therapist 
0 1 1 2 3 4   
x) Community 
psychiatrist 
0 1 1 2 3 4   
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xi) Psychologist 0 1 1 2 3 4   
xii) Care manager 0 1 1 2 3 4   
xiii) Social worker 0 1 1 2 3 4   
          
xv) Care assistant 0 1 1 2 3 4   
xvi) Chiropodist  0 1 1 2 3 4   
xvii) Sitting scheme 0 1 1 2 3 4   
xviii) Self-help group 0 1 1 2 3 4   
xix) Meals on 
wheels 
0 1 1 2 3 4  No of 
days 
xx) Laundry service 0 1 1 2 3 4   
xxi) Dentist 0 1 1 2 3 4   
xxii) Optician 0 1 1 2 3 4   
xxiii) Counsellor 0 1 1 2 3 4   
xxiv) Physiotherapist 0 1 1 2 3 4   
xxv) Other doctor 0 1 1 2 3 4   
 
Other community-based services: 
 
xxvi) _____________ 0 1  1 2 3 4    
xxvii) _____________ 0 1 1 2 3 4   
xxviii) _____________ 0 1 1 2 3 4   
xxix) _____________ 0 1 1 2 3 4   
 
 
Part Two: Carer Schedule 
 
All the questions below relate only to the last six months. 
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 ?ZZ ?^DW>KzDEd 
5. Regular employment status 
(Circle one only) 
Paid employment 1 
Retired 2 
Housewife / husband 3 
Unemployed / Student 4 
Full time carer 5 
6. Cut down on paid work in order to 
provide care for (participant). 
No 0 
(Also complete Question 7 and 8) Reduced hours 1 
Given up work 2 
   
By how many hours per week? 
(Only if reduced hours or given up work) 
 
KŶůǇĐŽŵƉůĞƚĞŝĨŝŶ “WĂŝĚŵƉůŽǇŵĞŶƚ ? 
7. Most recent occupation type 
(State main type if more than one) 
Manager / administrator 1 
Professional 2 
Associate professional 3 
Clerical worker / Secretary 4 
Skilled labourer 5 
Services / Sales 6 
Factory worker 7 
Other: ________________________ 8 
KŶůǇĐŽŵƉůĞƚĞŝĨŝŶ “WĂŝĚŵƉůŽǇŵĞŶƚ ? 
8. Total number of paid hours per week 
(Round to the nearest whole number) 
 
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 ?ZZ ?^ACCOMMODATION 
 
9. Usual place of residence during the last 
six months? 
Owner occupied house/flat 1 
Privately rented house/flat 2 
House/flat rented from housing 
associated/local authority 
3 
Sheltered housing/warden control 4 
Residential home 5 
Nursing home 6 
Other: ________________________ 7 
 
 
E. TIME SPENT WITH PARTICIPANT BY PRINCIPAL CARER (i.e. Informant) 
 
10a. Normally live with the participant No 0 
Yes 1 
 
10b. If No: 
How many hours are spent giving care 
to the participant each week? 
(Round to the nearest whole number) 
 
10c. If Yes: 
On a typical day, how much of the time 
can you leave the participant at home 
alone? 
Less than 25% of the time 1 
Between 25% and 49% of the time 2 
Between 50% and 74% of the time 3 
Between 75% and 100% of the time 4 
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F. TIME SPENT WITH PARTICIPANT BY OTHER INFORMAL CARERS 
 
11a. Do any other people (eg friends and 
relatives) regularly provide help for the 
participant 
No 0 
Yes 1 
 
11b.  If Yes: 
In an average/typical week, what is the 
total number of hours these people 
spend caring for the participant? 
(Round to the nearest whole number) 
 
 
12a. Have any friends or relatives taken 
time off paid work (over the past three 
months) to help with care giving? 
No 0 
Yes 1 
 
12b. If Yes: 
Estimate the total number of days 
taken off work? 
(Round to the nearest whole number) 
 
 
The end - thank you 
 
 
